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Abstract 
My MAE was undertaken at the South Australian Health and Medical Research Institute 
(SAHMRI), during 2018-2019. My studies focussed on the health and wellbeing of adolescent 
and young Aboriginal and Torres Strait Islander peoples, with the exception of my outbreak 
project. My studies included:  
Analysis of public health dataset – A retrospective study of South Australian adolescents aged 
10-24 years utilising data from the Integrated South Australian Activity Collection dataset.
The aim of the study was to assess leading causes and trends in hospital separations among
adolescents in South Australia (SA) between 2006 and 2015, by sex, age groups and
Aboriginal status. Counts and proportions of leading causes of separation were calculated as
age-standardised rates and negative binominal regression was used to assess trend over
time.
Epidemiological study – Let’s Talk About It 2019, an online survey of sexual health, 
knowledge, behaviours and access to health services for sexually transmitted infections (STI) 
and bloodborne viruses (BBV), amongst young South Australians aged 16-29 years, both 
Aboriginal and Torres Strait Islander and non-Indigenous. Descriptive analysis, univariate and 
adjusted logistic regression models were used to determine whether socio-demographic 
characteristics and sexual risk behaviours were associated with specific behaviours.  
Evaluation of a public health surveillance system – The preliminary evaluation of the ATLAS 
Aboriginal and Torres Strait Islander Sexual Health Surveillance Network – a national sentinel 
surveillance system within Aboriginal community-controlled health services (ACCHS). The 
evaluation of ATLAS involved a document review, stakeholder interviews and analysis of 
ATLAS data using the Centers for Disease Control and Prevention (United States of America) 
Updated Guidelines for Evaluating Public Health Surveillance Systems. I assessed the 
following attributes: acceptability, simplicity, flexibility, data quality, representativeness, 
timeliness, stability, and usefulness.  
Outbreak investigation – An epidemiological investigation and a retrospective case-control 
study of an outbreak of Salmonella Havana in alfalfa sprouts, in Adelaide. The outbreak was 
conducted during June and July 2018 with colleagues from SA Health. Investigations 
identified the most likely source to be alfalfa sprouts. Public health action lead to a consumer 
level recall of all alfalfa sprout products and public health alert.  
iv 
Teaching – This chapter outlines two teaching sessions, (i) a teaching session to first year 
MAE scholars, on a Single Overarching Communication Outcome (SOCO) in relation to the 
communication of a public health message; and (ii) a Lessons From the Field to my fellow 
scholars, on ‘Conducting research with Aboriginal and Torres Strait Islander communities’.
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Chapter 1. Introduction and overview of my Master of 
Philosophy in Applied Epidemiology experience  
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1.1. Acknowledgement  
I would like to acknowledge Aboriginal and Torres Strait Islander people as the oldest 
continuous living culture in the world and recognise the diversity that existing among 
Aboriginal and Torres Strait Islander people. I would like to also acknowledge elders, past, 
present and future, for your knowledge and authority, and unwavering resolve for our 
people. Finally, Iwould like to acknowledge the Aboriginal and Torres Strait Islander people 
who have informed or contributed to this thesis, or who this thesis is about. 
1.2. Positioning and standpoint  
As a Nurrunga and Ngarrindjeri man from South Australia, I have a deep connection to this 
country. My sense of belonging to country and its peoples is the driving force behind what I 
do and what I want my mob to achieve. It is central to who I am as a person and shapes my 
beliefs and values and how I see the world.  
My concept of health and wellbeing has been shaped by my lived experience and those of 
my family and community, and is articulated perfectly by the aunties and uncles who drafted 
the 1989 National Aboriginal Health Strategy and defined Aboriginal and Torres Strait 
Islander health as;  
[N]ot just the physical wellbeing of an individual but refers to the social, emotional 
and cultural wellbeing of the whole Community in which each individual is able to 
achieve their full potential as a human being, thereby bringing about the total 
wellbeing of their Community. It is a whole-of-life view and includes the cyclical 
concept of life-death-life. (1)  
Furthermore, my concept of health and wellbeing is guided by the Universal Declaration of 
Human Rights and the United Nations Declaration on the Rights of Indigenous Peoples. 
The Universal Declaration of Human Rights, Article 25 (1) states,  
Everyone has the right to a standard of living adequate for the health and well-being 
of himself and of his family, including food, clothing, housing and medical care and 
necessary social services, and the right to security in the event of unemployment, 
sickness, disability, widowhood, old age or other lack of livelihood in circumstances 
beyond his control. (2) 
The United Nations Declaration on the Rights of Indigenous Peoples, Articles 21 (1) & 24 (2) 
states,  
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Indigenous peoples have the right, without discrimination, to the improvement of 
their […], health…. 
Indigenous individuals have an equal right to the enjoyment of the highest attainable 
standard of physical and mental health. (3)  
These documents enshrine and promote the right to a common standard of health and 
wellbeing that should be afforded to all humans and informs the practice of a human rights-
based approach to health, which is a guiding principle in many aspects of Aboriginal and 
Torres Strait Islander health and wellbeing, which I support.   
My motivation in pursuing the Master of Philosophy in Applied Epidemiology (MAE) builds 
on my innate determination to make a difference. The MAE has broadened my knowledge 
base and provided opportunities to utilise applied epidemiology in my pursuit to improve 
the health and wellbeing of Aboriginal and Torres Strait Islander people and future 
generations.  
1.3. Aboriginal and Torres Strait Islander people  
Throughout this thesis I use the terms Aboriginal and Torres Strait Islander. Within the 
context of South Australia (SA), I used the preferred term Aboriginal to refer to the original 
inhabitants of SA (Chapter 2); however, I also used the term Aboriginal and or Torres Strait 
Islander to refer to those individuals who have identify as such in Chapter 3. Within the 
national context, where appropriate I have used the term Aboriginal and Torres Strait 
Islander (Chapter 4). 
1.4. Field placement  
My MAE placement was at the Wardliparingga Aboriginal Health Equity theme at SAHMRI. 
Within Wardliparingga, I undertook my projects with the Sexual Health and Wellbeing, and 
the Population Health platforms.  
The Sexual Health and Wellbeing platform is led by Professor James Ward, a descendent of 
the Pitjantjatjara and Nurrunga clans of Central and South Australia; whose research 
program aims to address disparities existing between Aboriginal and non-Aboriginal 
Australians across sexual health, blood borne viruses and alcohol and illicit drug use, with a 
focus on research engaging strength-based approaches and existing agency within 
communities.  
The Population Health platform is led by Dr Odette Pearson, an eastern Kuku Yalanji and 
Torres Strait Islander women from North Queensland. The platform utilises epidemiological 
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monitoring and data sciences to measure health inequalities, with a focus on the use of 
administrative data to support Aboriginal services and government agencies to better handle 
and understand existing data sources, and adequately manage and curate data of relevance 
to Aboriginal and Torres Strait Islander health and social outcomes in a culturally appropriate 
manner. In addition to my time at SAHMRI, I also spent time at the Communicable Disease 
Control Branch, Department of Health and Aging (SA Health), SA, where I conducted my 
outbreak investigation project. 
In addition, to the projects presented in this thesis, I had two opportunities throughout my 
MAE to apply epidemiology in the field. The first opportunity was as a volunteer 
epidemiologist at the Australian Jamboree 2019, hosted by Scouts SA and held at Tailem 
Bend, SA. Over the course of five days, I was immersed in the frenzy that was Jamboree. I 
was engaged with the medical team and the health and safety team; spent a morning with 
an Environmental Health Officer from the local council inspecting food outlets, food storage 
facilities, the pool and toilet and shower facilities at Jamboree; and assisted with the 
investigation of unwell participants who had experienced vomiting and diarrhoea. It was 
later reported that several of the unwell participants had norovirus, however, many of the 
others were related to heat exhaustion and dehydration.  
The second opportunity for shoe-leather epidemiology was 19 days spent in Samoa, as a 
team leader for the Surveillance and Monitoring to Eliminate Lymphatic Filariasis and Scabies 
from Samoa: SaMELFS Samoa project. I was involved in the mosquito survey component of 
the study and was responsible for supervision of SaMELFS field members including both 
Australian and Samoan Red Cross team members. This included overseeing the preparation 
for each village visit and trap setting, collections and sorting and pooling of mosquitoes in 
the laboratory; data management, including checking for completeness and cleaning of data; 
management of finances and payments for accommodation, vehicle hire and petrol, 
allowances for Samoan Red Cross workers, and supplies; and reporting to project leaders, 
including drafting of a weekly report. It was a fantastic learning opportunity. Although I learnt 
a lot, I also strengthened skills that I had previously acquired from other fieldwork, research 
and projects. However, it was my soft skills that I developed the most. I am thankful for this 
experience. It is opportunities such as this that provide invaluable experiences as a MAE 
scholar and as an epidemiologist, it has enriched my overall MAE experience. 
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1.5. Thesis structure and competencies  
This thesis meets the core competency of the MAE in the subsequent chapters, as listed in 
Table 1.1. Chapter two presents a retrospective study of South Australian adolescents aged 
10-24 years using data from the Integrated South Australian Activity Collection dataset. The 
aim of the study was to assess leading causes and trends in hospital separations among 
adolescents in SA between 2006 and 2015, by sex, age groups and Aboriginal status. Counts 
and proportions of leading causes of separation were calculated as age-standardised rates 
and negative binominal regression was used to assess trend over time. This study fulfils the 
requirements of analysis of a public health dataset and was presented at three separate 
conferences.  
TABLE 1.1: SUMMARY OF CORE COMPETENCIES, MASTER OF PHILOSOPHY IN APPLIED EPIDEMIOLOGY 
 Chapter 2  Chapter 3  Chapter 4  Chapter 5  Chapter 6 
Field projects      
Analyse a public health 
dataset  X     
Conduct an epidemiological 
study  X    
Evaluate a surveillance 
system   X   
Investigate an acute public 
health problem    X  
Additional requirements      
Complete a literature 
review    X   
Report to a non-scientific 
audience     X  
Publish a peer review 
journal article     X  
Complete an oral 
presentation  X     
Teaching      
Lessons from the field     X 
Teaching to the first year 
MAEs     X 
 
Chapter three explores the results of Let’s Talk About It 2019. An online survey of sexual 
health, knowledge, behaviours and access to health services in relation to sexually 
transmitted infections (STI) and bloodborne viruses (BBV) amongst young South Australians 
aged 16-29 years, both Aboriginal and/or Torres Strait Islander and non-Indigenous. 
Descriptive analysis, univariate and adjusted logistic regression models were used to 
determine whether socio-demographic characteristics and sexual risk behaviours were 
associated with specific behaviours. This study fulfils the requirements of conducting an 
epidemiological study.  
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Chapter four fulfils the requirements of evaluating a surveillance system. The preliminary 
evaluation of the ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance 
Network – a national sentinel surveillance system within ACCHS. The evaluation of ATLAS 
involved a document review, stakeholder interviews and analysis of ATLAS data using the 
Centers for Disease Control and Prevention (United States of America) Updated Guidelines 
for Evaluating Public Health Surveillance Systems. A literature review was undertaken as part 
of the evaluation.  
Chapter five presents the outcomes of an epidemiological investigation and a retrospective 
case-control study into an outbreak of Salmonella Havana in alfalfa sprouts, in Adelaide, 
South Australia. The outbreak was conducted during June and July 2018 with colleagues from 
SA Health. Epidemiological investigation and a retrospective case-control study identified the 
most likely source to be alfalfa sprouts. This project fulfils the requirements of an outbreak 
investigation and the requirements of a report to a non-scientific audience (ministerial brief) 
and was published as a peer review journal article in Communicable Diseases Intelligence.   
Chapter six outlines two teaching sessions, which fulfil the teaching requirements of the 
MAE; (i) a teaching session to first year MAE scholars on a Single Overarching Communication 
Outcome (SOCO) in relation to the communication of a public health message; and (ii) a 
Lessons From the Field to my fellow scholars on ‘Conducting research with Aboriginal and 
Torres Strait Islander communities’. 
1.6. Summary of public health impact 
Three of my chapters focused on the health and wellbeing of Aboriginal and Torres Strait 
Islander adolescents and young people. This stage of life is often considered an important 
period in which the foundations for later life health and wellbeing are established. 
Unfortunately, much of the adversity experienced by Aboriginal and Torres Strait Islander 
adolescents and young people during this period is the result of the ongoing effects of 
colonisation and intergenerational trauma. Therefore, addressing the inequalities 
experienced by Aboriginal and Torres Strait Islander adolescents and young people deserves 
attention and investment. 
The data analysis project focused on the leading causes of public hospital separations among 
adolescents in SA between 2006-2015. Overall, there was minimal change in causes and rates 
of separation in adolescents during the study period. However, Aboriginal adolescents had 
significantly higher age-standardised rates for all separations than non-Aboriginal 
adolescents. The findings provide an evidence base for policy reform and program 
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development, and for improving health care delivery for adolescents in SA. The findings are 
also relevant to better understanding of drivers of morbidity and the health needs of this 
population nationally. 
The epidemiological study explored the sexual health, knowledge, behaviours and access to 
health services in relation to STI and BBV amongst young South Australians, both Aboriginal 
and Torres Strait Islander and non-Indigenous. Overall, young South Australians are engaged 
in behaviours which increases their risk of acquiring STI. This evidence is important for 
informing public health practice and policy development, and development of STI and BBV 
preventative health programs – particularly those targeting young Aboriginal and/or Torres 
Strait Islander people.  
The evaluation of a surveillance system assessed the ATLAS Aboriginal and Torres Strait 
Islander Sexual Health Surveillance Network ability to provide important information and 
data on STI and BBV among the Aboriginal and Torres Strait population. It was agreed ATLAS 
is a useful addition to enhanced efforts in STI and BBV control. The utilisation of ACCHS, 
provides a unique opportunity to strengthen STI and BBV testing, care and management for 
health services, and improve surveillance, monitoring and evaluation of STI and BBV. Overall, 
ATLAS has the potential to enhance the current knowledge of STI and BBV among the 
Aboriginal and Torres Strait Islander population, by identifying where to target interventions 
and informing clinical guidelines and policy, ultimately reducing disease burden. 
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2.1. Prologue 
I would like to acknowledge the adolescents whose data was provided for this project. 
2.1.1. My role 
My analysis of a public health dataset project involved: 
• drafting a study proposal and data analysis plan
• obtaining ethics approval
• liaising with/seeking the advice of specialists regarding trend analysis
• constructing a dataset from an administrative dataset
• cleaning and recoding variables
• data analysis and interpretation
• drafting of initial and subsequent versions of the chapter
• obtaining feedback and comments on the chapter from co-investigators and
supervisors
• liaising with data custodians for approval of the chapter.
2.1.2. Lessons learnt 
I learnt three important lessons from this project. The first lesson: itis important to manage 
your data including the analysis and results. Itis a lesson I am still learning to grasp. This 
dataset contained 333,096 observations across several different variables. The analysis, 
including stratification by age, sex and Indigenous status produced 10 times more 
information than I started with. This has been a lot to contend with, particularly when it is 
the first time you have ever done quantitative analysis such as this. What helped was 
ensuring that every Stata do-file, dataset, MS Excel file and spreadsheet, table and graph was 
appropriately labelled and marked and saved in a logical structure.    
Second lesson: there is such a thing as too much ANALYSIS!!! I have lost count of the number 
of times I have analysed and presented results from this dataset. The challenge has been 
undertaking this journey of discovery to understand the data and what the data is telling me. 
Having never used or analysed data like this before, I am grateful to have had the assistance 
of people who understand this dataset and population better than I do.  
Finally, the third lesson: the presentation of data and results is important to the story you 
want to tell. Part of the challenge in telling the story is working out the best format in which 
the results should be presented to convey the story you want to tell. In the end I found myself 
asking the following questions to determine what results to present and in what format: 
‘Does this answer my question?’; ‘What is the important message I am trying to relay?’; and 
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‘Is it significant and noteworthy?’. If I couldn’t answer yes to all three, it wasn’t highlighted 
within the text or included at all.   
2.1.3. Public health implications  
Administrative datasets provide a wealth of knowledge about a population. Often that 
information is not intended to be used for research purposes. However, administrative 
datasets are increasingly used to answer research questions, as they provide valuable insight 
into a population. Also, and importantly, we must remember that data represents people; 
we must respect the data and honour the knowledge provided by that information, in a way 
that is a strength-based approach. This is critically important when that data involves 
Aboriginal and Torres Strait Islander (hereafter Aboriginal) people.     
This study is the first analysis of public hospital separation data in South Australia (SA) to 
identify the leading causes of hospitalisation for Aboriginal and non-Aboriginal adolescents. 
Pregnancy, childbirth and the puerperium; injury, poisoning and certain other consequences 
of external causes; mental and behavioural disorders; and diseases of the digestive system 
were the leading causes of separation among all adolescents and age-standardised rates 
were significantly higher among Aboriginal adolescents than non-Aboriginal adolescents. The 
results from this study will be useful in informing policy, programs and health care delivery 
for adolescents in SA. The results could potentially also be applied nationally to understand 
drivers of morbidity and the health needs of this population across jurisdictions. 
2.1.4. Acknowledgements 
I would like to acknowledge my co-authors and supervisors for their support and guidance: 
Dr Odette Pearson, Professor James Ward, Dr Tambri Housen and Dr Peter Azzopardi. A 
particular mention to Ms Victoria Shtangey, whose knowledge and experience of the data 
was invaluable; I am forever grateful for your time and commitment; and to Dr Alice 
Richardson for her guidance and support with all things trend and regression analysis. Finally, 
I would like to acknowledge the Landscape Governance Group for its support, and the South 
Australian Department for Health and Wellbeing for its approval of this chapter.  
2.1.5. MAE core requirements 
This project fulfils the analysis of a public health dataset project component of the Master of 
Philosophy in Applied Epidemiology. The project was presented at the South Australian State 
Population Health Conference, 1 December 2018, Adelaide; Australian Association for 
Adolescent Health Youth Health Conference, 7-9 November 2018, Gold Coast; and Lowitja 
Institute International Indigenous Health and Wellbeing Conference, 18-20 June 2019, 
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Darwin (Appendix 2.C). A version of this chapter will also be drafted into a manuscript for 
publication in a peer reviewed journal.  
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2.2. Abstract   
2.2.1. Objective 
To investigate leading causes and trends in adolescent hospital separations in South 
Australia. 
2.2.2. Design, setting and participants 
A retrospective study of South Australian adolescents (aged 10-24 years) hospitalised in 
public hospitals, during the period 1 January 2006 – 31 December 2015. Data were extracted 
from the Integrated South Australian Activity Collection.  
2.2.3. Outcomes measures 
Methods: Leading causes of separation were defined by primary diagnosis coded according 
to the International Statistical Classification of Diseases and Related Health Problems, 
Australian modification. Counts and proportions of leading causes of separation were 
calculated as age-standardised rates by sex, age groups (10-14, 15-19 and 20-24 years) and 
by Aboriginal status. Age-standardised rates were calculated using estimated population 
census data relevant to the study period. Negative binominal regression was used to assess 
trend over time. Separations at private hospitals where Aboriginal status was unknown, and 
for people living in the far northern region of the state where hospital access occurs 
predominantly across the border in the Northern Territory, were excluded.    
2.2.4. Results 
Overall, our study included 333,096 separations by adolescents, comprising three percent of 
all hospital separations during the study period. Females had the highest proportion of 
separations (62%), and separations increased with each age group. Aboriginal adolescents 
comprised six percent of all adolescent separations. Leading causes of separation were 
pregnancy, childbirth and the puerperium; injury, poisoning and certain other consequences 
of external causes; mental and behavioural disorders; and diseases of the digestive system. 
Aboriginal adolescents had significantly higher age-standardised rates of separation for all 
causes than non-Aboriginal adolescents. Overall, there was minimal change in causes and 
rates of separation in adolescents during the study period.   
2.2.5. Conclusion 
During the study period, the leading causes of separations in South Australia were similar for 
all adolescents; however, significantly higher rates of separation among Aboriginal 
adolescents are of concern, as Aboriginal adolescent often experience inequitable outcomes. 
This is the first analysis of hospital separation data focusing on adolescents in South Australia, 
and the findings provide an evidence base for policy reform and program development, and 
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for improving health care delivery for adolescents in this jurisdiction. The findings are also 
relevant to better understanding of drivers of morbidity and the health needs of this 
population nationally.  
2.3. Introduction 
It is estimated that there are 1.8 billon adolescents aged 10-24 years old in the world today, 
comprising 25% of the global population (1). This is the largest cohort of adolescents in the 
world’s history (2). Adolescence is often regarded as a period of peak health; however, for 
the majority of adolescents this is not the case, with 89% of the world’s adolescents living in 
less developed countries (1). This presents significant challenges to achieving equitable 
health and wellbeing of adolescents when poverty and limited access to health care and 
education are known drivers of morbidity (2). Further, marginalised populations – including 
ethnic minorities, Indigenous and tribal peoples, offenders, gender and sexually diverse 
populations, and refugees – face far greater challenges to their health and wellbeing (2).  
In Australia, adolescents generally experience relatively good health. However, Aboriginal 
adolescents disproportionately experience ill health and report lower levels of wellbeing in 
comparison to their non-Aboriginal counterparts (3). A study by Azzopardi et al. on the health 
and wellbeing of adolescents in Australia found Aboriginal adolescents ‘had a mortality rate 
of 70 per 100,000 per year on average, more than twice that of non-Indigenous adolescents’ 
(4, p770). In addition, mortality risk increased with age, and was most noticeable among 
males in mid-to-late adolescence (4). The hospital separation rates for Aboriginal adolescents 
for pregnancy, ischaemic heart disease, stroke and intentional self-harm were twice that of 
non-Aboriginal adolescents; four times higher for pneumonia; and six times higher for 
endocarditis and assault-related injury. Separations due to type 2 diabetes for Aboriginal 
adolescents were more than 10 times that for non-Aboriginal adolescents (4). Other reports 
have shown higher rates of morbidity attributable to injury, psychiatric disorders, and poor 
sexual and reproductive health outcomes among Aboriginal adolescents (3, 5-8). Similarly, 
disparities in health and hospital separations are experienced by Indigenous adolescents in 
New Zealand (9, 10), Canada (11, 12) and the United States of America (13-15).  
Understanding leading causes for hospital separations can inform policy, programs and 
health care delivery for adolescents. In this study we assessed leading causes and trends in 
hospital separations among adolescents in South Australia (SA) between 2006 and 2015, by 
sex, age group (10-14, 15-19 and 20-24 years), and by Aboriginal status.  
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2.4. Methods  
This study is a retrospective data analysis of adolescent (aged 10-24 years) (2, 16, 17) hospital 
separation data from South Australia, during the period 1 January 2006 – 31 December 2015.  
Data were extracted from the Integrated South Australian Activity Collection (ISAAC). 
The ISAAC is a database of routinely collected hospital separation data from all public and 
private hospitals in SA, administered by the South Australian Department of Health and 
Wellbeing (SA Health), and primarily collected for funding purposes. Variables within the 
ISAAC dataset, and used in this analysis, were primary diagnoses coded according to the 
International Statistical Classification of Diseases and Related Health Problems 10th Revision 
(ICD-10), Australian modification (18-20); and separation year, gender, age, and Aboriginal 
status. Data were de-identified, representing all hospital separations during the study period 
and not attributable to an individual.   
Some data were excluded, including private hospital separations, observations with 
Aboriginal status unknown, and adolescents not resident in South Australia. Almost 90% of 
separations for Aboriginal people occur at public hospitals (21). Further, residents of the 
Anangu Pitjantjatjara Yankunytjatjara Lands were excluded, as this community generally 
accesses hospital care in the Northern Territory (22).  
2.4.1. Statistical analysis  
The outcome measure of interest was primary reason for hospital separation, reported by 
primary diagnosis. The number of separations was calculated for all adolescents and 
stratified by sex, age group and by Aboriginal status.  
The primary diagnosis as listed in the data was used to identify and describe the causes and 
rates of hospital separations. Hospital separation data were aggregated into ICD-10 chapters. 
The focus of our analysis was on the leading ICD-10 chapters accounting for the greatest 
proportion of separations. These were further analysed by sex, Aboriginal status and three 
age groups (10-14, 15-19, 20-24 years).  
Numbers and age-standardised rates (ASR) per 1,000 population were calculated. Population 
census estimates from the Australian Bureau of Statistics for 2006, 2011 and 2015, and 
estimates in between census years generated by Prometheus Pty Ltd (Appendix 2.A), were 
used to calculate direct age-standardised separation rates (23), using distrate, a Stata user 
written command (24). Incidence rate ratios were calculated to compare Aboriginal and non-
Aboriginal age-standardised rates.   
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After assessing the distribution of data, negative binominal regression was used to assess 
trend over time (year-on-year), with the number of hospital separations by ICD-10 chapter 
as the dependent variable, time (in years) as the independent variable and population size 
as the offset, expressed as incidence rate ratios. Data were reported with 95% confidence 
intervals (CI) and the significance level was set at 0.05. Statistical analyses were performed 
with the statistical software Stata version 15 (25). Graphs were generated using Stata and 
MS Excel 2016 (26). 
2.4.2. Ethics approval  
This study sits within a broader project, The Aboriginal Health Landscape: Identifying and 
monitoring Aboriginal health disparities in South Australia (27). The project obtained ethics 
approval from the South Australian Department of Health and Wellbeing (SA Health) 
(HREC/14/SAH/22), the Aboriginal Human Research Ethics Committee (South Australia) 
(HREC 04-14-546), and the Human Research Ethics Committee of the Australian National 
University (HREC 2018/399). 
2.5. Results  
The ISAAC dataset included 498,291 (5%) hospital separations of adolescents age 10-24 years 
separated from all South Australian hospitals. Of these 165,195 (33%) separation 
observations were excluded from the dataset, including: private hospital separations 
(n=142,384), observations where Aboriginal status was unknown (n=14,371), separations for 
adolescents not resident in SA (n= 8,145), and separations for residents of the Anangu 
Pitjantjatjara Yankunytjatjara Lands (n=292); and an additional three (n=3) observations were 
excluded due to ICD-10 coding error. The final dataset for analysis included 333,096 
observations representing 3% of all hospital separations in the study period.  
Overall, females accounted for the majority (n=204,850, 62%) of separations and 
proportionately, separations increased with each five-year age group. Aboriginal adolescents 
comprised 20,513 (6%) of all separations and Aboriginal females comprised a larger 
proportion of separations in this population than non-Aboriginal female adolescents (69% vs 
61%) (Table 2.1).  
2.5.1. Leading causes and rates of hospital separations for all 
adolescents  
The top four causes for separations, by ICD-10 chapter, for all adolescents were: (i) 
pregnancy, childbirth and the puerperium (O00-O99) (pregnancy) (n=72,818, 22%); (ii) injury, 
poisoning and other related external causes (S00-T98) (injury) (n=56,656, 17%); (iii) diseases 
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of the digestive system (K00-K93) (digestive system) (n=32,858, 10%); and (iv) mental and 
behavioural disorders (F00-F99) (n=25,228, 8%) (Table 2.2). These four causes accounted for 
57% of all adolescent separations, with the remaining separations distributed across the 
remaining 16 ICD-10 chapters (Appendix 2.B).  
TABLE 2.1: CHARACTERISTICS OF HOSPITAL SEPARATIONS BY ABORIGINAL STATUS, SOUTH AUSTRALIAN ADOLESCENTS 
10 – 24 YEARS, 2006-2015 
Characteristics  Aboriginal 
n (%) 
non-Aboriginal 
n (%) 
All adolescents 
n (%)  
Separations   20,513 
(6.2%) 
312,583  
(93.8%) 
333,096  
(100%) 
Sex    
Male  6,432 
(31.4%) 
121,814  
(39.0%) 
128,246  
(38.5%) 
Female  14,081 
(68.6%) 
190,769  
(61.0%) 
204,850  
(61.5%) 
Age groups    
10-14 years 3,073 
(15.0%) 
58,716  
(18.8%) 
61,789  
(18.5%) 
15-19 years 6,915 
(33.7%) 
108,274  
(34.6%) 
115,189  
(34.6%) 
20-24 years 10,525 
(51.3%) 
145,593  
(46.6%) 
156,118  
(46.9%) 
 
Among females, pregnancy, and among males, injury, were the leading causes accounting for 
36% and 29% of separations, respectively. Further, the ASR for injury among males was 75% 
higher than for females (22.5 vs 12.8 per 1000 population) and by age groups, other than 
pregnancy, injury was the leading cause for separation (Table 2.2). 
2.5.2. Hospital separations and rates by Aboriginal status    
The ASR for all causes of hospital separations among Aboriginal adolescents was 193.5 per 
1,000 (CI: 190.8-196.1), almost double the ASR of 100.4 per 1,000 (CI: 100.0-100.7) for non-
Aboriginal adolescents (data not shown). Pregnancy and injury were the two leading causes 
for separations for both Aboriginal and non-Aboriginal adolescents, followed by mental 
health and digestive system for Aboriginal adolescents; whereas digestive system and mental 
health were the third and fourth leading causes among non-Aboriginal adolescents (Table 
2.2). Among Aboriginal adolescents aged 10-24 years, age-standardised incidence rate ratios 
for mental health, pregnancy, injury and digestive were 3.1 (CI: 2.86-3.30), 2.5 (CI: 2.43-2.62), 
1.7 (CI: 1.66-1.80) and 1.2 (CI: 1.10-1.14) times higher, respectively, than non-Aboriginal  
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adolescents aged 10-24 years for the same causes (Table 2.2 and Figure 2.1). The ASR for all 
causes of hospitalisation increased with age for both Aboriginal and non-Aboriginal 
adolescents (Table 2.3). 
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TABLE 2.2: AGE-STANDARDISED RATES AND INCIDENCE RATE RATIOS FOR LEADING CAUSES OF HOSPITAL SEPARATIONS, BY SEX AND AGE GROUP STRATIFIED BY ABORIGINAL STATUS, SOUTH AUSTRALIAN 
ADOLESCENTS 10 – 24 YEARS, 2006-2015  
 Aboriginal non-Aboriginal  Aboriginal non-Aboriginal  
 n (%) Rate* (CI) n (%) Rate* (CI) IRRα (CI) n (%) Rate* (CI) n (%) Rate* (CI) IRRα (CI) 
IDC-10 chapter Male Female 
Pregnancy, childbirth and the 
puerperium (O00-O99)  
- - - - - 6,018 
(42.7%) 
118.2 
(115.21-
121.20) 
66,800 
(35.0%) 
42.1 
(41.78-
42.42) 
2.5  
(2.43- 
2.61 
Injury, poisoning and certain 
other consequences of 
external causes (S00-T98) 
1,970 
 (30.6%) 
35.8  
(34.28-
37.47) 
34,837 
(28.6%) 
22.1 
(21.91-
22.38) 
1.5  
(1.51-
1.67) 
1,338 
(9.5%) 
25.5 
(24.17-
26.93) 
18,511 
(9.7%) 
12.4 
(12.25-
12.61) 
2.0  
(1.88- 
2.13) 
Diseases of the digestive 
system (K00-K93) 
1,201  
(18.7%) 
22.3  
(21.09-
3.94) 
14,208 
(11.7%) 
9.1 
(8.91- 
9.21) 
1.2  
(1.05- 
1.25 
1,303 
(9.3%) 
14.1 
(13.19-
15.25) 
17,325 
(9.1%) 
11.4 
(11.28-
11.63) 
1.2  
(1.09- 
1.28) 
Mental and behavioural 
disorders (F00-F99) 
584 
 (9.1%) 
10.6  
(9.80-
1.55) 
10,556 
(8.7%) 
6.5 
(6.35- 
6.60) 
3.2  
(2.96-
3.43) 
741  
(5.3%) 
25.2 
(23.88-
26.64) 
12,168 
(6.4%) 
8.0 
(7.87- 
8.15) 
3.0  
(2.74- 
3.21) 
   10-14 years   15-19 years 
Pregnancy, childbirth and the 
puerperium (O00-O99)  
54  
(1.8%) 
1.4 
(1.03-
1.78) 
204  
(0.3%) 
0.2 
(0.19- 
0.25) 
6.3  
(4.34-
9.24) 
2,149 
(31.1%) 
57.6 
(55.26-
60.16) 
17,122 
(15.8%) 
16.9 
(16.67-
17.18) 
3.5  
(3.24- 
3.74) 
Injury, poisoning and certain 
other consequences of 
external causes (S00-T98) 
714 
(23.2%) 
18.0 
(16.74-
9.42) 
13,364 
(22.8%) 
14.1 
(13.88-
14.36) 
1.3  
(1.18-
1.39) 
1,229 
(17.8%) 
32.9 
(31.16-
34.88) 
20,799 
(19.2%) 
20.5 
(20.28-
20.84) 
1.6  
(1.51- 
1.71) 
Diseases of the digestive 
system (K00-K93) 
181  
(5.9%) 
8.2 
(7.32-
9.13) 
7,122 
(12.1%) 
7.5 
(7.35- 
7.70) 
1.1  
(0.94-
1.22) 
990 
(14.3%) 
10.1 
(9.07- 
11.13) 
11,789 
(15.8%) 
11.6 
(11.44-
11.86) 
0.9  
(0.77- 
0.96) 
Mental and behavioural 
disorders (F00-F99) 
324 
(10.5%) 
4.6 
(3.93-
5.39) 
1,837 
(3.1%) 
1.9 
(1.85- 
2.03) 
2.4  
(1.98-
2.80) 
375  
(5.4%) 
26.5 
(24.94-
28.27) 
9,752 
(9.0%) 
9.6 
(9.45- 
9.83) 
2.8  
(2.50- 
3.05) 
 20-24 year 10-24 years 
Pregnancy, childbirth and the 
puerperium (O00-O99)  
3,815 
(36.2%) 
57.8 
(56.39-
59.33) 
49,474 
(34.0%) 
20.4 
(20.35-
20.66) 
2.5  
(2.43- 
2.62) 
6,018 
(29.3%) 
116.7 
(113.02-
120.46) 
66,800 
(21.4%) 
45.2 
(44.88-
45.68) 
2.6  
(2.49- 
2.69) 
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 Aboriginal non-Aboriginal  Aboriginal non-Aboriginal  
 n (%) Rate* (CI) n (%) Rate* (CI) IRRα (CI) n (%) Rate* (CI) n (%) Rate* (CI) IRRα (CI) 
Injury, poisoning and certain 
other consequences of 
external causes (S00-T98) 
1,365 
(13.0%) 
30.7 
(29.75-
31.86) 
19,185 
(13.2%) 
17.4 
(17.27-
17.56) 
1.7  
(1.66- 
1.80)  
3,308 
(16.1%) 
41.7 
(39.56-
44.02) 
53,348 
(17.1%) 
17.5 
(17.31-
17.81) 
2.4  
(2.23- 
2.55) 
Diseases of the digestive 
system (K00-K93) 
1,333 
(12.7%) 
12.3 
(11.72-
13.07) 
12,622 
(8.7%) 
10.2 
(10.1- 
10.3) 
1.2  
(1.10- 
1.14)  
2,504 
(12.2%) 
19.1 
(17.67-
20.70) 
31,533 
(10.1%) 
11.5 
(11.35-
11.75) 
1.7  
(1.50- 
1.83) 
Mental and behavioural 
disorders (F00-F99) 
626  
(5.9%) 
23.7 
(22.84-
24.71) 
11,135 
(7.6%) 
7.2 
(7.12- 
7.31) 
3.1  
(2.86- 
3.30) 
1,325 
(6.5%) 
40.7 
(38.61-
43.02) 
22,724 
(7.3%) 
10.1 
(10.00-
10.38) 
4.0 
(3.64- 
4.41) 
*Rates are age-standardised rates per 1,000 adolescents calculated using population estimates generated by Prometheus Pty Ltd (Appendix 2.B). IRRα – Incidence Rate Ratios, comparing 
Aboriginal and non-Aboriginal age-standardised rates. CI – Confidence Interval.  
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FIGURE 2.1 AGE-STANDARDISED RATE PER 1,000 ADOLESCENTS, LEADING CAUSES FOR HOSPITAL SEPARATIONS, BY 
ABORIGINAL STATUS, SOUTH AUSTRALIAN ADOLESCENTS AGED 10-24 YEARS, 2006-2015 
 
N.B. Confidence intervals for non-Aboriginal adolescents have been included but are too small to clearly 
identify.  
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2.5.3. Trends in hospital separations 
During the study period, among all adolescents, there were small changes in the rates for the 
leading causes for separation by age, gender and Aboriginal status as noted in Table 2.3 and 
Figure 2.1.  
 
TABLE 2.3: TRENDS OVERTIME, COMPARING YEAR-ON-YEAR, IN HOSPITAL SEPARATIONS BY LEADING CAUSES, SOUTH 
AUSTRALIA ADOLESCENTS 10 – 24 YEARS, 2006-2015 
 Pregnancy Injury Digestive system Mental health 
 ↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
Sex         
Male  
- - ↓ (0.97-0.98) <0.001 
↑  
(1.01-1.03) 
<0.001 
↓ 
 (0.99-1.01) 
0.459 
Female  ↓  
(0.96-0.97) 
<0.001 ↓ (1.01-1.02) <0.001 
↑  
(1.00-1.02) 
<0.001 
↑  
(1.02-1.04) 
<0.001 
Age group        
10-14 years ↓  
(0.84-0.97) 
0.009 
↓ 
 (0.99-1.01) 
0.518 
↑  
(1.02-1.05) 
<0.001 
↑  
(0.99-1.04) 
0.291 
15-19 years ↓  
(0.92-0.94) 
<0.001 
↓ 
(0.99-1.00) 
0.087 
↑  
(1.02-1.04) 
<0.001 
↑  
(1.02-1.05) 
<0.001 
20-24 years ↓  
(0.97-0.98) 
<0.001 
↓  
(0.97-0.99) 
0.009 
↑  
(1.00-1.02) 
0.122 
↔ 
(0.98-1.01) 
0.621 
Aboriginal status        
Aboriginal ↓  
(0.97-0.99) 
0.027 
↓ 
(0.98-1.01) 
0.470 
↑  
(1.00-1.04) 
0.013 
↓ 
(0.99-1.01) 
0.438 
Non-
Aboriginal 
↓  
(0.96-0.97) 
<0.001 
↓  
(0.98-0.99) 
0.024 
↑  
(1.01-1.02) 
<0.001 
↑  
(1.00-1.03) 
0.006 
Sex & Aboriginal status        
Male & 
Aboriginal 
- - 
↓  
(0.97-1.02) 
0.881 
↑ 
(0.99-1.05) 
0.202 
↓  
(0.95-1.00) 
0.020 
Male & non-
Aboriginal 
- - 
↓  
(0.98-0.99) 
<0.001 
↑  
(1.02-1.03) 
<0.001 
↓ 
(0.99-1.00) 
0.770 
Female & 
Aboriginal 
↓  
(0.97-0.99) 
0.011 
↓  
(0.97-1.00) 
0.197 
↑ 
(0.99-1.07) 
0.137 
↑ 
(0.99-1.04) 
0.396 
Female & 
non-
Aboriginal 
↓  
(0.96-0.97) 
<0.001 
↑  
(1.01-1.02) 
<0.001 
↑  
(1.01-1.03) 
<0.001 
↑  
(1.02-1.05) 
<0.001 
Age group & Aboriginal status       
10-14 years & 
Aboriginal 
↓  
(0.79-0.96) 
0.008 
↑  
(0.98-1.04) 
0.556 
↑  
(1.06-1.17) 
<0.001 
↑ 
(0.97-1.07) 
0.543 
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 Pregnancy Injury Digestive system Mental health 
 ↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
↑↓  
(95% CI) p-value 
10-14 years & 
non-
Aboriginal 
↓  
(0.85-0.99) 
0.028 
↑ 
(0.99-1.01) 
0.609 
↑  
(1.01-1.04) 
<0.001 
↑ 
(0.99-1.04) 
0.370 
15-19 years & 
Aboriginal 
↓  
(0.95-0.98) 
<0.001 
↓ 
(0.95-1.01) 
0.154 
↑  
(1.01-1.09) 
0.010 
↓  
(0.96-1.01) 
0.283 
15-19 years & 
non-
Aboriginal 
↓  
(0.92-0.94) 
<0.001 
↓ 
(0.99-1.00) 
0.100 
↑  
(1.02-1.04) 
<0.001 
↑  
(1.02-1.05) 
<0.001 
20-24 years & 
Aboriginal 
↓ 
(0.98-1.01) 
0.336 
↓ 
(0.97-1.02) 
0.652 
↓ 
(0.93-1.00) 
0.073 
↓ 
(0.96-1.02) 
0.339 
20-24 years & 
non-
Aboriginal 
↓  
(0.97-0.98) 
<0.001 
↓  
(0.98-1.00) 
0.010 
↑ 
(1.00-1.02) 
0.079 
↓ 
 (0.98-1.01) 
0.644 
# Trend was calculated using Negative Binomial Regression, comparing year-on-year (2006-2015) and is 
reported as either an increase (↑) or decrease (↓) in ASR.  
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2.6. Discussion  
This detailed analysis of public hospital separation data for South Australian adolescents is 
the first of its kind with a focus on Aboriginal adolescents. Overall, pregnancy, injury, mental 
health, and the digestive system were the leading causes of hospital separation among all 
adolescents. Separations calculated as ASR were significantly higher among Aboriginal 
adolescents than for their non-Aboriginal peers. We found little or no change in the causes 
and rates of separations during the 10-year period.  
Our results are consistent with national data for both Aboriginal and non-Aboriginal 
adolescents. A report by the Australian Institute of Health and Welfare on Aboriginal 
adolescent health and wellbeing (3), showed differences in separation rates for Aboriginal 
people. Overall separation rates for Aboriginal adolescents were higher and increased with 
age. A study by Azzopardi et al. (2018) (4), also indicated separation rates for Aboriginal 
adolescents were significantly higher than non-Aboriginal adolescents. These trends were 
consistent with overall national population separations characteristics (28, 29).  
Aboriginal adolescents experience similar levels of disparity in relation to separations, illness 
and disease as other Indigenous adolescents across the globe (2, 30). For example, in 
Aotearoa (New Zealand), separations were higher among young Māori people aged 15–24 
years compared to their non-Māori counterparts, and the most common reasons for 
separations were pregnancy, injury or poisoning, and mental health related admissions (9). 
Similarly, in Canada, ASR separation rates for First Nations, Métis and Inuit adolescents aged 
10-19 years were considerably higher than for their non-Aboriginal counterparts, and 
pregnancy and injury were the leading causes of separation (11).  
The high rate of separations for mental health, pregnancy and injury among Aboriginal 
adolescents is due to complex and diverse factors. The causes of mental health issues are 
multifaceted, however, several factors have been identified that contribute to poor mental 
health among the Aboriginal population, including among adolescents. These include the 
ongoing effects of colonisation and intergeneration trauma (31-33), loss of culture and 
identity (32, 34), death of a family member or close friend (32, 35, 36), serious illness or 
accident (35), alcohol or drug-related problems (32, 35, 36), racism and discrimination (36, 
37), and socioeconomic disadvantage (32, 35).   
It is well known that Aboriginal females give birth at a younger age compared to non-
Aboriginal females (38, 39). The reasons for this are unclear, although several factors have 
been associated with pregnancy during adolescence, such as social attitudes and behaviours, 
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family history of teenage pregnancy, socioeconomic disadvantage, and a one-parent family 
structure (40-44). A study by Larkins et al. (43) investigated social attitudes and behaviours 
of young Indigenous people with regard to relationships and pregnancy. They found the most 
common reasons for not using or inconsistent contraception use was unplanned sex, 
contraception was not considered or “I don’t think I/she will get pregnant” (43). Several 
studies indicate low socioeconomic status (access and attainment of education, 
employment, parental income) is a risk factor for earlier age at first sexual intercourse and 
increased risk of teenage pregnancy particularly among minority groups (45-48). What is 
clear is that adolescent mothers experience disadvantage because of their younger age. 
Babies born to adolescent mothers are at greater risk of being born pre-term, of low 
birthweight and are more likely to suffer higher morbidity and mortality throughout their life 
(38, 39).  
Injury is one of the leading causes of morbidity and mortality among Aboriginal adolescents 
for all injury types (3). Limited evidence exists on the underlying risk factors for injury among 
Aboriginal adolescents, however, several studies have shown a relationship between risk 
taking, social disadvantage and living in remote communities. A study by Cercarelli and 
Knuiman (49) identified an increase in hospitalisation due to road traffic injury was 
significantly associated with being male, aged between 0–14 years and living in rural areas. 
Other studies found that lower socioeconomic status and remoteness was associated with 
an increased risk of unintentional injury (50), risk taking behaviour and being male (51, 52). 
A possible explanation as to why these factors are associated with higher rates of injury is 
that those living in remote areas tend to be more socioeconomically disadvantaged (53), and 
those who are disadvantaged are exposed to a wider range of hazards in their environment 
(54).   
Unfortunately, the inequalities experienced by Aboriginal adolescents reflect those of 
Aboriginal peoples across the life course (4). Adolescence is often considered an important 
period to mitigate and reduce inequalities (30). It is a life stage in which the foundations for 
later life health and wellbeing are established (2, 30), and efforts to address these inequalities 
will have an impact on the long-term health of Aboriginal communities. The adversity 
experienced by Aboriginal adolescents such as the ongoing effects of colonisation and 
intergenerational trauma (31-33), has been associated with increased risk of mental health 
conditions, particularly among those whose parent or primary carer was forcibly separated 
from their family. Adolescence is a critical period of life and addressing the inequalities 
experienced by Aboriginal adolescents deserves attention and investment. 
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Azzopardi et al. suggest ‘current national adolescent health policies and programmes will not 
be sufficient to improve the specific health needs of Indigenous adolescents’ (4 p779). 
Further, concerns should be raised regarding the lack of inclusion of adolescents and their 
health in key South Australian strategic health documents such as the SA Health Strategic 
Plan 2017 to 2020 (55) and the Health and Wellbeing Strategy 2019 to 2020 (56). Resnick and 
colleagues in the second Lancet series on adolescent health, argue that ‘failure to invest in 
the health of the largest generation of adolescents in the world’s history jeopardises earlier 
investments in maternal and child health, erodes future quality and length of life, and 
escalates suffering, inequality, and social instability’ (57 p1565). 
So, what can be done to address adolescent separations and ultimately adolescent health 
and wellbeing? While pregnancy is not an illness, it is an important stage of life. Action is 
required to prevent unplanned pregnancy during early adolescence and strengthen antenatal 
services’ capacity to engage female adolescents and their families in antenatal care, to 
ensure they are supported and can reach full-term without complications. A review by Savage 
(58), found limited evidence on what works to prevent pregnancy during adolescence. Sexual 
and reproductive programs that are school and or community-based, linked to contraceptive 
services and developed in conjunction with adolescents, have had some impact on reducing 
pregnancy during adolescents (58). 
A greater public health response is required to address the rates of injury in adolescents. Any 
response to injury prevention should consider that injury related separations increase with 
age and are more likely to occur in males. Similarly, a focus on adolescent mental health is 
needed particularly at the community level, on prevention and early intervention tailored for 
and by the community and addressing the upstream social determinants of social and 
emotional wellbeing, have demonstrated to be effective (32, 59). Prevention of disease of 
the digestive system should focus on oral health care (60-62) and nutrition (63). Additionally, 
any response to addressing adolescent health should include primary health care, oral health, 
health promotion and prevention, sexual health, the social determinants of health and 
education (4).  
Overall, a targeted investment into adolescent health is required. The study results draw 
attention to where investment should be focused on in future policy and programs to reduce 
the leading causes of separation for adolescents in SA. One way this can be done is through 
the development of an adolescent health strategy for SA that incorporates all aspects of 
adolescent health and wellbeing and considers the social and cultural determinants of health, 
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including actions specifically targeting Aboriginal young people. Development of the strategy 
must involve adolescents themselves and be innovative and bold and reflect the diversity 
that exists among adolescents of today. If governments are serious about enabling a healthy 
ageing population and closing the gap in disparities between the Aboriginal and non-
Aboriginal population, they must invest in adolescent health.   
2.7. Limitations  
This study is limited by its retrospective design. The data is from an administrative dataset 
which limits the type of analysis that can be conducted, as the primary purpose is not to 
explore research questions. Separation data provides insight into health end points rather 
than burden of disease; therefore, these results must not be interpreted as a complete 
picture of adolescent health. Furthermore, primary diagnosis was used to identify cause of 
separation, excluding additional diagnosis, thus a holistic picture of each separation cannot 
be considered. Additionally, a proportion of adolescent hospital separations were not 
included. There were 142,384 private hospital separations excluded. Other analysis of 
hospital separation data show that a very small proportion of Aboriginal people use private 
hospitals (21).With this in mind, the inclusion of private hospital separations would have 
slightly increased the estimates but unlikely to change the top 5 conditions for both 
Aboriginal and non-Aboriginal adolescents. However, the inclusion of these separations may 
reduce the disparity in rates of hospitalisation for particular conditions, between Aboriginal 
and non-Aboriginal adolescents, although not to the point of reaching equitable outcomes. 
The exclusion of Anangu Pitjantjatjara Yankunytjatjara Lands adolescents due to incomplete 
data capture is a major limitation in that the results of this study are not inclusive of South 
Australia’s Aboriginal adolescent population. It is highly likely that the inclusion of 
adolescents residing in the Anangu Pitjantjatjara Yankunytjatjara Lands, is likely to have 
increased the Aboriginal estimates. The ABS 2016 census estimated 589 Aboriginal 
adolescents between the age of 10 and 24 resided in the Anangu Pitjantjatjara 
Yankunytjatjara Lands at this time, a proportion of whom would have been hospitalised 
during the study period. Lastly, the under-reporting of Aboriginal status in the dataset can 
result in an understatement of morbidity patterns among Aboriginal people (64), which can 
prevent the delivery of targeted services to Aboriginal people where need is highest. 
Additionally, it is unclear if under-reporting of among Aboriginal people occurs for certain 
conditions, this may affect estimates.   
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2.8. Conclusion  
Hospital separation data can be used to understand causes for adolescent separations and 
provide insight into adolescent health needs. Pregnancy, injury, digestive system and mental 
health were the leading causes for adolescent contact with the hospital system in SA. 
Knowing this can help inform and influence policy, programs and health care delivery, by 
addressing the issues of most concern and where the greatest impact to improving 
adolescent health and wellbeing can occur.   
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Appendix 2.A 
South Australian population estimates by sex and age group stratified by 
Aboriginal Status, 2006-2015 
 Male 
Female All 
adolescents  
Year 
10-14 
years 
n 
15-19 
years  
n 
20-24 
years  
n 
10-24 
years  
n 
10-14 
years  
n 
15-19 
years  
n 
20-24 
years  
n 
10-24 
years  
n 
Total  
n 
 All adolescents 
2006 51,672 53,152 54,549 159,373 49,188 50,179 52,386 151,753 311,126 
2007 51,429 53,973 55,558 160,960 48,903 50,941 53,217 153,061 314,021 
2008 51,119 54,602 56,390 162,111 48,728 51,619 53,934 154,281 316,392 
2009 51,093 54,608 58,032 163,733 48,690 52,044 54,872 155,606 319,339 
2010 50,734 54,544 59,009 164,287 48,460 51,816 55,964 156,240 320,527 
2011 50,145 54,265 59,129 163,539 48,112 51,543 55,923 155,578 319,117 
2012 50,008 53,862 59,204 163,074 47,800 51,218 55,960 154,978 318,052 
2013 49,750 53,542 59,206 162,498 47,589 50,887 55,718 154,194 316,692 
2014 49,846 53,616 58,794 162,256 47,243 51,147 55,635 154,025 316,281 
2015 49,850 52,973 58,845 161,667 47,288 50,679 55,563 153,531 315,198 
 Aboriginal  
2006 1,999 1,811 1,520 5,330 1,769 1,749 1,507 5,025 10,355 
2007 2,056 1,882 1,589 5,527 1,867 1,751 1,617 5,235 10,762 
2008 2,078 1,940 1,645 5,663 1,960 1,781 1,659 5,400 11,063 
2009 2,088 2,004 1,703 5,795 2,040 1,823 1,687 5,550 11,345 
2010 2,128 2,055 1,742 5,925 2,116 1,871 1,716 5,703 11,628 
2011 2,158 2,071 1,825 6,054 2,155 1,888 1,794 5,837 11,891 
2012 2,156 2,117 1,888 6,161 2,131 1,975 1,793 5,899 12,060 
2013 2,161 2,133 1,945 6,239 2,115 2,059 1,821 5,995 12,234 
2014 2,148 2,142 2,003 6,293 2,130 2,128 1,862 6,120 12,413 
2015 2,138 2,176 2,051 6,365 2,101 2,192 1,908 6,201 12,566 
 Non-Aboriginal 
2006 49,673 51,341 53,029 154,043 47,419 48,430 50,879 146,728 300,771 
2007 49,373 52,091 53,969 155,433 47,036 49,190 51,600 147,826 303,259 
2008 49,041 52,662 54,745 156,448 46,768 49,838 52,275 148,881 305,329 
2009 49,005 52,604 56,329 157,938 46,650 50,221 53,185 150,056 307,994 
2010 48,606 52,489 57,267 158,362 46,344 49,945 54,248 150,537 308,899 
2011 47,987 52,194 57,304 157,485 45,957 49,655 54,129 149,741 307,226 
2012 47,852 51,745 57,316 156,913 45,669 49,243 54,167 149,079 305,992 
2013 47,589 51,409 57,261 156,259 45,474 48,828 53,897 148,199 304,458 
2014 47,698 51,474 56,791 155,963 45,113 49,019 53,773 147,905 303,868 
2015 47,711 50,797 56,793 155,302 45,187 48,488 53,655 147,330 302,632 
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Appendix 2.B 
Age-standardised rates for leading causes of hospital separations, by sex and age group stratified by Aboriginal status, 
South Australian adolescents, 2006-2015 
 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
 All adolescents 
 N=128,246 N=204,850 N=61,789 N=115,189 N=156,118 N=333,096 
Pregnancy, childbirth and the 
puerperium (O00-O99)   
- - 
72,818 
(35.5%) 
44.5 
(44.20-
44.85) 
258  
(0.4%) 
0.3 
(0.23-
0.30) 
19,271 
(16.7%) 
18.3 
(18.12-
18.64) 
53,289 
(34.1%) 
47.3 
(46.96-
47.77) 
72,818 
(21.9%) 
21.6 
(21.52-
21.84) 
Injury, poisoning and certain 
other consequences of external 
causes (S00-T98) 
36,807 
 (28.7%) 
22.5 
(22.36-
22.82) 
19,849 
(9.7%) 
12.8 
(12.67-
13.03) 
14,078 
(22.8%) 
14.2 
(14.05-
14.52) 
22,028 
(19.1%) 
21.0 
(20.73-
21.28) 
20,550 
(13.2%) 
18.2 
(18.02-
18.52) 
56,656 
(17.0%) 
17.8 
(17.70-
18.00) 
Diseases of the digestive system 
(K00-K93) 14,792 
 (11.5%) 
9.1 
(8.95-
9.25) 
18,066 
(8.8%) 
11.5 
(11.37-
11.71) 
7,446 
(12.1%) 
7.6 
(7.38-
7.72) 
12,164 
(10.6%) 
11.5 
(11.39-
11.81) 
13,248 
(8.5%) 
11.7 
(11.57-
11.98) 
32,858 
(9.9%) 
10.2 
(10.18-
10.40) 
Mental and behavioural disorders 
(F00-F99) 11,757  
(9.2%) 
7.0 
(6.85-
7.10) 
13,471 
(6.6%) 
8.6 
(8.41-
8.70) 
2,018 
(3.3%) 
2.0 
(0.95-
2.13) 
10,742 
(9.3%) 
10.2 
(10.05-
10.45) 
12,468 
(8.0%) 
11.7 
(10.89-
11.28) 
25,228 
(7.6%) 
7.7 
(7.65-
7.84) 
Symptoms, signs and abnormal 
clinical and laboratory findings, 
not elsewhere classified (R00-
R99) 
8,081 
 (6.3%) 
4.9 
(4.83-
5.05) 
14,273 
(7.0%) 
9.1 
(8.96-
9.26) 
4,612 
(7.5%) 
4.7 
(4.54-
4.81) 
8,272 
(7.2%) 
7.9 
(7.71-
8.05) 
9,470 
(6.1%) 
8.4 
(8.24-
8.58) 
22,354 
(6.7%) 
7.0 
(6.88-
7.06) 
Diseases of the respiratory 
system (J00-J99)  9,442 
 (7.4%) 
5.9 
(5.76-
5.99) 
11,643 
(5.7%) 
7.6 
(7.45-
7.73) 
6,586 
(10.7%) 
6.7 
(6.52-
6.84) 
8,186 
(7.1%) 
7.8 
(7.63-
7.97) 
6,313 
(4.0%) 
5.6 
(5.47-
5.75) 
21,085 
(6.3%) 
6.7 
(6.62-
6.80) 
Factors influencing health status 
and contact with health services 
(Z00-Z99) 
10,037 
 (7.8%) 
6.1 
(6.02-
6.26) 
9,625 
(4.7%) 
6.0 
(5.92-
6.16) 
4,382 
(7.1%) 
4.4 
(4.31-
4.57) 
5,426 
(4.7%) 
5.17 
(5.03-
5.31) 
9,854 
(6.3%) 
8.8 
(8.58-
8.93) 
19,662 
(5.9%) 
6.1 
(6.00-
6.17) 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
Diseases of the genitourinary 
system (N00-N99)  4,361 
 (3.4%) 
2.7 
(2.62-
2.78) 
10,297 
(5.0%) 
6.4 
(6.32-
6.57) 
2,409 
(3.9%) 
2.4 
(2.34-
2.54) 
5,011 
(4.4%) 
4.8 
(4.64-
4.91) 
7,238 
(4.6%) 
6.4 
(6.28-
6.58) 
14,658 
(4.4%) 
4.5 
(4.45-
4.60) 
Diseases of the skin and 
subcutaneous tissue (L00-L99) 6,848 
 (5.3%) 
4.2 
(4.06-
4.26) 
5,556 
(2.7%) 
3.6 
(3.47-
3.65) 
2,448 
(4.0%) 
2.5 
(2.38-
2.58) 
4,799 
(4.2%) 
4.6 
(4.44-
4.70) 
5,157 
(3.3%) 
4.6 
(4.45-
4.71) 
12,404 
(3.7%) 
3.9 
(3.80-
3.94) 
Diseases of the musculoskeletal 
system and connective tissue 
(M00-M99) 
4,859 
 (3.8%) 
3.0 
(2.87-
3.04) 
4,060 
(2.0%) 
2.6 
(2.54-
2.70) 
2,037 
(3.3%) 
2.1 
(1.97-
2.15) 
3,360 
(2.9%) 
3.2 
(3.09-
3.31) 
3,522 
(2.3%) 
3.1 
(3.02-
3.23) 
8,919 
(2.7%) 
2.8 
(2.73-
2.85) 
Certain infectious and parasitic 
diseases (A00-B99)   3,839 
 (3.0%) 
2.4 
(2.29-
2.44) 
4,847 
(2.4%) 
3.1 
(3.04-
3.21) 
2,379 
(3.9%) 
2.4 
(2.31-
2.51) 
3,183 
(2.8%) 
3.0 
(2.93-
3.14) 
3,124 
(2.0%) 
2.8 
(2.67-
2.87) 
8,686 
(2.6%) 
2.7 
(2.68-
2.79) 
Neoplasms (C00-D48)   
3,323 
 (2.6%) 
2.1 
(2.01-
2.15) 
4,582 
(2.2%) 
2.9 
(2.86-
3.03) 
2,563 
(4.1%) 
2.6 
(2.50-
2.70) 
2,559 
(2.2%) 
2.4 
(2.34-
2.53) 
2,783 
(1.8%) 
2.5 
(2.38-
2.56) 
7,905 
(2.4%) 
2.5 
(2.44-
2.56) 
Endocrine, nutritional and 
metabolic diseases (E00-E90) 3,387 
 (2.6%) 
2.1 
(2.03-
2.18) 
4,320 
(2.1%) 
2.8 
(2.74-
2.90) 
2,469 
(4.0%) 
2.5 
(2.40-
2.60) 
3,011 
(2.6%) 
2.9 
(2.76-
2.97) 
2,227 
(1.4%) 
2.0 
(1.89-
2.06) 
7,707 
(2.3%) 
2.5 
(2.40-
2.51) 
Diseases of the nervous system 
(G00-G99)   3,285 
 (2.6%) 
2.0 
(1.97-
2.11) 
3,849 
(1.9%) 
2.5 
(2.40-
2.56) 
2,256 
(3.7%) 
2.3 
(2.19-
2.38) 
2,328 
(2.0%) 
2.2 
(2.13-
2.31) 
2,550 
(1.6%) 
2.3 
(2.17-
2.35) 
7,134 
(2.1%) 
2.3 
(2.20-
2.31) 
Diseases of the blood and blood-
forming organs and certain 
disorders involving the immune 
mechanism (D50-D89) 
2,320 
 (1.8%) 
1.5 
(1.40-
1.52) 
2,505 
(1.2%) 
1.6 
(1.55-
1.68) 
1,744 
(2.8%) 
1.8 
(1.68-
1.58) 
1,589 
(1.4%) 
1.5 
(1.44-
1.59) 
1,492 
(1.0%) 
1.3 
(1.25-
1.39) 
4,825 
(1.4%) 
1.5 
(1.49-
1.58) 
Diseases of the circulatory 
system (I00-I99) 1,759 
 (1.4%) 
1.1 
(1.02-
1.12) 
1,627 
(0.8%) 
1.0 
(0.98-
1.08) 
666  
(1.1%) 
0.7 
(0.62-
0.73) 
1,158 
(1.0%) 
1.1 
(1.04-
1.16) 
1,562 
(1.0%) 
1.4 
(1.32-
1.45) 
3,386 
(1.0%) 
1.1 
(1.01-
1.08) 
Congenital malformations, 
deformations and chromosomal 
abnormalities (Q00-Q99) 
1,353 
 (1.1%) 
0.9 
(0.82-
0.92) 
1,351 
(0.7%) 
0.9 
(0.84-
0.94) 
1,322 
(2.1%) 
1.3 
(1.26-
1.41) 
928  
(0.8%) 
0.9 
(0.82-
0.94) 
454  
(0.3%) 
0.4 
(0.36-
0.44) 
2,704 
(0.8%) 
0.9 
(0.84-
0.92) 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
Diseases of the ear and mastoid 
process (H60-H95)   1,285 
 (1.0%) 
0.8 
(0.78-
0.88) 
1,335 
(0.7%) 
0.9 
(0.84-
0.94) 
1,515 
(2.5%) 
1.5 
(1.46-
1.61) 
691  
(0.6%) 
0.7 
(0.61-
0.71) 
414  
(0.3%) 
0.4 
(0.33-
0.41) 
2,620 
(0.8%) 
0.9 
(0.82-
0.89) 
Diseases of the eye and adnexa 
(H00-H59) 711 
 (0.6%) 
0.4 
(0.41-
0.48) 
776  
(0.4%) 
0.5 
(0.47-
0.55) 
601  
(1.0%) 
0.6 
(0.56-
0.66) 
483 
(0.4%) 
0.5 
(0.42-
0.50) 
403  
(0.3%) 
0.4 
(0.32-
0.39) 
1,487 
(0.4%) 
0.5 
(0.45-
0.50) 
 Aboriginal  
 N=6,432 N=14,081 N=3,073 N=6,915 N=10,525 N=20,513 
Pregnancy, childbirth and the 
puerperium (O00-O99)   
- - 
6,018 
(42.7%) 
118.2 
(115.21-
121.20) 
54  
(1.8%) 
1.4 
(1.03-
1.78) 
2,149 
(31.1%) 
57.6 
(55.26-
60.16) 
3,815 
(36.2%) 
116.7 
(113.02-
120.46) 
6,018 
(29.3%) 
57.8 
(56.39-
59.33) 
Injury, poisoning and certain 
other consequences of external 
causes (S00-T98) 
1,970 
 (30.6%) 
35.8 
(34.28-
37.47) 
1,338 
(9.5%) 
25.5 
(24.17-
26.93) 
714 
(23.2%) 
18.0 
(16.74-
19.42) 
1,229 
(17.8%) 
32.9 
(31.16-
34.88) 
1,365 
(13.0%) 
41.7 
(39.56-
44.02) 
3,308 
(16.1%) 
30.7 
(29.75-
31.86) 
Mental and behavioural disorders 
(F00-F99) 1,201  
(18.7%) 
22.3 
(21.09-
23.94) 
1,303 
(9.3%) 
25.2 
(23.88-
26.64) 
181  
(5.9%) 
4.6 
(3.93-
5.39) 
990 
(14.3%) 
26.5 
(24.94-
28.27) 
1,333 
(12.7%) 
40.7 
(38.61-
43.02) 
2,504 
(12.2%) 
23.7 
(22.84-
24.71) 
Factors influencing health status 
and contact with health services 
(Z00-Z99) 
322 
 (5.0%) 
6.0 
(5.36-
6.69) 
1,310 
(9.3%) 
25.9 
(24.59-
27.42) 
125  
(4.1%) 
3.2 
(2.63-
3.76) 
261  
(3.8%) 
7.0 
(6.18-
7.91) 
1,246 
(11.8%) 
38.1 
(36.02-
40.29) 
1,632  
(8.0%) 
15.8 
(15.06-
16.60) 
Diseases of the digestive system 
(K00-K93) 584 
 (9.1%) 
10.6 
(9.80-
11.55) 
741  
(5.3%) 
14.1 
(13.19-
15.25) 
324 
(10.5%) 
8.2 
(7.32-
9.13) 
375  
(5.4%) 
10.1 
(9.07-
11.13) 
626  
(5.9%) 
19.1 
(17.67-
20.70) 
1,325 
(6.5%) 
12.3 
(11.72-
13.07) 
Symptoms, signs and abnormal 
clinical and laboratory findings, 
not elsewhere classified (R00-
R99) 
445 
 (6.9%) 
8.1 
(7.40-
8.93) 
749  
(5.3%) 
14.3 
(13.32-
15.39) 
224  
(7.3%) 
5.7 
(4.95-
6.45) 
443  
(6.4%) 
11.8 
(10.80-
13.05) 
527  
(5.0%) 
16.1 
(14.77-
17.55) 
1,194 
(2.8%) 
11.1 
(10.54-
11.82) 
Diseases of the respiratory 
system (J00-J99)  437 
 (6.8%) 
7.7 
(7.04-
8.51) 
548  
(3.9%) 
10.2 
(9.41-
11.14) 
366 
(11.9%) 
9.3 
(8.33-
10.25) 
348  
(5.0%) 
9.3 
(8.38-
10.37) 
271  
(2.6%) 
8.3 
(7.33-
9.34) 
985  
(4.8%) 
9.0 
(8.41-
9.54) 
Diseases of the skin and 
subcutaneous tissue (L00-L99) 341 
 (5.3%) 6.2 
365  
(2.6%) 6.9 
178  
(5.8%) 4.5 
260  
(3.8%) 7.0 
268  
(2.5%) 8.2 
706  
(3.4%) 6.5 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
(5.53-
6.86) 
(6.23-
7.67) 
(3.86-
5.21) 
(6.16-
7.88) 
(7.25-
9.24) 
(0.06-
7.03) 
Diseases of the genitourinary 
system (N00-N99)  121 
 (1.9%) 
2.2 
(1.79-
2.57) 
552  
(3.9%) 
10.6 
(9.80-
11.59) 
122  
(4.0%) 
3.1 
(2.56-
3.68) 
220  
(3.2%) 
5.9 
(5.15-
6.74) 
331  
(3.1%) 
10.1 
(9.06-
11.27) 
673  
(3.3%) 
6.3 
(5.85-
6.82) 
Diseases of the musculoskeletal 
system and connective tissue 
(M00-M99) 
191 
 (3.0%) 
3.5 
(2.99-
4.00) 
193  
(1.4%) 
3.6 
(3.13-
4.18) 
109  
(3.5%) 
2.8 
(2.26-
3.32) 
130  
(1.9%) 
3.5 
(2.92-
4.14) 
145  
(1.4%) 
4.4 
(3.74-
5.22) 
384  
(1.9%) 
3.5 
(3.20-
3.92) 
Diseases of the nervous system 
(G00-G99)   207 
 (3.2%) 
3.7 
(3.23-
4.26) 
159  
(1.1%) 
3.0 
(2.57-
3.52) 
112  
(3.6%) 
2.8 
(2.33-
3.41) 
118  
(1.7%) 
3.2 
(2.62-
3.79) 
136  
(1.3%) 
4.2 
(3.49-
4.92) 
366  
(1.8%) 
3.4 
(3.03-
3.74) 
Certain infectious and parasitic 
diseases (A00-B99)    132 
 (2.1%) 
2.3 
(1.96-
2.78) 
217  
(1.5%) 
4.1 
(3.56-
4.66) 
122  
(4.0%) 
3.1 
(2.56-
3.68) 
117  
(1.7%) 
3.1 
(2.60-
3.76) 
110  
(1.0%) 
3.4 
(2.77-
4.06) 
349  
(1.7%) 
3.2 
(2.86-
3.54) 
Endocrine, nutritional and 
metabolic diseases (E00-E90) 148 
 (2.3%) 
2.6 
(2.24-
3.11) 
99  
(0.7%) 
1.9 
(1.54-
2.30) 
89  
(2.9%) 
2.2 
(1.81-
2.79) 
61  
(0.9%) 
1.6 
(1.25-
2.10) 
97  
(0.9%) 
3.0 
(2.41-
3.62) 
247  
(1.2%) 
2.3 
(2.00-
2.57) 
Neoplasms (C00-D48)   
86  
(1.3%) 
1.5 
(1.24-
1.91) 
147  
(1.0%) 
2.8 
(2.37-
3.30) 
82  
(2.7%) 
2.1 
(1.65-
2.57) 
45  
(0.7%) 
1.2 
(0.88-
1.62) 
106  
(1.0%) 
3.2 
(2.65-
3.92) 
233  
(1.1%) 
2.2 
(1.89-
2.45) 
Diseases of the ear and mastoid 
process (H60-H95) 107 
 (1.7%) 
1.9 
(1.52-
2.24) 
128  
(0.9%) 
2.3 
(1.93-
2.75) 
149  
(4.8%) 
3.8 
(3.19-
4.42) 
59  
(0.9%) 
1.6 
(1.21-
2.04) 
27  
(0.3%) 
0.8 
(0.54-
1.20) 
235  
(1.1%) 
2.1 
(1.81-
2.35) 
Diseases of the circulatory 
system (I00-I99) 65 
(1.0%) 
1.2 
(0.91-
1.50) 
63  
(0.4%) 
1.2 
(0.92-
1.54) 
33  
(1.1%) 
0.8 
(0.57-
1.17) 
42  
(0.6%) 
1.1 
(0.81-
1.52) 
53  
(0.5%) 
1.6 
(1.21-
2.12) 
128  
(0.6%) 
1.2 
(0.99-
1.41) 
Diseases of the blood and blood-
forming organs and certain 
disorders involving the immune 
mechanism (D50-D89) 
18  
(0.3%) 
0.3 
(0.19-
0.52) 
93  
(0.7%) 
1.8 
(1.42-
2.15) 
38  
(1.2%) 
1.0 
(0.68-
1.32) 
27  
(0.4%) 
0.7 
(0.48-
1.05) 
46  
(0.4%) 
1.4 
(1.03-
1.88) 
111  
(0.5%) 
1.0 
(0.84-
1.23) 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
Congenital malformations, 
deformations and chromosomal 
abnormalities (Q00-Q99) 
35  
(0.5%) 
0.6 
(0.42-
0.84) 
28  
(0.2%) 
0.5 
(0.34-
0.75) 
31  
(1.0%) 
0.8 
(0.53-
1.12) 
24  
(0.3%) 
0.6 
(0.41-
0.96) 
8  
(0.1%)  
0.2 
(0.11-
0.48) 
63  
(0.3%) 
0.6 
(0.43-
0.72) 
Diseases of the eye and adnexa 
(H00-H59) 22  
(0.3%) 
0.4 
(0.24-
0.59) 
30  
(0.2%) 
0.6 
(0.39-
0.80) 
20  
(0.7%) 
0.5 
(0.31-
0.78) 
17  
(0.2%) 
0.5 
(0.27-
0.73) 
15  
(0.1%) 
0.5 
(0.26-
0.76) 
52  
(0.3%) 
0.5 
(0.35-
0.61) 
 non-Aboriginal  
 N=121,814 N=190,769 N=58,716 N=108,274 N=145,593 N=312,583 
Pregnancy, childbirth and the 
puerperium (O00-O99)   
- - 
66,800 
(35.0%) 
42.1 
(41.78-
42.42) 
204  
(0.3%) 
0.2 
(0.19-
0.25) 
17,122 
(15.8%) 
16.9 
(16.67-
17.18) 
49,474 
(34.0%) 
45.2 
(44.88-
45.68) 
66,800 
(21.4%) 
20.4 
(20.35-
20.66) 
Injury, poisoning and certain 
other consequences of external 
causes (S00-T98) 
34,837 
(28.6%) 
22.1 
(21.91-
22.38) 
18,511 
(9.7%) 
12.4 
(12.25-
12.61) 
13,364 
(22.8%) 
14.1 
(13.88-
14.36) 
20,799 
(19.2%) 
20.5 
(20.28-
20.84) 
19,185 
(13.2%) 
17.5 
(17.31-
17.81) 
53,348 
(17.1%) 
17.4 
(17.27-
17.56) 
Diseases of the digestive system 
(K00-K93) 14,208 
(11.7%) 
9.1 
(8.91-
9.21) 
17,325 
(9.1%) 
11.4 
(11.28-
11.63) 
7,122 
(12.1%) 
7.5 
(7.35-
7.70) 
11,789 
(15.8%) 
11.6 
(11.44-
11.86) 
12,622 
(8.7%) 
11.5 
(11.35-
11.75) 
31,533 
(10.1%) 
10.2 
(10.1-
10.3) 
Mental and behavioural disorders 
(F00-F99) 10,556 
(8.7%) 
6.5 
(6.35-
6.60) 
12,168 
(6.4%) 
8.0 
(7.87-
8.15) 
1,837 
(3.1%) 
1.9 
(1.85-
2.03) 
9,752 
(9.0%) 
9.6 
(9.45-
9.83) 
11,135 
(7.6%) 
10.1 
(10.00-
10.38) 
22,724 
(7.3%) 
7.2 
(7.12-
7.31) 
Symptoms, signs and abnormal 
clinical and laboratory findings, 
not elsewhere classified (R00-
R99) 
7,636 
 (6.3%) 
4.8 
(4.73-
4.95) 
13,524 
(7.1%) 
8.9 
(8.79-
9.09) 
4,388 
(7.5%) 
4.6 
(4.50-
4.78) 
7,829 
(7.2%) 
7.7 
(7.57-
7.91) 
8,943 
(6.1%) 
8.2 
(8.02-
8.36) 
21,160 
(6.8%) 
6.8 
(6.74-
6.93) 
Diseases of the respiratory 
system (J00-J99)  9,005 
 (7.4%) 
5.8 
(5.69-
5.93) 
11,095 
(5.8%) 
7.5 
(7.36-
7.64) 
6,220 
(10.6%) 
6.6 
(6.41-
6.74) 
7,838 
(7.2%) 
7.7 
(7.58) 
6,042 
(4.1%) 
5.5 
(5.39-
5.67) 
20,100 
(6.4%) 
6.6 
(6.53-
6.72) 
Factors influencing health status 
and contact with health services 
(Z00-Z99) 
9,715 
 (8.0%) 
6.2 
(6.04-
6.28) 
8,315 
(4.4%) 
5.4 
(5.33-
5.55) 
4,257 
(7.3%) 
4.5 
(4.37-
4.64) 
5,165 
(4.8%) 
5.1 
(4.98-
5.28) 
8,608 
(5.9%) 
7.9 
(7.71-
8.05) 
18,030 
(5.8%) 
5.8 
(5.17-
5.88) 
Diseases of the genitourinary 
system (N00-N99)  4,240 
 (3.5%) 2.7 
9,745 
(5.1%) 6.3 
2,287 
(3.9%) 2.4 
4,791 
(4.4%) 4.7 
6,907 
(4.7%) 6.3 
13,985 
(4.5%) 4.5 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
(2.64-
2.81) 
(6.18-
6.43) 
(2.32-
2.52) 
(4.60-
4.87) 
(6.17-
6.47) 
(4.39-
4.54) 
Diseases of the skin and 
subcutaneous tissue (L00-L99) 6,507 
 (5.3%) 
4.1 
(3.99-
4.19) 
5,191 
(2.7%) 
3.4 
(3.35-
3.554) 
2,270 
(3.9%) 
2.4 
(2.30-
2.50) 
4,539 
(4.4%) 
4.5 
(4.36-
4.62) 
4,889 
(3.4%) 
4.5 
(4.35-
4.60) 
11,698 
(3.7%) 
3.8 
(3.71-
3.84) 
Diseases of the musculoskeletal 
system and connective tissue 
(M00-M99) 
4,668 
 (3.8%) 
2.9 
(2.86-
3.03) 
3,867 
(2.0%) 
2.6 
(2.50-
2.67) 
1,928 
(3.3%) 
2.0 
(1.95-
2.13) 
3,230 
(3.0%) 
3.2 
(3.08-
3.31) 
3,377 
(2.3%) 
3.1 
(2.99-
3.20) 
8,535 
(2.7%) 
2.8 
(2.71-
2.82) 
Certain infectious and parasitic 
diseases (A00-B99)     3,707 
 (3.0%) 
2.4 
(2.30-
2.45) 
4,630 
(2.4%) 
3.1 
(3.01-
3.19) 
2,257 
(3.8%) 
2.4 
(2.29-
2.49) 
3,066 
(2.8%) 
3.0 
(2.92-
3.14) 
3,014 
(2.1%) 
2.8 
(2.66-
2.86) 
8,337 
(2.7%) 
2.7 
(2.66-
2.78) 
Neoplasms (C00-D48)  
3,237 
 (2.7%) 
2.1 
(2.03-
2.18) 
4,435 
(2.3%) 
3.0 
(2.87-
3.05) 
2,481 
(4.2%) 
2.6 
(2.52-
2.73) 
2,514 
(2.3%) 
2.5 
(2.39-
2.58) 
2,677 
(1.8%) 
2.5 
(2.36-
2.55) 
7,672 
(2.5%) 
2.5 
(2.46-
2.57) 
Endocrine, nutritional and 
metabolic diseases (E00-E90) 3,239 
 (2.7%) 
2.1 
(2.02-
2.16) 
4,221 
(2.2%) 
2.9 
(2.78-
2.95) 
2,380 
(4.1%) 
2.5 
(2.42-
2.62) 
2,950 
(2.7%) 
2.9 
(2.81-
3.02) 
2,130 
(1.5%) 
1.9 
(1.87-
2.03) 
7,460 
(2.4%) 
2.5 
(2.41-
2.52) 
Diseases of the nervous system 
(G00-G99)  3,078 
 (2.5%) 
2.0 
(1.91-
2.06) 
3,690 
(1.9%) 
2.5 
(2.39-
2.55) 
2,144 
(3.7%) 
2.3 
(2.17-
2.36) 
2,210 
(2.0%) 
2.2 
(2.09-
2.28) 
2,414 
(1.5%) 
2.2 
(2.12-
2.30) 
6,768 
(2.2%) 
2.2 
(2.16-
2.27) 
Diseases of the blood and blood-
forming organs and certain 
disorders involving the immune 
mechanism (D50-D89) 
2,302 
 (1.9%) 
1.5 
(1.44-
1.57) 
2,412 
(1.3%) 
1.6 
(1.55-
1.69) 
1,706 
(2.9%) 
1.8 
(1.72-
1.89) 
1,562 
(1.4%) 
1.5 
(1.47-
1.62) 
1,446 
(1.0%) 
1.3 
(1.26-
1.39) 
4,714 
(1.5%) 
1.6 
(1.51-
1.60) 
Diseases of the circulatory 
system (I00-I99) 1,694  
(1.4%) 
1.1 
(1.02-
1.12) 
1,564 
 (0.8%) 
1.0 
(0.98-
1.08) 
633  
(1.1%) 
0.7 
(0.32-
0.72) 
1,116 
 (1.0%) 
1.1 
(1.04-
1.17) 
1,509 
 (1.0%) 
1.4 
(1.31-
1.45) 
3,258 
 (1.0%) 
1.0 
(1.01-
1.08) 
Congenital malformations, 
deformations and chromosomal 
abnormalities (Q00-Q99) 
1,318  
(1.1%) 
0.9 
(0.83-
0.93) 
1,323 
 (0.7%) 
0.9 
(0.86-
0.96) 
1,291 
 (2.2%) 
1.4 
(1.29-
1.44) 
904  
(0.8%) 
0.9 
(0.84-
0.95) 
446  
(0.3%) 
0.4 
(0.37-
0.45) 
2,641 
 (0.8%) 
0.9 
(0.86-
0.93) 
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 Male Female 10-14 years 15-19 years 20-24 years 10-24 years  
IDC-10 primary diagnosis 
category n (%) Rate* (CI)  n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   n (%) Rate* (CI)   
Diseases of the ear and mastoid 
process (H60-H95)  1,178  
(1.0%) 
0.8 
(0.74-
0.84) 
1,207 
 (0.6%) 
0.8 
(0.79-
0.89) 
1,366 
 (2.3%) 
1.4 
(1.37-
1.52) 
632  
(0.6%) 
0.6 
(0.58-
0.68) 
387  
(0.3%) 
0.4 
(0.32-
0.39) 
2,385 
 (0.8%) 
0.8 
(0.78-
0.85) 
Diseases of the eye and adnexa 
(H00-H59) 689  
(0.6%) 
0.4 
(0.42-
0.48) 
746  
(0.4%) 
0.5 
(0.47-
0.55) 
581  
(1.0%) 
0.6 
(0.57-
0.67) 
466  
(0.4%) 
0.5 
(0.42-
0.50) 
388  
(0.3%) 
0.4 
(0.32-
0.39) 
1,435 
 (0.5%) 
0.5 
(0.45-
0.50) 
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 Aboriginal  
  Male Female 10-14 15-19 20-24 All adolescents 
IDC-10 primary diagnosis category n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  
Pregnancy, childbirth and the 
puerperium   
- - 
6,018 
(42.7%) 118.2 
54  
(1.8%) 1.4 
2,149 
(31.1%) 57.6 
3,815 
(36.2%) 116 
6,018 
(29.3%) 57.8 
Injury, poisoning and certain other 
consequences of external causes  1,970 
 (30.6%) 35.8 
1,338 
(9.5%) 25.5 
714 
(23.2%) 18.0 
1,229 
(17.8%) 32.9 
1,365 
(13.0%) 41.7 
3,308 
(16.1%) 30.7 
Mental and behavioural disorders  
1,201  
(18.7%) 22.3 
1,303 
(9.3%) 25.2 
181  
(5.9%) 4.6 
990 
(14.3%) 26.5 
1,333 
(12.7%) 40.7 
2,504 
(12.2%) 23.7 
Factors influencing health status and 
contact with health services  322 
 (5.0%) 6 
1,310 
(9.3%) 25.9 
125  
(4.1%) 3.2 
261  
(3.8%) 7.0 
1,246 
(11.8%) 38.1 
1,632  
(8.0%) 15.8 
Diseases of the digestive system  
584 
 (9.1%) 10.6 
741  
(5.3%) 14.1 
324 
(10.5%) 8.2 
375  
(5.4%) 10.1 
626  
(5.9%) 19.1 
1,325 
(6.5%) 12.3 
Symptoms, signs and abnormal clinical 
and laboratory findings, not elsewhere 
classified 
445 
 (6.9%) 8.1 
749  
(5.3%) 14.3 
224  
(7.3%) 5.7 
443  
(6.4%) 11.8 
527  
(5.0%) 16.1 
1,194 
(2.8%) 11.1 
Diseases of the respiratory system   
437 
 (6.8%) 7.7 
548  
(3.9%) 10.2 
366 
(11.9%) 9.3 
348  
(5.0%) 9.3 
271  
(2.6%) 8.3 
985  
(4.8%) 9.0 
Diseases of the skin and subcutaneous 
tissue  341 
 (5.3%) 6.2 
365  
(2.6%) 6.9 
178  
(5.8%) 4.5 
260  
(3.8%) 7.0 
268  
(2.5%) 8.2 
706  
(3.4%) 6.5 
Diseases of the genitourinary system   
121 
 (1.9%) 2.2 
552  
(3.9%) 10.6 
122  
(4.0%) 3.1 
220  
(3.2%) 5.9 
331  
(3.1%) 10.1 
673  
(3.3%) 6.3 
Diseases of the musculoskeletal system 
and connective tissue  191 
 (3.0%) 3.5 
193  
(1.4%) 3.6 
109  
(3.5%) 2.8 
130  
(1.9%) 3.5 
145  
(1.4%) 4.4 
384  
(1.9%) 3.5 
Diseases of the nervous system   
207 
 (3.2%) 3.7 
159  
(1.1%) 3.0 
112  
(3.6%) 2.8 
118  
(1.7%) 3.2 
136  
(1.3%) 4.2 
366  
(1.8%) 3.4 
Certain infectious and parasitic diseases   
132 
 (2.1%) 2.3 
217  
(1.5%) 4.1 
122  
(4.0%) 3.1 
117  
(1.7%) 3.1 
110  
(1.0%) 3.4 
349  
(1.7%) 3.2 
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Endocrine, nutritional and metabolic 
diseases 148 
 (2.3%) 2.6 
99  
(0.7%) 1.9 
89  
(2.9%) 2.2 
61  
(0.9%) 1.6 
97  
(0.9%) 3.0 
247  
(1.2%) 2.3 
Neoplasms   
86  
(1.3%) 1.5 
147  
(1.0%) 2.8 
82  
(2.7%) 2.1 
45  
(0.7%) 1.2 
106  
(1.0%) 3.2 
233  
(1.1%) 2.2 
Diseases of the ear and mastoid process   
107 
 (1.7%) 1.9 
128  
(0.9%) 2.3 
149  
(4.8%) 3.8 
59  
(0.9%) 1.6 
27  
(0.3%) 0.8 
235  
(1.1%) 2.1 
Diseases of the circulatory system  
65 
(1.0%) 1.2 
63  
(0.4%) 1.2 
33  
(1.1%) 0.8 
42  
(0.6%) 1.1 
53  
(0.5%) 1.6 
128  
(0.6%) 1.2 
Diseases of the blood and blood-forming 
organs and certain disorders involving 
the immune mechanism 
18  
(0.3%) 0.3 
93  
(0.7%) 1.8 
38  
(1.2%) 1.0 
27  
(0.4%) 0.7 
46  
(0.4%) 1.4 
111  
(0.5%) 1.0 
Congenital malformations, deformations 
and chromosomal abnormalities  35  
(0.5%) 0.6 
28  
(0.2%) 0.5 
31  
(1.0%) 0.8 
24  
(0.3%) 0.6 
8  
(0.1%)  0.2 
63  
(0.3%) 0.6 
Diseases of the eye and adnexa  22  
(0.3%) 0.4 
30  
(0.2%) 0.6 
20  
(0.7%) 0.5 
17  
(0.2%) 0.5 
15  
(0.1%) 0.5 
52  
(0.3%) 0.5 
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 non-Aboriginal  
 Male Female 10-14 15-19 20-24 All adolescents  
IDC-10 primary diagnosis category n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  n (%) Rate*  
Pregnancy, childbirth and the 
puerperium   
- - 
66,800 
(35.0%) 42.1 
204  
(0.3%) 0.2 
17,122 
(15.8%) 16.9 
49,474 
(34.0%) 45.2 
66,800 
(21.4%) 20.4 
Injury, poisoning and certain other 
consequences of external causes  34,837 
(28.6%) 22.1 
18,511 
(9.7%) 12.4 
13,364 
(22.8%) 14.1 
20,799 
(19.2%) 20.5 
19,185 
(13.2%) 17.5 
53,348 
(17.1%) 17.4 
Diseases of the digestive system  
14,208 
(11.7%) 9.1 
17,325 
(9.1%) 11.4 
7,122 
(12.1%) 7.5 
11,789 
(15.8%) 11.6 
12,622 
(8.7%) 11.5 
31,533 
(10.1%) 10.2 
Mental and behavioural disorders  
10,556 
(8.7%) 6.5 
12,168 
(6.4%) 8.0 
1,837 
(3.1%) 1.9 
9,752 
(9.0%) 9.6 
11,135 
(7.6%) 10.1 
22,724 
(7.3%) 7.2 
Symptoms, signs and abnormal clinical 
and laboratory findings, not elsewhere 
classified 
7,636 
 (6.3%) 4.8 
13,524 
(7.1%) 8.9 
4,388 
(7.5%) 4.6 
7,829 
(7.2%) 7.7 
8,943 
(6.1%) 8.2 
21,160 
(6.8%) 6.8 
Diseases of the respiratory system   
9,005 
 (7.4%) 5.8 
11,095 
(5.8%) 7.5 
6,220 
(10.6%) 6.6 
7,838 
(7.2%) 7.7 
6,042 
(4.1%) 5.5 
20,100 
(6.4%) 6.6 
Factors influencing health status and 
contact with health services  9,715 
 (8.0%) 6.2 
8,315 
(4.4%) 5.4 
4,257 
(7.3%) 4.5 
5,165 
(4.8%) 5.1 
8,608 
(5.9%) 7.9 
18,030 
(5.8%) 5.8 
Diseases of the genitourinary system   
4,240 
 (3.5%) 2.7 
9,745 
(5.1%) 6.3 
2,287 
(3.9%) 2.4 
4,791 
(4.4%) 4.7 
6,907 
(4.7%) 6.3 
13,985 
(4.5%) 4.5 
Diseases of the skin and subcutaneous 
tissue  6,507 
 (5.3%) 4.1 
5,191 
(2.7%) 3.4 
2,270 
(3.9%) 2.4 
4,539 
(4.4%) 4.5 
4,889 
(3.4%) 4.5 
11,698 
(3.7%) 3.8 
Diseases of the musculoskeletal system 
and connective tissue  4,668 
 (3.8%) 2.9 
3,867 
(2.0%) 2.6 
1,928 
(3.3%) 2.0 
3,230 
(3.0%) 3.2 
3,377 
(2.3%) 3.1 
8,535 
(2.7%) 2.8 
Certain infectious and parasitic diseases   
3,707 
 (3.0%) 2.8 
4,630 
(2.4%) 3.1 
2,257 
(3.8%) 2.4 
3,066 
(2.8%) 3.0 
3,014 
(2.1%) 2.8 
8,337 
(2.7%) 2.7 
Neoplasms   
3,237 
 (2.7%) 2.1 
4,435 
(2.3%) 3.0 
2,481 
(4.2%) 2.6 
2,514 
(2.3%) 2.5 
2,677 
(1.8%) 2.5 
7,672 
(2.5%) 2.5 
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Endocrine, nutritional and metabolic 
diseases 3,239 
 (2.7%) 2.1 
4,221 
(2.2%) 2.9 
2,380 
(4.1%) 2.5 
2,950 
(2.7%) 2.9 
2,130 
(1.5%) 1.9 
7,460 
(2.4%) 2.5 
Diseases of the nervous system   
3,078 
 (2.5%) 2.0 
3,690 
(1.9%) 2.5 
2,144 
(3.7%) 2.3 
2,210 
(2.0%) 2.2 
2,414 
(1.5%) 2.2 
6,768 
(2.2%) 2.2 
Diseases of the blood and blood-forming 
organs and certain disorders involving 
the immune mechanism 
2,302 
 (1.9%) 1.5 
2,412 
(1.3%) 1.6 
1,706 
(2.9%) 1.8 
1,562 
(1.4%) 1.5 
1,446 
(1.0%) 1.3 
4,714 
(1.5%) 1.6 
Diseases of the circulatory system  
1,694  
(1.4%) 1.1 
1,564 
 (0.8%) 1.0 
633  
(1.1%) 0.7 
1,116 
 (1.0%) 1.1 
1,509 
 (1.0%) 1.4 
3,258 
 (1.0%) 1.0 
Congenital malformations, deformations 
and chromosomal abnormalities  1,318  
(1.1%) 0.9 
1,323 
 (0.7%) 0.9 
1,291 
 (2.2%) 1.4 
904  
(0.8%) 0.9 
446  
(0.3%) 0.4 
2,641 
 (0.8%) 0.9 
Diseases of the ear and mastoid process   
1,178  
(1.0%) 0.8 
1,207 
 (0.6%) 0.8 
1,366 
 (2.3%) 1.4 
632  
(0.6%) 0.6 
387  
(0.3%) 0.4 
2,385 
 (0.8%) 0.8 
Diseases of the eye and adnexa  689  
(0.6%) 0.4 
746  
(0.4%) 0.5 
581  
(1.0%) 0.6 
466  
(0.4%) 0.5 
388  
(0.3%) 0.4 
1,435 
 (0.5%) 0.5 
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Abstract  
Aboriginal and Torres Strait Islander Australians are a relatively young population. In 2016, 
the median age was 23 years and over 30 percent were aged 10-24. Understanding reasons 
for and rates of hospitalisation of Aboriginal and Torres Strait Islander adolescents will help 
identify priority health needs to inform service delivery and policy. This study aims to 
understand if there has been a change in adolescent hospitalisations in South Australia 
between 2006-2015.  
Using public hospital separation data from the Integrated South Australian Activity 
Collection, SA Department for Health and Wellbeing, a retrospective study of adolescent 
hospitalisations in South Australia was conducted. For 2006-2015, the reason and rate of 
hospitalisation was calculated per 1,000 adolescent population by Aboriginal status, sex, age 
group (10-14, 15-19 and 20-24 years) and remoteness. Reason for hospitalisation was 
defined by International Classification of Disease (ICD-10AM) and presented by ICD chapter 
and service related group. 
There was a total of 333,096 adolescent separations in South Australian public hospitals from 
2006 to 2015 inclusive. Females had a higher proportion of hospitalisations (62%) than males 
over the ten-year period. Of all hospitalisations, 6% were by Aboriginal adolescents. For 
Aboriginal adolescents, the top four reasons for hospitalisation were pregnancy, childbirth 
and the puerperium, injury, poisoning and other related external causes, mental and 
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behavioural disorders and disease of the digestive system. The findings show that the rates 
for hospitalisation varied over the ten-year period by Aboriginal status, sex, age group and 
remoteness.  
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3.1. Prologue 
Rates of sexually transmitted infections (STI) have been rising among young Australians and 
disproportionately affect the Aboriginal and Torres Strait Islander population. However, 
limited evidence exists to provide insight into the social and behavioural factors of young 
Australians. One approach to collecting such information is via cross-sectional surveys of a 
broadly representative population group at a point in time. Previous surveys have provided 
some evidence on the topic, yet none to date have been collected at the state level in South 
Australia. Additionally, despite the over-representation of STI among Aboriginal and Torres 
Strait Islander peoples, very few studies have included a sufficient number of Aboriginal and 
Torres Strait Islander people to enable direct comparisons between Indigenous and non-
Indigenous population groups. This chapter describes the piloting of Let’s Talk About It 2019, 
an online survey of South Australian young people aged 16-29 years.  
3.1.1. My role  
My epidemiological study involved: 
• drafting a study proposal and data analysis plan  
• obtaining ethics approval  
• engaging with an advisory group comprised of Aboriginal and non-Indigenous young 
people aged 16-29 years 
• reviewing the survey questions  
• engaging with a communication and marketing specialist regarding the promotion 
and management of the survey on social media 
• cleaning and recoding variables  
• data analysis and interpretation 
• presentation of results 
• drafting of initial and subsequent versions of the chapter  
• obtaining feedback and comments on the chapter from co-investigators and 
supervisors. 
3.1.2. Lessons learnt  
This is the first project I have conducted that uses a survey as the main method and only form 
of data collection. This method of data collection is typically used in epidemiology, as it is 
easier to undertake and less costly than many other study designs, and surveys can provide 
valuable insight into a population at a particular point in time but also over time to assess 
trends if repeated.  
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This is what was achieved with Let’s Talk About It 2019: 
• In total 2,380 young South Australians over a 6-week period provided information on 
their current sexual health, knowledge, behaviours and access to health services in 
relation to sexually transmitted infections (STI) and bloodborne viruses (BBV). 
• We collected a significant amount of information and compared data obtained from 
Aboriginal and/or Torres Strait Islander respondents with data from non-Indigenous 
respondents. We examined socio-demographic factors, behaviours, sexual health 
knowledge and health service access including STI and BBV testing for associations.  
• I learnt about developing and conducting adjusted logistic regression analysis and 
models and worked with a biostatistician to ensure my approach was appropriate. 
• Another lesson I learnt is how to best present data and results. Deciding between 
whether to present results in a table or as a graph is ultimately dependent on the 
type of data being presented. First and foremost, regardless of how data is 
presented, whether it is in a table or graph, it should be self-explanatory; the reader 
should be able to understand the table or graph without the need to read the text 
that refers to it. Tables can be ideal where a lot of information needs to be included. 
For example, demographic data which is categorical can be presented by distribution 
with counts (n) and percentages (%) and include the denominator (N). This is 
particularly important when the denominator might be different for each category 
being presented and are not comparable across categories. 
• It is not always possible to effectively communicate data on a table, particularly when 
multiple categories are being presented. Graphs can be a simple way to 
communicate results and can often have a greater impact than tables, as similarities 
and differences can be seen without requiring too much interpretation.  
• Finally, when you are immersed in and working with the data, you become aware of 
how you might change or restructure future surveys and how to code these for ease 
of analysis. These are only small changes but ultimately it is about ensuring the data 
is user-friendly, so there is less cleaning and recoding of variables and values 
required.  
3.1.3. Public health implications  
Most STI in Australia occur in young people aged 15-29 years and disproportionately affect 
the Aboriginal and Torres Strait Islander population in the same age group. STI are easy to 
detect and treat but can lead to serious sexual and reproductive health consequences if left 
untreated. It is important to understand key clinical, social and behavioural factors 
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underlying STI notification data to allow trends to be interpreted and assist in the 
development and design of public health interventions aimed at addressing STI among young 
Australians. 
This study is the first to describe current sexual health, knowledge, behaviours and access to 
health services for STI and BBV and related issues amongst young South Australians, both 
Aboriginal and/or Torres Strait Islander and non-Indigenous. 
We found similar proportions of Aboriginal and/or Torres Strait Islander and non-Indigenous 
participants reporting behaviours such as: being sexually active; having a sexual partner at 
the same time as a regular partner (concurrency); and multiple sexual partners in the past 12 
months. Each group equally used internet/mobile applications (apps) to meet partners.  
Aboriginal and or Torres Strait Islander participants initiated sexual activity marginally earlier; 
were more likely to report being ‘drunk’ or ‘high’ during their last sexual encounter; were 
less likely to use a condom with a casual sexual partner; were more likely to report having 
ever or recently tested for an STI; and were more likely to have been diagnosed with an STI 
than non-Indigenous participants. 
Overall, young South Australians are engaged in behaviours which increases their risk of 
acquiring STI. This evidence is important for informing public health practice and policy 
development, and development of STI and BBV preventative health programs – particularly 
those targeting young Aboriginal and/or Torres Strait Islander people. As a result of this 
survey the South Australian Government have initiated social media campaigns to promote 
condom awareness and use in this population group. We propose that consideration be given 
to conducting surveys on an ongoing basis to health shape future public health policy and 
programs within the state of South Australia.  
3.1.4. Acknowledgements  
Firstly, I would like to acknowledge and thank the young people who participated in Let’s Talk 
About It 2019. Additionally, I would like to acknowledge and thank the investigator team, Dr 
Salenna Elliot and Professor James Ward for their guidance, support and leadership, and Dr 
Handan Wand for her statistical data analysis support. 
3.1.5. MAE core requirements  
This project fulfils the ‘conducting an epidemiological study’ component of the Master of 
Applied Epidemiology. Summary results were made available to participants through social 
media and the South Australian Health and Medical Research Institute website.   
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3.2. Abstract 
3.2.1. Objective 
The aim of this study was to 1) to conduct a sexual health survey of young South Australians; 
2) to include Aboriginal and/or Torres Strait Islander and non-Indigenous young people in the 
same survey to allow for comparisons; and 3) to assess the acceptability and feasibility of
collecting STI and BBV data in an online format with a view to delivering future surveys
utilising the same format.
3.2.2. Methods 
This study was an online cross-sectional survey, completed by participants aged between 16-
29 years, and residents of South Australia. Descriptive analysis, univariate and adjusted 
logistic regression models were used to assess association, whether socio-demographic 
characteristics and sexual risk behaviours were associated with specific behaviours. 
3.2.3. Results 
Between July and August 2019, 2,380 young South Australians participated in Let’s Talk About 
It 2019, an online survey of South Australian young people aged 16-29 years. Participants 
provided information on their current sexual health, knowledge, behaviours and access to 
health services in relation to sexually transmissible infections and blood-borne viruses. Over 
half (52%) of participants were female; the median age was 20 years; 72% identified as 
straight (heterosexual) and as 17% bisexual; 78% were from the urban Adelaide area; and 
10% identified as Aboriginal and/or Torres Strait Islander. 
Similar proportions of Aboriginal and/or Torres Strait Islander and non-Indigenous 
participants reported: being sexually active (81% vs 78%); having two sexual partners at the 
same time (concurrency) (13% vs 12%); and multiple sexual partners in past 12 months. Both 
population groups reported the same rate for using the internet or mobile applications to 
meet partners (30%). However, Aboriginal and/or Torres Strait Islander participants reported 
an earlier age of sexual debut (vaginal - 16.0 years of age vs 16.7 years of age); were more 
likely to report being ‘drunk’ or ‘high’ when they last had sex (28% vs 17%); were less likely 
to always use a condom with a casual sexual partner (25% vs 36%); were more likely to report 
having ever tested for an STI (69% vs 46%) or recently tested for an STI (46% vs 27%); and 
were more likely to have tested positive for an STI (30% vs 21%) than non-Indigenous 
participants. 
3.2.4. Conclusion   
Let’s Talk About It 2019 is the first study to describe current sexual health, knowledge, 
behaviours and access to health services for sexually transmissible infections and blood-
67 
 
borne viruses and related issues amongst young South Australians. This evidence is important 
for informing both public health practice and policy, and the development of sexually 
transmissible infections and blood-borne viruses preventative health programs. We propose 
that consideration be given to conducting surveys on an ongoing basis to help shape future 
public health policy and programs within the state of South Australia.  
3.3. Introduction  
Rates of sexually transmitted infections (STI), particularly Chlamydia trachomatis 
(chlamydia), and Neisseria gonorrhoeae (gonorrhoea), have been rising among young 
Australians. In 2017, chlamydia was the most notified STI in Australia; almost three-quarters 
of notifications were among young people aged 15-29 years, and rates were higher among 
females than males (441.8 vs 394.9 per 100 000) (1). Gonorrhoea was the second most 
notified STI in Australia in 2017, increasing by 16% from 2016 (1). Over half of the 
notifications for gonorrhoea were among people aged 15-29 years and most notifications 
were among males (74%) (1). These and other STI disproportionately affect the Aboriginal 
and Torres Strait Islander population. In 2017, diagnosis rates of chlamydia and gonorrhoea  
were 2.8 and 6.6 times higher respectively than non-Indigenous rates (1, 2).  
Similarly, in South Australia (SA), STI notifications are increasing. Notification rates for 
chlamydia increased by 8% between 2016 and 2017 (340.7 and 367.9 per 100,000 
respectively), gonorrhoea increased by 15% and there was an 80% increase in infectious 
syphilis over the same period (1). Young South Australians aged 15-29 accounted for most of 
the notifications and Aboriginal and Torres Strait Islanders people experienced higher STI 
rates compared to their non-Indigenous peers (1, 3). 
Sexually transmissible infections are easy to detect and treat but can lead to serious sexual 
and reproductive health consequences if left untreated (4-6). It is important to understand 
key clinical, social and behavioural factors underlying these notification data to allow trends 
to be interpreted and assist in the development and design of public health interventions 
aimed at addressing STI among young Australians. However, there has been limited evidence 
to date which provides insight into the social and behavioural factors of young Australians. 
One approach to building an evidence base is to collect such information via cross-sectional 
surveys of a broadly representative population group at a point in time. If these types of 
surveys are collected regularly using similar methods, they also enable an assessment of 
trends over time. 
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Previous surveys have provided some evidence on the topic, yet none to date have been 
collected at the state level in SA. Additionally, despite the over representation of STI among 
Aboriginal and Torres Strait Islander peoples, very few studies have included both non-
Indigenous participants and a sufficient number of Aboriginal and/or Torres Strait Islander 
people to enable direct comparisons between the two population groups.  
Established surveys such as the annual ‘Sex, Drugs, and Rock'n'Roll’ survey (Big Day Out 
Study) (SDRR) conducted in Victoria (Australia) among people aged 16-29 years, commenced 
in 2005, initially collected at music festivals and with online data collection since 2015 (7). 
The SDRR covers sexual behaviour, and alcohol and other drug use. Every year SDRR includes 
an additional set of questions about a specific topic, for example in 2019, it was pornography, 
the two years prior it was sexting, pornography and sexual harassment (8, 9). The proportion 
of Aboriginal and Torres Strait Islander SDRR participants has been approximately 2% or less 
in each survey (accounting for <50 participants in each survey) (10), making this difficult to 
conduct further analysis to assess for differences between populations.  
The ‘It’s Your Love Life’ survey is an online survey on sexuality, relationships and sexual health 
of young people aged 15 to 29 living in New South Wales and the Australian Capital Territory 
(11, 12). The first ‘It’s Your Love Life’ survey was conducted between December 2015 and 
March 2016 and again in May and July 2017. Around 2% (n=56 and n=60) of participants in 
each survey identified as Aboriginal and/or Torres Strait Islander; however, no results were 
presented by Indigenous status (11, 12). Another survey of young people, the ‘Debrief 
Survey’, a national behavioural online survey on sexual health among young people aged 15–
29 years in Australia, was conducted over a four-month period from December 2017 to April 
2018. It recruited 2,303 participants through social media (13). Preliminary results indicate 
3% (n=58) of participants identified as Aboriginal and/or Torres Strait Islander and similarly 
to ‘It’s Your Love Life’, results were not disaggregated by Indigenous status. This is a major 
limitation of such surveys.    
The GOANNA survey was collected at 40 Aboriginal and Torres Strait Islander community 
events across Australia between 2011-13 using personal digital assistant devices. It was the 
first study to gather data on social and behavioural factors relating to sexual health from a 
large sample (n=2877) of Aboriginal and/or Torres Strait Islander young people (14). The 
GOANNA Survey 2 is now in progress and has been underway since 2017, and thus far has 
collected surveys from 1200 participants. This mode of survey data collection has strengths 
and weaknesses; the yield and representativeness of survey participants is broadly 
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representative but there are various logistical challenges in conducting the survey at a 
national level because surveys are collected at community events with relative higher 
financial costs and logistical efforts required than for an online survey. Therefore, an online 
survey format may be more appropriate for regular surveillance and may also achieve a 
sample of participants that is equally representative of the broader population.  
This chapter describes the piloting of an online version of an adapted GOANNA survey, 
named Let’s Talk About It 2019, a survey of South Australian young people aged 16-29 years. 
Let’s Talk About It 2019 has three goals: 1) to conduct a sexual health survey of young South 
Australians; 2) to include Aboriginal and/or Torres Strait Islander and non-Indigenous young 
people in the same survey to allow for comparisons; and 3) to pilot an online survey with a 
view to delivering the GOANNA survey via this format in the future enabling an assessment 
of trends over time. The aim of this study is to describe current sexual health, knowledge, 
protective/risk behaviours and access to health services for STI and blood-borne viruses 
(BBV) and related issues amongst young South Australians aged 16-29 years, both Aboriginal 
and or Torres Strait Islander and non-Indigenous.  
3.4. Methods  
3.4.1. Study design and setting   
This study was a cross-sectional survey, completed by participants aged between 16-29 
years, and residents of South Australia. The survey was completed online via a survey 
website. The survey was a pilot study to assess the acceptability and feasibility of collecting 
this data from young people with a view of collecting on an ongoing basis. The survey was 
conducted over a six-week period between July and August 2019. 
3.4.2. Study governance 
A study advisory group for the survey was established to oversee the project. The advisory 
group comprised of Aboriginal and/or Torres Strait Islander and non-Indigenous young 
people aged 16-29 years, including members of each gender. The role of the committee was 
to provide input from the perspective of young people on appropriateness of survey 
questions and on marketing of the survey to various groups within this population, such as 
to people living in regional and remote areas, people from a culturally and linguistically 
diverse background, Aboriginal peoples, university students, and employed/unemployed 
people.  
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3.4.3. Participants and recruitment  
To be eligible, participants needed to be 16-29 years old, residents of South Australia and 
able to provide informed consent. There were no specified exclusion criteria. Participants 
were recruited online via marketing of the survey on social media (Facebook and Instagram) 
and via email networks. The marketing was reviewed on a regular basis and altered to target 
underrepresented populations completing the survey. The marketing of the survey utilised 
emojis representing intimacy, male and female genitals and the Aboriginal and Torres Strait 
Islander flags. Two images were created using the emojis and were used during the period 
the survey was open (Figure 3.1).    
The advertisement was linked to the survey webpage which included a downloadable 
participant information statement. Potential participants then proceeded to the survey by 
selecting 'Start Survey', where they were presented with eligibility and consent questions. 
Eligibility criteria included; ‘Do you live in South Australia?’, ‘Are you 16-29 years old?’, and 
‘Do you consent?’. Participants were excluded if they selected 'No' or 'Disagree' for any of 
these questions and were exited from the survey. Otherwise participants were directed to 
the survey. 
The advertisement advised that participants had the opportunity to win 1 of 10 $100 gift 
vouchers, as an incentive. At completion of the survey, participants were invited to submit 
their email address to enter the prize draw. This component was not linked to the survey and 
could not be linked to an individual's survey response.  Email addresses were deleted after 
completion of the prize draw. 
  
FIGURE 3.1: IMAGES USED FOR ADVERTISING OF THE SURVEY ON SOCIAL MEDIA, JUL-AUG 2019, SOUTH AUSTRALIA, 
LET’S TALK ABOUT IT 2019 
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3.4.4. Sample size 
The aim was to recruit at least 150 Aboriginal and/or Torres Strait Islander and 300 non-
Indigenous young people aged between 16-29 years old. With this sample size, the study 
would have 80% power to detect a 10% difference in proportions between the two groups 
(significance level 5%). This sample size would allow us to estimate prevalence of several 
characteristics with acceptable precision among the groups (±6% absolute width (for non-
Indigenous participants) and ±13% absolute width (for Aboriginal participants) for 95% CIs). 
3.4.5. Survey  
The online survey was a modified version of the one used for the GOANNA Survey 2, to make 
it suitable for both Aboriginal and/or Torres Strait Islander and non-Indigenous participants 
(Appendix 3.A). The survey questions sought information on demographic characteristics, 
knowledge of STI and BBV, previous experience of testing and diagnosis of an STI or BBV, risk 
behaviours associated with acquisition of STI and BBV, experience of use of health services 
for sexual health, and a section on how participants felt about the survey. None of the 
questions were mandatory and some questions were conditional questions, e.g. ‘Are you 
currently studying’ and ‘Where are you studying?’ or ‘Have you ever tested positive for an 
STI?’ and ‘Which STI(s) [have you tested positive for]?’. The survey was administered online 
using REDCap, a secure web application for building and managing online surveys and 
databases.  
3.4.6. Data analysis  
We compared and examined socio-demographic factors, behaviours, sexual health 
knowledge, health service access for STI and BBV, and associations between self-reported 
STI/BBV diagnosis among Aboriginal and/or Torres Strait Islander and non-Indigenous young 
people. Data were compiled into a single dataset, cleaned and analysed using Stata version 
15 (15). Data analyses included descriptive analysis; calculation of proportions, means and 
medians, as appropriate. Missing data (e.g. not reported by participants) were included in 
calculations of proportions and reported in tables, where appropriate. Counts less than 5 are 
reported as <5, also counts less than 10 are reported without a percentage. Chi-squared, 
Fishers exact and Kruskal Wallis tests were used to test differences among variables 
comparing Indigenous status; the significance level was set at <0.05.  
Univariate and adjusted logistic regression models were used to determine whether socio-
demographic characteristics and sexual risk behaviours were associated with specific 
behaviours; ever been tested for an STI; and ever tested positive. Adjusted odds ratios (aOR) 
and 95 % Confidence Intervals (CI) are presented for all participants and by Indigenous status. 
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The fitness of models was tested using the Hosmere-Lemeshow criteria (16) and multi 
collinearity was also assessed using the variance inflation factor. The socio-demographic 
characteristics and sexual risk behaviours used in logistic regression analysis were included 
based on existing literature (17-28) and public health importance: Indigenous status, gender, 
age group, sexuality, remoteness, marital status, education level, employment status, 
concurrency, number of sexual partners, use of internet and mobile apps, condom use, 
alcohol and illicit drug use, and drug score. A ‘drug score’ for each participant was created by 
assigning a score of ‘1’ (if yes, illicit drugs were reported as being used) and ‘0’ (if no, illicit 
drugs were reported as being used); scores were added for each drug used by a participant, 
and re-categorised according to their final drug score: (0: no drug, 1: one drug only, 2: two 
or more drugs). 
3.4.7. Ethics approval 
Ethics approval was obtained from the Aboriginal Human Research Ethics Committee (South 
Australia) (04-18-797), Flinders University Social and Behavioural Research Ethics Committee 
(OH-00202) and the Australian National University Human Research Ethics Committee 
(2019/311). 
3.5. Results  
3.5.1. Participant recruitment and eligibility 
To assess the acceptability and feasibility of this survey among our target population we 
assessed the participation rate and broad demographics of the survey over time. Within the 
first four days of the survey being advertised on social media, over 400 young people had 
accessed the survey. Over two-thirds were female, the median age was 18 years 
(interquartile range, IQR:17-23 years) and only two participants were Aboriginal and/or 
Torres Strait Islander. The initial target sample size was 450 young people; however, given 
that the survey was overrepresented in this early phase by younger age groups and females, 
and very few Aboriginal and Torres Strait Islander participants the investigator team chose 
to keep the survey open. During the six-week period the survey was open the marketing 
strategy and emoji image was altered to attract underrepresented populations. Specifically, 
targeting via social media among males, young people from rural and remote areas and those 
with an interest in Aboriginal and Torres Strait Islander culture, history, language, National 
Aborigines and Islanders Day Observance Committee (NAIDOC) and reconciliation were 
trialled during the remaining weeks of the survey. To enhance the appeal to males the 
background of the original image was changed to a navy-blue colour and used specifically for 
targeting of the survey to males only (Figure 3.2).  
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FIGURE 3.2: MODIFIED IMAGES USED FOR ADVERTISING OF THE SURVEY ON SOCIAL MEDIA WITH NAVY BLUE 
BACKGROUND, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 
In total 2,724 people accessed the survey during the six-week period. Figure 3.3 provides 
details on the number of people who accessed the survey by gender and Figure 3.4 by 
Indigenous status. Of those who accessed the survey, 2,528 were eligible, having met the 
three survey eligibility questions. However, 141 were excluded based on not completing 
basic demographic information or any other part of the survey. A further six participants 
were excluded: five provided postcodes not from SA and one was under the age of 16 
(despite agreeing to the eligibility questions about age and residence in SA).  In total 2,380 
survey participants were included in the analysis.  
 
FIGURE 3.3: YOUNG PEOPLE WHO ACCESSED THE SURVEY, BY GENDER, JUL-AUG 2019, SOUTH AUSTRALIA, LET’S TALK 
ABOUT IT 2019 
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FIGURE 3.4: YOUNG PEOPLE WHO ACCESSED THE SURVEY, BY INDIGENOUS STATUS, JUL-AUG 2019, SOUTH AUSTRALIA, 
LET’S TALK ABOUT IT 2019 
 
3.5.2. Participant characteristics  
Table 3.1 presents the characteristics of survey participants by Indigenous status. Overall 
there were more females (52%, n=1,228) than males (45%, n=1,078); the overall median age 
was 20 years (IQR:17-24 years); less than half (44%, n=1,039) of participants were aged 16-
19 years; almost three-quarters (72%, n=1,706) of participants identified as straight 
(heterosexual) followed by bisexual (17%, n=404), gay (4%, n=92), lesbian (2%, n=42), 
(identifying their sexuality as) other (2%, n=44), and unsure ( 3% , n=82); and over three-
quarters (78%, n=1,861) were from the Adelaide urban area.  
Most participants were not married (77%, n=1,828) and over half (61%, n=1,445) lived with 
their parents. Almost two-thirds (62%, n=1,469) of participants were currently engaged in 
study, at high school (43%, n=637) and university – undergraduate level (38%, n=552); and 
over one-third (37%, n=871) of participants had completed secondary education compared 
to tertiary education (university) (17%, n=401). Over half (51%, n=1,204) were engaged in 
part-time/casual employment.  
Ten percent (n=231) of participants identified as Aboriginal and or Torres Strait Islander; most 
(73%, n=168) were female and the median age for Aboriginal and or Torres Strait Islander 
participants was 22 years (IQR:18-26 years). In comparison, less than half (49%, n=1,019) of 
non-Indigenous participants were female and the median age for all non-Indigenous 
participants was 21 years (IQR:17-24 years) (Table 3.1). From here on results are presented 
by Indigenous status.  
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TABLE 3.1: SURVEY PARTICIPANT CHARACTERISTICS BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 
2019 
 Total  Indigenous status 
 All participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous  
n (%) 
Not stated 
n (%) 
Participants (n) 2,380 231 2,062 87 
Gender      
Female  1,228 (52%) 168 (73%) 1,019 (49%) 41 (47%) 
Male  1,078 (45%) 55 (24%) 980 (48%) 43 (49%) 
Transgender  35 (1%) <5 30 (1%) <5  
Other  29 (1%) <5 27 (1%) 0  
Not reported  10 (<1%) <5 6  <5  
Sexual identity     
Straight  1,706 (72%) 156 (68%) 1,484 (72%) 66 (76%) 
Gay  92 (4%) 7 84 (4%) <5 
Lesbian  42 (2%) <5 37 (2%) <5 
Bisexual 404 (17%) 49 (21%) 342 (17%) 13 (15%) 
Unsure  82 (3%) 9 71 (3%) <5 
Other  44 (2%) 5 38 (2%) <5 
Not reported  10 (<1%) <5 6  <5 
Age group     
16-19 years 1,039 (44%) 76 (33%) 924 (45%) 39 (45%) 
20-24 years 819 (34%) 85 (37%) 716 (35%) 18 (21%) 
25-29 years 492 (21%) 66 (29%) 404 (20%) 22 (25%) 
Not reported 30 (1%) <5 18 (1%) 8 
Residential status     
Urban 1,861 (78%) 172 (74%) 1,631 (79%) 58 (67%) 
Rural  385 (16%) 38 (16%) 332 (16%) 15 (17%) 
Remote  55 (2%) 12 (5%) 41 (2%) <5 
Not reported 79 (3%) 9 58 (3%) 12 (14%) 
Relationship status      
Married 104 (4%) 11 (5%) 88 (4%) 5 
De-facto 427 (18%) 53 (23%) 360 (17%) 14 (16%) 
Not married 1,828 (77%) 164 (71%) 1,599 (78%) 65 (75%) 
Not reported  21 (1%) <5 15 (1%) <5 
Living arrangements#       
With parents  1,445 (61%) 91 (39%) 1,293 (63%) 61 (70%) 
With partner 535 (22%) 60 (26%) 456 (22%) 19 (22%) 
With children 142 (6%) 37 (16%) 103 (5%) <5 
Other family 480 (20%) 42 (18%) 415 (20%) 23 (26%) 
Friends/housemate 313 (13%) 31 (13%) 277 (13%) 5 
Alone  129 (5%) 24 (10%) 103 (5%) <5 
Currently studying      
Yes 1,469 (62%) 115 (50%) 1,299 (63%) 55 (63%) 
No  900 (38%) 114 (49%) 756 (37%) 30 (34%) 
Not reported  11 (<1%) <5 7 <5 
Study location     
High school 637 (43%) 39 (34%) 570 (44%) 28 (51%) 
TAFE/college 144 (10%) 30 (26%) 107 (8%) 7  
University – 
undergraduate 
552 (38%) 33 (29%) 503 (39%) 133 (29%) 
University – 
postgraduate 
102 (7%) 6 93 (7%) <5 
Other  30 (2%) 7 23 (2%) 0 
Not reported  <5 0 <5 <5 
Highest level of 
education  
    
Primary school 37 (2%)  <5 33 (2%) <5 
Before year 10 30 (1%) 12 (5%) 17 (1%) <5 
Completed year 10 665 (28%) 60 (26%) 577 (28%) 28 (32%) 
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 Total  Indigenous status 
 All participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous  
n (%) 
Not stated 
n (%) 
Completed year 12 871 (37%) 82 (36%) 771 (37%) 18 (21%) 
TAFE/college 355 (15%) 52 (23%) 293 (14%) 10 (11%) 
     
University – 
undergraduate  
333 (14%) 16 (7%) 294 (14%) 23 (26%) 
University – 
postgraduate 
68 (3%) <5 63 (3%) <5 
Not reported 21 (1%) <5 14 (1%) <5 
Employment status     
Yes, part-time/casual 1,204 (51%) 73 (32%) 1,084 (53%) 47 (54%) 
Yes, full-time 531 (22%) 54 (23%) 459 (22%) 18 (21%) 
No 636 (27%) 102 (44%) 514 (25%) 20 (23%) 
Not reported 9 <5 <5 <5 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
# Participants were able to select all options that applied; therefore, the denominator is not the same. 
 
3.5.3. Knowledge of sexually transmitted infections and bloodborne 
viruses  
Participants’ knowledge of STI and BBV was assessed using the following 10 questions. 
1. If a woman with HIV is pregnant, can her baby become infected with HIV? 
2. Does a person with a STI always have symptoms? 
3. Are people who have injected drugs at risk for hepatitis C? 
4. Does the pill (birth control) protect a woman from HIV infection? 
5. Can chlamydia make a woman unable to have a baby? 
6. If condoms are used during sex, does this help to protect people from getting HIV? 
7. Is there medicine that can cure hepatitis C? 
8. Could someone who looks healthy pass on HIV infection? 
9. Can hepatitis B be passed on by sex? 
10. Can chlamydia be easily treated with antibiotics? 
The questions which received the highest proportion of correct answers by all participants 
were questions two (88%), four (89%), six (86%), and eight (86%). The questions that received 
the lowest proportion of correct answers were questions five (43%), seven (18%), and nine 
(43%). Both Aboriginal and/or Torres Strait Islander and non-Indigenous participants 
provided similar proportions of correct answers for each question. Appendix 3.B provides 
further detail on count and proportion for each question by Indigenous status.  
Participants’ scores on each question were aggregated to form a composite knowledge scale 
with scores ranging from 0-10. Over 75% of participants responded correctly to at least six or 
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more questions. Aboriginal and/or Torres Strait Islander and non-Indigenous participants 
both scored an average of seven. Table 3.2 presents participants’ knowledge of STI and BBV 
average scores by Indigenous status. There was no difference in knowledge of STI and BBV 
average scores by Indigenous status (p-value=0.206).  
TABLE 3.2 SEXUALLY TRANSMITTED INFECTIONS AND BLOODBORNE VIRUSES KNOWLEDGE QUESTIONS AVERAGE SCORE 
BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total  Indigenous status  
 
All participants  
N=2,205 
Aboriginal and 
or Torres Strait 
Islander 
N=220 
Non-
Indigenous 
N=1,985 
Not stated 
N=78 
 
p-value 
Lowest  
(score 0-5) 
n (%) 
540 (24%) 43 (20%) 483 (24%) 14 (18%) 
0.206* 
Average  
(score 6-7) 
n (%) 
853 (37%) 91 (41%) 752 (37%) 37 (47%) 
Highest  
(score 8-10) 
n (%) 
890 (39%) 86 (39%) 777 (39%) 27 (35%) 
N.B. Counts less than 10 are reported without a percentage; percentages have been rounded up to the nearest 
whole number, columns may not equal 100%. 
Test for independence by Indigenous status and knowledge question average score, Pearson Chi-square test*. 
 
3.5.4. Sexual behaviour  
Overall, 1,867 (78%) participants reported ever being sexually active (oral, vaginal or anal 
sex). Eighty-one percent of Aboriginal and or Torres Strait Islander and 78% (n=1,618) of non-
Indigenous participants, reported ever being sexually active and 97% (n=180) and 94% 
(n=1,516) respectively, of those sexually active had ever had sexual intercourse (penetrative 
vaginal or anal sex); there were statistically significant differences in sexually active and 
sexual intercourse by Indigenous status (p-value=0.028 and p-value=0.006, respectively) 
(Appendix 3.C).  
Participants were asked about their age of sexual debut for oral, vaginal and anal sex. Overall, 
the median age at sexual debut among participants who reported having had oral sex was 
16.5 years (IQR:15-17 years), for vaginal sex 16.6 years (IQR:15-18 years), and for anal sex 
18.9 years (IQR:17-21 years) (Appendix 3.C). Figure 3.5 presents the median age of sexual 
debut of participants by Indigenous status. Generally, Aboriginal and or Torres Strait Islander 
participants reported their age of sexual debut for oral, vaginal and anal sex to be marginally 
earlier than non-Indigenous participants, a difference of 0.5 years for oral sex, 0.7 years for 
vaginal sex, and 0.4 years for anal sex. There were statistically significant differences in 
median age of sexual debut for oral sex and vaginal sexual debut by Indigenous status (p-
78 
value=0.013 and p-value=<0.001, respectively); however no difference in median age of 
sexual debut for anal sex by Indigenous status (p-value=0.177).  
FIGURE 3.5: PARTICIPANTS SEXUAL DEBUT BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019  
3.5.4.1. Sexual partners and concurrency  
Sexual concurrency is defined as “overlapping sexual partnerships where sexual intercourse 
with one partner occurs between two acts of intercourse with another partner” (29), and is 
an important risk factor for STI transmission and acquisition. Overall, 71% (n=1,320) of 
participants who were sexually active reported they had a regular sexual partner (someone 
they have an ongoing sexual relationship with). Almost two-thirds, 65% (n=120) of Aboriginal 
and or Torres Strait Islander participants reported having a regular sexual partner compared 
to 71% (n=1,156) of non-Indigenous participants and both groups reported similar sexual 
partner concurrency (1 & 2) of between 10-13%; there was no difference in reported regular 
sexual partner and concurrency by Indigenous status (p-value=0.539, p-value=0.639, and p-
value=0.248, respectively) (Table 3.3).  
3.5.4.2. Last sexual partner 
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were statistically significant differences in relationship with last sexual partner by Indigenous 
status (p-value=0.008).  
3.5.4.3. Number of sexual partners  
The majority of both Aboriginal and or Torres Strait Islander (53%) and non-Indigenous (58%) 
participants reported one sexual partner and similar proportions of two or more partners in 
the past 12 months; there was no difference in number of sexual partners in the past 12 
months by Indigenous status (p-value=0.151) (Table 3.4).  
3.5.4.4. Internet and mobile apps  
Overall, 30% (n=713) of participants reported using the internet/mobile apps to meet 
partners in the last year. Aboriginal and/or Torres Strait Islander and non-Indigenous 
participants were equally likely to use internet/mobile apps to meet partners; there was no 
difference in use of internet/mobile apps to meet partners by Indigenous status (p-
value=0.767) (Table 3.5).  
TABLE 3.3: SEXUAL PARTNER CONCURRENCY, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019  
 Total Indigenous status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value  
Regular sexual 
partner (n) 1,867 186 1,618 63  
Yes  1,320 (71%) 120 (65%) 1,156 (71%) 44 (70%) 0.539* No 543 (29%) 66 (35%) 458 (28%) 19 (30%) 
Not reported  <5 0 <5 0  
Only have sex with 
your partner, 
concurrency 1 (n) 1,320 120 1,156 44 
 
Yes  1,160 (88%) 104 (87%) 1,017 (88%) 39 (89%) 0.639* No 158 (12%) 16 (13%) 137 (12%) 5 
Not reported  <5 0 <5 0  
Partner only has sex 
with you, concurrency 
2 (n) 1,320 120 1,156 44 
 
Yes  1,182 (90%) 104 (87%) 1,039 (90%) 39 (89%) 0.248* No 136 (10%) 16 (13%) 115 (10%) 5 
Not reported  <5 0 <5 0  
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and sexual partner concurrency, Pearson Chi-square test*. 
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TABLE 3.4: PARTICIPANTS RELATIONSHIP WITH LAST SEXUAL PARTNER AND NUMBER OF SEXUAL PARTNERS IN PAST 12 
MONTHS, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total  Indigenous status  
 All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value  
Relationship with last 
sexual partner (n) 1,867 186 1,618 63  
Current partner  1,183 (63%) 108 (58%) 1,036 (64%) 39 (62%) 
0.008* Just met for the first time 181 (10%) 12 (6%) 162 (10%) 7 Known for a while, not 
current partner  
491 (26%) 66 (35%) 408 (25%) 17 (27%) 
Not reported  12 (1%) 0 12 (1%) 0  
Number of sexual 
partners in the last year 
(n) 1,755 180 1,516 59 
 
None  63 (4%) 11 (6%) 50 (3%) <5 
0.151* 1  1,008 (57%) 96 (53%) 877 (58%) 35 (59%) 2-4 people  468 (27%) 46 (26%) 405 (27%) 17 (29%) 
5 or more people  215 (12%) 27 (15%) 183 (12%) 5 
Not reported  <5 0 <5 0  
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and relationship of last sexual partner and number of sexual 
partners in past 12 months, Pearson Chi-square test*. 
 
 
TABLE 3.5: PARTICIPANTS USE OF INTERNET/MOBILE PHONE APPS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total   Indigenous status  
 All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Used the 
internet/mobile 
phone apps to 
meet partners (n) 2,380 231 2,062 87  
Yes  713 (30%) 69 (30%) 618 (30%) 26 (30%) 0.767* No 1,437 (60%) 134 (58%) 1,257 (61%) 46 (53%) 
Not reported 230 (10%) 28 (12%) 187 (9%) 15 (17%)  
N.B. Counts less than 10 are reported without a percentage; percentages have been rounded up to the nearest 
whole number, columns may not equal 100%. 
Test for independence by Indigenous status and participant use of internet/mobile phone apps, Pearson Chi-
square test*. 
 
 
3.5.4.5. Behaviour at last sexual encounter  
Eighteen percent (n=342) of all participants reported being ‘drunk’ or ‘high’ during their last 
sexual encounter. Aboriginal participants were more like to report being drunk’ or ‘high’ at 
their last sexual encounter than non-Indigenous participants, 28% (n=52) and 17% (n=283) 
respectively; there were statistically significant differences in being ‘drunk’ or ‘high’ during 
their last sexual encounter by Indigenous status (p-value=0.001).  
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3.5.5. Behavioural factors influencing risk of sexually transmitted 
infection or bloodborne virus  
3.5.5.1. Contraception  
Overall, condoms were reported as the most frequent form of contraception used at last 
sexual encounter by all participants (49%, n=767) and by Indigenous status. After condoms, 
the pill (n=651, 43%), the withdrawal method (23%, n=343) and implant (14%, n=205) were 
the most common forms of contraception used by all participants, regardless of Indigenous 
status (Appendix 3.D).  
3.5.5.2. Condom use 
Of those participants who reported having a regular partner, 21% (n=265) reported always 
using a condom with their regular partner in the past 12 months, 36% (n=455) sometimes, 
and 42% (n=534) never. Aboriginal and or Torres Strait Islander participants were half as likely 
(n=12, 10%) to use a condom with a regular partner than non-Indigenous participants (n=245, 
22%); there were statistically significant differences in condom use with their regular partner 
by Indigenous status (p-value=0.005) (Table 3.6).  
Among participants who reported having a casual sexual partner, 36% (n=352) reported 
always using a condom in the past 12 months, 39% (n=384) sometimes, and 25% (n=247) 
never (Table 3.6). Non-Indigenous participants were more likely to report always using a 
condom with a casual partner (37%, n=309) than Aboriginal and/or Torres Strait Islander 
participants (25%, n=31). There were statistically significant differences in condom use with 
casual sexual partners by Indigenous status (p-value=<0.001). 
Participants were more likely to get their condoms from a shop/chemist than any other 
source (74%, n=1,290), while 9% (n=156) reported their sexual partner provided the condoms 
(Table 3.7). There were statistically significant differences in ‘Where do you usually get 
condoms from?’ by Indigenous status (p-value=<0.001). 
3.5.5.3. Alcohol, tobacco and other drugs 
3.5.5.3.1. Alcohol 
Eighty percent (n=1,904) of all participants reported drinking alcohol in the past 12 months. 
Drinking alcohol once a week or more was reported by 38% (n=726) of all participants, 
followed by ‘about once a month’ 32% (n=600), ‘every few months’ 19% (n=369), ‘once or 
twice a year’ 9% (n=170), and ‘every day’ 2% (n=38). Of participants who reported drinking 
alcohol in the past 12 months, 60% (n=1,142) reported drinking 1-4 drinks on each occasion, 
compared to 40% (n=759) of participants who reported drinking 5 or more drinks on each 
occasion - which is considered risky drinking behaviour (30). There were statistically 
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significant differences in frequency of alcohol consumption by Indigenous status (p-
value=<0.001). 
Table 3.8 presents frequency of alcohol consumption and number of drinks on each occasion 
by Indigenous status. Non-Indigenous participants consumed alcohol more frequently than 
Aboriginal and or Torres Strait Islander participants; however, over half, 56% (n=100) of 
Aboriginal and or Torres Strait Islander participants reported drinking 5 or more drinks on 
each occasion, more than non-Indigenous participants (38%, n=636). There were statistically 
significant differences in number of drinks on each occasion by Indigenous status (p-
value=<0.001). 
TABLE 3.6: HEATMAP OF PARTICIPANT CONDOM USE WITH REGULAR AND CASUAL SEXUAL PARTNER IN THE PAST 12 
MONTHS, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total  Indigenous status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait 
Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
   
Condom use with 
regular partner (n) 1,254 115 1,097 42 
 
Always  265 (21%) 12 (10%) 245 (22%) 8 
0.005† Sometimes 455 (36%) 40 (35%) 400 (36%) 15 (36%) 
Never  534 (43%) 63 (55%) 452 (41%) 19 (45%) 
Exclusions       
Not reported or no 
regular partner and/or 
not sexually active 
1,126 116 965 45  
   
Condom use with 
casual sexual partner 
(n) 983 122 829 32 
 
Always  352 (36%) 31 (25%) 309 (37%) 12 (38%) 
<0.001* Sometimes 384 (39%) 47 (39%) 321 (39%) 16 (50%) 
Never  247 (25%) 44 (36%) 199 (24%) <5 
Exclusions      
Not reported or no 
casual sexual partner 
and/or not sexually 
active 
1,397 109 1,233 55  
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and condom use with regular partner, and by Indigenous status and 
condom use with casual sexual partner, Pearson Chi-square test* and Fishers exact test†.    
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TABLE 3.7: WHERE PARTICIPANTS REPORTED GETTING THEIR CONDOMS FROM, BY INDIGENOUS STATUS, SOUTH 
AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total Indigenous status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait 
Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Where do you usually 
get condoms from (n) 1,755 178 1,475 59 
 
Shop/chemist  1,290 (75%) 121 (68%) 1,126 (76%) 43 (73%) 
<0.001† 
Medical clinic/GP 21 (1%) 7 14 (1%) 0 
Aboriginal medical 
service  
10 (1%) 9 <5 0 
Friends  16 (1%) <5 12 (1%) <5 
Family member  11 (1%) 0 11 (1%) 0 
Sexual partner 156 (9%) 12 (7%) 137 (9%) 7 
Other  23 (1%) <5 21 (1%) 0 
Never use condoms  185 (11%) 25 (14%) 153 (10%) 7 
Exclusions  625 53 587 28  
Not reported       
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and where participants reported getting condom from, Fishers 
exact test†. 
 
3.5.5.3.2. Tobacco  
Thirteen percent (n=318) of participants reported they smoked cigarettes. Aboriginal and 
Torres Strait Islander participants were almost twice as likely (23%, n=54) to report smoking 
cigarettes than non-Indigenous participants (12%, n=253). There were statistically significant 
differences in reported cigarette smoked by Indigenous status (p-value=<0.001). Regardless 
of Indigenous status, most participants reported smoking between 1-10 cigarettes per day -  
63% (n=34) Aboriginal and/or Torres Strait Islander, and 58% (n=146) non-Indigenous 
participants; there was no difference in number of cigarette smoked per day by Indigenous 
status (p-value=1.000).  
 
TABLE 3.8: FREQUENCY OF ALCOHOL CONSUMPTION AND NUMBER OF DRINKS PER OCCASION BY INDIGENOUS STATUS, 
SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total Aboriginal status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait 
Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value  
Drink alcohol (n= 2,380) 2,380 231 2,062 67  
Yes 1,904 (80%) 180 (78%) 1,663 (81%) 61 (70%) 0.793* No 211 (9%) 21 (9%) 182 (9%) 8 
Not reported 265 (11%) 30 (13%) 217 (11%) 18 (21%)  
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 Total Aboriginal status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait 
Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value  
Frequency of alcohol 
consumption (n=1,904) 1,904 180 1,663 61  
Everyday  38 (2%) <5 35 (2%) <5 
<0.001* 
Once a week or more 726 (38%) 55 (31%) 649 (39%) 22 (36%) 
About once a month 600 (32%) 38 (21%) 538 (32%) 24 (39%) 
Every few months 369 (19%) 59 (33%) 301 (18%) 9 
Once of twice a year  170 (9%) 27 (15%) 139 (8%) <5 
Not reported  <5 0 <5 0  
Number of drinks on 
each occasion (n=1,904) 1,904 180 1,663 61  
1-4 drinks  1,142 (60%) 80 (44%) 1,024 (62%) 38 (62%) <0.001* 5 or more drinks 759 (40%) 100 (56%) 636 (38%) 23 (38%) 
Not reported  <5 0 <5 0  
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and frequency of alcohol consumption and number of drinks per 
occasion, Pearson Chi-square test*. 
 
3.5.5.3.3. Illicit drugs  
Over a third (36%, n=863) of participants reported using marijuana in the past 12 months. 
Among Aboriginal and/or Torres Strait Islander participants, 45% (n=103) reported using 
marijuana, compared to 36% (n=740) of non-Indigenous participants. Frequency of 
marijuana use by Indigenous status is presented in Table 3.9. Aboriginal and/or Torres Strait 
Islander participants were three times more likely (33%, n=34) to report using marijuana 
everyday than non-Indigenous participants (10%, n=72). There were statistically significant 
differences in reported use and frequency of marijuana by Indigenous status (p-value=0.002 
and p-value=<0.001, respectively). 
Forty-eight (2%) participants reported using meth/amphetamine in the past 12 months, 
seven of those were Aboriginal and/or Torres Strait Islander and 39 (2%) were non-
Indigenous. Table 3.9 presents frequency of meth/amphetamine use by Indigenous status. 
There was no difference in reported use and frequency of meth/amphetamine by Indigenous 
status (p-value=0.214 and p-value=0.353, respectively). Ice or crystal (73%, n=35) was the 
most common form of meth/amphetamine used by participants, followed by speed (23%, 
n=11) and base (n=2). Inhaling/smoking (60%, n=29) was reported as the most common 
method for taking meth/amphetamine, followed by snorting (n=9), swallowing (n=8) and 
injecting (n=2).  
Fifteen percent (n=348) of participants reported using ecstasy in the past 12 months. Similar 
proportions of Aboriginal and or Torres Strait Islander (17%, n=40) and non-Indigenous (14%, 
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n=298) participants reported using ecstasy in the past 12 months. Frequency of ecstasy use 
by Indigenous status is presented in Table 3.9. There was no difference in reported use and 
frequency of ecstasy by Indigenous status (p-value=0.174 and p-value=0.574, respectively). 
TABLE 3.9: FREQUENCY OF MARIJUANA, METH/AMPHETAMINE AND ECSTASY USE, BY INDIGENOUS STATUS, SOUTH 
AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total  Aboriginal status  
 
 
All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Used marijuana (n) 2,380 231 2,062 87  
Yes  863 (36%) 103 (45%) 740 (36%) 20 (23%) 0.002* No 1,249 (52%) 98 (42%) 1,102 (53%) 49 (56%) 
Not reported  268 (11%) 30 (13%) 220 (11%) 18 (21%)  
Frequency of marijuana use 
(n) 863 103 740 20  
Everyday  107 (12%) 34 (33%) 72 (10%) <5 
<0.001* 
Once a week or more 128 (15%) 18 (17%) 110 (15%) 0 
Once a month 109 (13%) 12 (12%) 94 (13%) <5 
Every few months 198 (23%) 17 (17%) 173 (23%) 8 
Once or twice a year 321 (37%) 22 (21%) 291 (39%) 8 
Used meth/amphetamine 
(n) 2,380 231 2,062 87  
Yes  48 (2%) 7 39 (2%) <5 0.214* No 2,066 (87%) 194 (84%) 1,805 (88%) 67 (77%) 
Not reported  266 (11%) 30 (13%) 218 (11%) 18 (21%)  
Frequency of 
meth/amphetamine use (n) 48 7 39 <5  
Everyday  11 (23%) 0 11 (28%) 0 
0.353† 
Once a week or more <5 <5 <5 0 
Once a month 6 <5 5 0 
Every few months 9 <5 7 <5 
Once or twice a year 19 (40%) <5 14 (36%) <5 
Used ecstasy (n=2,380) 2,380 231 2,062 87  
Yes  348 (15%) 40 (17%) 298 (14%) 10 (11%) 0.174* No 1,767 (72%) 161 (70%) 1,547 (75%) 59 (68%) 
Not reported  265 (11%) 30 (13%) 217 (11%) 18 (21%)  
Frequency of ecstasy use 
(n=348) 348 40 298 10  
Everyday  <5 0 <5 0 
0.574† 
Once a week or more 11 (3%) <5 8 0 
Once a month 60 (70%) 7 51 (17%) <5 
Every few months 101 (29%) 11 (28%) 86 (29%) <5 
Once or twice a year 173 (50%) 19 (48%) 150 (50%) 4 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and frequency of marijuana, meth/amphetamine and ecstasy use, 
Pearson Chi-square test* and Fisher’s exact test†.  
 
3.5.5.3.4. Other drugs 
Cocaine was the most common type of other drug used (11%, n=254) by all participants, 
followed by LSD/acid/mushrooms (6%, n=135), benzodiazepines (2%, n=48), ketamine (2%, 
n=44) and other (5%, n=128) (Appendix 3.E). Ten percent (n=23) of Aboriginal and or Torres 
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Strait Islander and 11% (n=221) of non-Indigenous participants reported using cocaine. Use 
of LSD/acid/mushrooms was higher among non-Indigenous participants (6%, n=122) than 
Aboriginal and or Torres Strait Islander participants (3%, n=8). 
3.5.6. Previous diagnosis of a sexually transmitted infection or 
bloodborne virus  
3.5.6.1. Tested for a sexually transmitted infection 
Of sexually active participants, almost half, 48% (n=898) of participants reported ever being 
tested for an STI. Aboriginal and or Torres Strait Islander participants were more likely to 
have ever been tested for an STI (69%, n=128) than non-Indigenous participants (46%, 
n=746). Almost a third (29%, n=539) of participants reported having been tested in the past 
12 months (Appendix 3.F). There were statistically significant differences in ever been tested 
for an STI by Indigenous status (p-value=<0.001). 
Of those who had ever been tested for an STI, participants reported the medical 
clinic/general practice was the most common place where an STI test was likely to been 
performed (70%, n=627), followed by family planning/sexual health clinic (25%, n=228), 
Aboriginal Medical Service (3%, n=30) and other (2%, n=14). Similarly, the medical 
clinic/general practice was the most common place where an STI test was likely to been 
performed regardless of Indigenous status (Appendix 3.F).   
Adjusted logistic regression models suggested that among Aboriginal and Torres Strait 
Islander participants, ever having been tested for an STI was significantly associated with 
female gender, older age groups (20-24 and 25-29), having completed TAFE/university, and 
not using a condom during last sex or with casual sexual partners. Among non-Indigenous 
participants, ever having been tested for an STI was significantly associated with female 
gender, older age groups (20-24 and 25-29), participants whose partner had sex with other 
people, having had 2-4 or 5 of more sexual partners in the past 12 months, not using a 
condom during last sex, drinking 1-4 drinks alcoholic drinks per occasion, using marijuana, 
and having a drug score of  1 or 2 or more (Table 3.10). Results of univariate analysis can be 
found in Appendix 3.G. 
TABLE 3.10: ADJUSTED LOGISTIC REGRESSION ANALYSIS# – EVER TESTED FOR A SEXUALLY TRANSMITTED INFECTION 
AMONG SEXUALLY ACTIVE PARTICIPANTS, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 All participants 
N= 1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
N= 1,564 
 aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value 
Indigenous status 
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 All participants 
N= 1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
N= 1,564 
 aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value 
Non-Indigenous Reference       
Aboriginal and or 
Torres Strait 
Islander 
2.16  
(1.29-3.91) 
0.011     
Gender  
Male  Reference  Reference  Reference  
Female 3.06 
(2.22-4.22) 
<0.001 2.41 
(1.07-3.51) 
0.034 3.03 
(2.17-4.23) 
<0.001 
Age group 
16-19  Reference  Reference  Reference  
20-24 3.12 
(2.07-4.70) 
<0.001 3.34 
(1.41-7.29) 
0.006 3.16 
(2.04-4.87) 
<0.001 
25-29 7.89 
(4.62-13.48) 
<0.001 6.47 
(2.40-17.41) 
0.000 8.38 
(4.76-14.76) 
<0.001 
Sexuality  
Straight/heterosexu
al  
Reference  Reference  Reference  
LGBTI/homosexual  1.40 
(1.00-1.97) 
0.052 1.29 
(0.61-2.74) 
0.502 1.42 
(1.00-2.01) 
0.051 
Remoteness 
Rural and remote  Reference  Reference  Reference  
Urban 1.18 
(0.80-1.73) 
0.387 1.13 
(0.45-2.85) 
0.792 1.12 
(0.75-1.67) 
0.584 
Marital status 
Not married  Reference  Reference  Reference  
Married/De-facto 0.98 
(0.70-1.38) 
0.909 1.76 
(0.81-3.83) 
0.154 1.06 
(0.75-1.51) 
0.729 
Education level 
Completed less 
than year 12  
Reference  Reference  Reference  
Completed year 12 0.94 
(0.61-1.46) 
0.795 1.72 
(0.75-3.95) 
0.203 0.95 
(.061-1.49) 
0.832 
TAFE/University 1.56 
(0.97-2.51) 
0.067 2.80 
(1.17-6.70) 
0.021 1.57 
(0.97-2.57) 
0.069 
Employed 
No Reference  Reference  Reference  
Yes  1.00 
(0.69-1.46) 
0.997 1.80 
(0.91-3.57) 
0.092 1.00 
(0.67-1.48) 
0.981 
Concurrency - partner only has sex with you  
Yes  Reference  Reference  Reference  
No 1.92 
(1.04-3.57) 
0.037 1.20 
(0.22-6.56) 
0.835 2.00 
(1.06-3.81) 
0.033 
No. of sexual partners in past 12 months 
1  Reference   Reference  Reference  
2-4 1.74 
(1.10-2.75) 
0.017 0.61 
(0.26-1.41) 
0.244 2.00 
(1.24-3.25) 
0.004 
5 or more  4.89 
(2.40-9.98) 
<0.001 7.60 
(0.95-60.98) 
0.056 4.80 
(2.28-10.08) 
<0.001 
Used internet/mobile apps to meet partners 
No  Reference  Reference  Reference  
Yes  1.08 
(0.71-1.65) 
0.707 0.75 
(0.35-1.59) 
0.454 1.04 
(0.67-1.61) 
0.853 
Used a condom last time had sex 
Yes  Reference  Reference  Reference  
No  1.76 
(1.27-2.45) 
0.001 2.33 
(1.03-5.29) 
0.043 1.62 
(1.15-2.27) 
0.005 
Used a condom with casual sexual partner 
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 All participants 
N= 1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
N= 1,564 
 aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value 
Yes Reference  Reference  Reference  
No  0.96 
(0.64-1.43) 
0.833 7.63 
(1.31-44.46) 
0.024 1.14 
(0.75-1.73) 
0.535 
Drunk or high last sexual encounter 
No  Reference  Reference  Reference  
Yes  1.14 
(0.72-1.79) 
0.580 0.53 
(0.25-1.11) 
0.095 1.09 
(0.68-1.76) 
0.724 
No. alcohol drinks per session 
5 or more  Reference  Reference  Reference  
1-4  1.57 
(1.12-2.21) 
0.009 1.43 
(0.69-2.97) 
0.333 1.65 
(1.16-2.37) 
0.006 
Used marijuana  
No  Reference  Reference  Reference  
Yes  0.35 
(1.07-1.55) 
0.017 0.95 
(0.48-1.87) 
0.872 0.37 
(0.15-0.88) 
0.025 
Used meth/amphetamine  
No  Reference  Reference  Reference  
Yes  2.21 
(0.64-7.57) 
0.208 0.69 
(0.12-3.88) 
0.671 2.64 
(0.70-10.40) 
0.165 
Used ecstasy  
No  Reference  Reference  Reference  
Yes  0.68 
(0.35-1.33) 
0.262 0.69 
(0.31-1.55) 
0.375 0.71 
(0.36-1.40) 
0.321 
Used cocaine  
No  Reference  Reference  Reference  
Yes 1.10 
(0.60-2.00) 
0.759 0.83 
(0.29-2.35) 
0.728 1.29 
(0.69-2.41) 
0.420 
Drug score  
0 Reference  Reference  Reference  
1  3.10 
(1.31-7.35) 
0.010 1.43 
(0.62-3.30) 
0.402 2.91 
(1.12-6.97) 
0.017 
2 or more  7.25 
(2.16-
24.17) 
0.001 0.79 
(0.35-1.80) 
0.579 6.86 
(1.98-
23.77) 
0.002 
# Independent variables used in adjusted logistic regression analysis are highlighted in bold and have been 
accounted for in the analysis.  
aOR – Adjusted odds ratio; CI – Confidence interval. 
63 participants were not included as their indigenous status was not stated.  
 
3.5.6.2. Tested positive for a sexually transmitted infection 
Of sexually active participants who had even been tested for an STI, 23% (n=201) reported 
ever testing positive for an STI. Testing positive for an STI was higher among Aboriginal 
and/or Torres Strait Islander participants (n=38, 30%) than among non-Indigenous 
participants (21%, n=158) (Appendix 3.F). There were statistically significant differences in 
ever tested positive for an STI by Indigenous status (p-value=0.034). Chlamydia was the most 
commonly diagnosed STI among all participants to had ever been tested for an STI (16%, 
n=145), regardless of Indigenous status (Table 3.11).    
Adjusted logistic regression models suggested that among Aboriginal and Torres Strait 
Islander participants, ever testing positive for an STI was significantly associated with having 
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completed year 12, and having 2-4 sexual partners in the past 12 months. Among non-
Indigenous participants, ever testing positive for an STI was significantly associated with older 
age groups (20-24 and 25-29), having 2-4 or 5 or more sexual partners, and using cocaine 
(Table 3.12). Results of univariate analysis can be found in Appendix 3.H. 
TABLE 3.11: POSITIVE SEXUAL TRANSMITTED INFECTION AMONG PARTICIPANTS EVER TESTED#, BY INDIGENOUS STATUS, 
SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
 Total   Indigenous status  
 All participants 
n (%) 
N=2,380 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
N=231 
Non-
Indigenous 
n (%) 
N=2,062 
Not stated 
n (%) 
N=87 
 
p-value  
Chlamydia 145 (16%) 30 (23%) 113 (15%) <5 0.019* 
Gonorrhoea 21 (2%) 6 15 (2%) 0 0.068* 
Syphilis 5 <5 <5 0 0.548† 
Trichomoniasis <5 <5 <5 0 0.379† 
Genital Herpes 35 (4%) 5 29 (4%) <5 1.000† 
Genital Warts 10 (1%) <5 7 <5 0.627† 
Other  25 (3%) <5 19 (3%) <5 0.763† 
# Participants were able to select all options that applied. 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and positive sexual transmitted infection among participants ever 
tested, Pearson Chi-square test* and Fisher’s exact test†.  
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TABLE 3.12: ADJUSTED LOGISTIC REGRESSION ANALYSIS# – EVER TESTED POSITIVE FOR A SEXUALLY TRANSMITTED 
INFECTION AMONG SEXUALLY ACTIVE PARTICIPANTS, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 
2019 
 All participants 
N=847 
Aboriginal and or  
Torres Strait Islander  
N=122 
Non-Indigenous 
N=717 
 aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value 
Indigenous status 
Non-Indigenous Reference       
Aboriginal and or 
Torres Strait 
Islander 
1.52 
(0.97-2.37) 
0.065     
Gender  
Male  Reference  Reference  Reference  
Female 1.47 
(1.01-2.13) 
0.044 2.27 
(0.72-7.13) 
0.159 1.24 
(0.83-1.84) 
0.296 
Age group 
16-19  Reference  Reference  Reference  
20-24 2.12 
(1.02-4.41) 
0.044 1.58 
(0.45-5.55) 
0.474 2.14 
(1.21-3.78) 
0.009 
25-29 2.40 
(1.06-5.44) 
0.036 3.58 
(0.96-13.41) 
0.058 2.09 
(1.15-3.79) 
0.015 
Sexuality  
Straight/heterosexu
al  
Reference  Reference  Reference  
LGBTI/homosexual  1.00 
(0.71-1.41) 
0.987 0.55 
(0.22-1.39) 
0.206 1.06 
(0.73-1.54) 
0.766 
Remoteness 
Rural and remote  Reference  Reference  Reference  
Urban 0.80 
(0.51-1.27) 
0.348 0.52 
(0.16-1.69) 
0.276 0.87 
(0.53-1.44) 
0.587 
Marital status 
Not married  Reference  Reference  Reference  
Married/De-facto 1.40 
(0.95-2.06) 
0.085 1.91 
(0.72-5.08) 
0.196 1.42 
(0.94-2.14) 
0.095 
Education level 
Completed less 
than year 12  
Reference  Reference  Reference  
Completed year 12 0.66 
(0.40-1.10) 
0.114 0.20 
(0.06-0.67) 
0.010 1.20 
(0.69-2.10) 
0.525 
TAFE/University 0.58 
(0.35-0.98) 
0.041 0.74 
(0.27-2.01) 
0.557 1.57 
(0.64-1.88) 
0.733 
Employed 
No Reference  Reference  Reference  
Yes  0.84 
(0.56-1.26) 
0.396 0.42 
(0.17-1.03) 
0.058 1.18 
(0.73-1.90) 
0.496 
Concurrency - partner only has sex with you  
Yes  Reference  Reference  Reference  
No 1.06 
(0.61-1.84) 
0.846 0.32 
(0.08-1.34) 
0.120 1.22 
(0.67-2.25) 
0.507 
No. of sexual partners in past 12 months 
1  Reference   Reference  Reference  
2-4 1.59 
(0.83-3.02) 
0.160 60.67 
(1.43-2569.72) 
0.032 1.37 
(0.67-7.45) 
0.392 
5 or more  2.77 
(1.30-5.87) 
0.008 4.86 
(0.07-339.42) 
0.465 3.13 
(1.31-7.45) 
0.010 
Used internet/mobile apps to meet partners 
No  Reference  Reference  Reference  
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 All participants 
N=847 
Aboriginal and or  
Torres Strait Islander  
N=122 
Non-Indigenous 
N=717 
 aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value aOR  
(95% CI) 
p-value 
Yes  1.15 
(0.76-1.73) 
0.516 1.33 
(0.49-3.64) 
0.577 1.27 
(0.81-2.00) 
0.305 
Used a condom last time had sex 
Yes  Reference  Reference  Reference  
No  1.33 
(0.92-1.91) 
0.129 1.46 
(0.59-3.61) 
0.413 1.45 
(0.97-2.16) 
0.067 
Used a condom with casual sexual partner 
Yes Reference  Reference  Reference  
No  1.01 
(0.67-1.52) 
0.948 0.73 
(0.29-1.87) 
0.517 1.10 
(0.67-1.74) 
0.698 
Drunk or high last sexual encounter 
No  Reference  Reference  Reference  
Yes  1.36 
(0.85-2.18) 
0.196 1.03 
(0.40-2.65) 
0.950 1.11 
(0.70-1.77) 
0.644 
No. alcohol drinks per session 
5 or more  Reference  Reference  Reference  
1-4  0.93 
(0.64-1.34) 
0.680 0.50 
(0.20-1.29) 
0.152 1.10 
(0.73-1.64) 
0.657 
Used marijuana  
No  Reference  Reference  Reference  
Yes  1.76 
(0.79-3.96) 
0.169 0.758 
(0.36-2.09) 
0.758 1.23 
(0.86-1.78) 
0.251 
Used meth/amphetamine  
No  Reference  Reference  Reference  
Yes  1.28 
(0.92-1.82) 
0.166 2.75 
(0.32-23.54) 
0.356 1.78 
(0.73-4.33) 
0.206 
Used ecstasy  
No  Reference  Reference  Reference  
Yes  1.10 
(0.72-1.67) 
0.650 1.64 
(0.63-4.30) 
0.311 1.38 
(0.92-2.07) 
0.123 
Used cocaine  
No  Reference  Reference  Reference  
Yes 2.14 
(1.01-4.54) 
0.049 1.23 
(0.40-3.83) 
0.712 1.75 
(1.15-2.67) 
0.009 
Drug score  
0 Reference  Reference  Reference  
1  1.06 
(0.69-1.61) 
0.799 1.00 
(0.36-2.81) 
0.988 0.95 
(0.59-1.51) 
0.815 
2 or more  1.29 
(0.77-2.16) 
0.342 1.34 
(0.47-3.81) 
0.581 1.32 
(0.87-2.01) 
0.193 
# Independent variables used in adjusted logistic regression analysis highlighted in bold and have been 
accounted for in the analysis.  
aOR – Adjusted odds ratio; CI – Confidence interval. 
24 participants were not included as their indigenous status was not stated.  
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3.5.6.3. Tested for a bloodborne virus 
Around a quarter of all participants reported ever being tested for HIV (28%, n=520) and 
hepatitis C (24%, n=449). Aboriginal and or Torres Strait Islander participants were more 
likely to have ever been tested for HIV (41%, n=77) and hepatitis C (40%, n=75) than non-
Indigenous participants (26%, n=432; and 22%, n=363, respectively) (Appendix 3.I). There 
were statistically significant differences in ever tested for HIV and hepatitis C by Indigenous 
status (p-value=<0.001 and p-value=<0.001, respectively). The medical clinic/general practice 
was the most common place where a test for HIV or hepatitis C was likely to been performed 
regardless of Indigenous status.   
3.5.7. Health service access – health check  
Over a third (34%, n=813) of participants reported having a full health check-up in the past 
12 months; 94% of check-ups were completed at the medical clinic/general practice; and less 
than half of participants were offered an STI test (43%, n=350). Aboriginal and or Torres Strait 
Islander participants were more likely to report having had a full health check-up in the past 
12 months (45%, n=104) than non-Indigenous participants (33%, n=680). Almost a third of 
full health check-ups among Aboriginal and or Torres Strait Islander participants were 
completed at the Aboriginal medical service. Aboriginal and or Torres Strait Islander 
participants were more likely to be offered an STI test than non-Indigenous participants 
(Table 3.13). There were statistically significant differences in having a full health check-up in 
the past 12 months, location of health check-up and offered an STI test by Indigenous status 
(p-value=<0.001, p-value=<0.001 and p-value=<0.001, respectively). 
93 
 
TABLE 3.13: HEALTH SERVICE ACCESS – HAD A HEALTH CHECK, LOCATION OF HEALTH CHECK AND WHETHER A TEST FOR 
SEXUALLY TRANSMITTED INFECTION WAS OFFERED, BY INDIGENOUS STATUS, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 
2019 
 Total  Indigenous status  
 All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait 
Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Health check past 12 
months (n) 2,380 231 2,062 87  
Yes  813 (34%) 104 (45%) 680 (33%) 29 (33%) <0.001* No 1,261 (53%) 95 (41%) 1,127 (55%) 39 (45%) 
Not reported  306 (13%) 32 (14%) 255 (12%) 19 (22%)  
Location of health check 
(n) 813 104 680 29  
Medical clinic/General 
Practice  
765 (94%) 71 (68%) 665 (98%) 29 (100%) 
<0.001† Aboriginal Medical 
Service 
35 (4%) 32 (31%) <5 0 
Other 13 (2%) <5 12 (2%) 0 
Offered a STI test (n) 813 104 680 29  
Yes  350 (43%) 65 (63%) 274 (40%) 11 (38%) <0.001* No 463 (57%) 39 (38%) 406 (60%) 18 (62%) 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and health service access, Pearson Chi-square test* and Fisher’s 
exact test†.  
 
3.5.8. Survey satisfaction  
At the end of the survey two questions were asked regarding participant survey satisfaction 
and preference. The first question was ‘Did you find this survey easy to complete?’. Of 
participants who responded to this question, 99% (n=2,029) responded with ‘Yes’ (or 85% of 
all participants). Those who responded ‘No’ (1%, n=19), were asked to provide a reason as to 
why they found it difficult (Table 3.14).  
TABLE 3.14: PARTICIPANT SURVEY SATISFACTION – SURVEY ISSUES, SOUTH AUSTRALIA, LET’S TALK ABOUT IT 2019 
Survey issues All participants 
n 
Too long <5 
Words I didn't understand <5 
Questions were confusing 5 
Embarrassing 5 
Other  <5 
No response  <5 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage. 
 
94 
 
The second question was ‘What is your preferred way to complete a survey?’. The majority 
of respondents, 95% (n=1939) preferred online, followed by in-person/face-to-face (3%, 
n=56), telephone/mobile (2%, n=40), and mail (1%, n=12). 
3.6. Discussion 
Let’s Talk About It 2019 is the first study to describe current sexual health knowledge, 
behaviours and access to health services in relation to STI and BBV amongst young South 
Australians. It achieved its three goals; conducting a sexual health survey of young South 
Australians; collecting surveys from both Aboriginal and non-Indigenous young people in the 
same survey to allow for comparisons; and piloting this collection via an online survey with 
an outcome of ascertaining whether this format could be completed on an ongoing basis.  
In total 2,380 young South Australians participated in Let’s Talk About It 2019 over a six-week 
period. Participants provided information on their current sexual health, knowledge, 
behaviours and access to health services for STI and BBV. This is the first time a 
comprehensive set of data has been collected regarding these issues from young people 
residing in SA. The sample represents around (1%) of the total SA population in this age group 
(31). Overall there were almost equal numbers of males and females who participated in the 
survey and the age distribution was almost equivalent to the entire SA population in this age 
group (31); however, the survey was not meant to be representative. There was under-
representation of some groups within this population, including; people from culturally and 
linguistically diverse backgrounds, people resident in regional and remote SA, and Aboriginal 
and Torres Strait Islander males. This should be a focus of future survey recruitment should 
they continue. 
Let’s Talk About It 2019 was able to achieve a participation rate of 10% Aboriginal and or 
Torres Strait Islander young people (equivalent to 2% of the SA Aboriginal and Torres Strait 
Islander population in this age group (31)), of which almost 75% were female. This is higher 
than any other survey on sexual health and wellbeing of young people in Australia apart from 
the GOANNA survey which exclusively surveyed Aboriginal and Torres Strait Islander people. 
All other surveys  have averaged a participation rate of Aboriginal and Torres Strait Islander 
people between 2-3% or less (10-13, 32-34). These data are often too small and can present 
several issues with representativeness, data analysis and interpretation. The genuine 
inclusion of Aboriginal and Torres Strait Islander people in the conceptualisation and design 
of research projects which utilise surveys as their main form of data collection may address 
this issue. Finally, small numbers of Aboriginal and Torres Strait Islander peoples in these 
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surveys often result in outcomes not being published by Indigenous status or available to 
inform policy and programming nor for shaping future research questions. This is a challenge 
that needs further consideration.   
In relation to risk behaviours for STI and BBV there were a few differences reported between 
the two populations, including age of sexual debut for oral, vaginal and anal sex; more likely 
to report being drunk’ or ‘high’ during their last time sexual encounter; and less likely to use 
a condom with a casual sexual partner. However, Aboriginal and/or Torres Strait Islander 
participants were more likely to report having ever been tested for an STI and more likely to 
have tested positive for an STI than non-Indigenous participants. Early age of first sex has 
been associated with a range of sexual risk behaviours and increased risk of STI (18, 23, 24, 
26, 28), as has sexual partner concurrency and multiple sexual partners (19-23, 25, 28), and 
risky drinking behaviour and use of illicit drugs (17, 25, 27, 28). Higher rates of STI testing 
among Aboriginal and or Torres Strait Islander participants may be because of ongoing health 
promotion campaigns that have been implemented by the Aboriginal Health Council of South 
Australia (35) and the Young Deadly Free initiative coordinated through the South Australian 
Health and Medical Research Institute (36). Both initiatives target clinicians and communities 
to encourage STI and BBV testing, particularly in this age group.    
These data also highlight the multiple issues that require addressing in STI and BBV control 
in relation to risk behaviours, STI and BBV knowledge, alcohol and other drug use, and health 
care access. It is important that the broader public health messaging and health promotion 
and prevention work around STI and BBV are inclusive of this new and existing evidence on 
the sexual health, knowledge, behaviours of young people.  
Overall only a third of all participants reported using a condom with a new casual sex partner. 
Low condom use, particularly with casual sexual partners, mixed with alcohol and illicit drug 
use has been associated with increased risk of STI (27, 37-39). Condoms are the most 
effective form of contraception to prevent STI and BBV and unwanted pregnancy. The low 
rate of condom use reported by young people is concerning - effective strategies to 
encourage an increase in condom use are required. 
The use of internet or mobile apps to find (sexual) partners has increased (40) and has been 
linked to an increase in STI. A review on geosocial networking apps and risk of STI by Wang 
et al. (41) found that among men who have sex with men, app-users were more likely to 
acquire an STI than non-app users. Additionally, use of apps has been linked to having 
previously had an STI (40, 42, 43). Mobile apps are increasingly used for STI and HIV 
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prevention and health promotion (44-46). Greater use of apps in STI prevention and testing 
campaigns should be considered, in addition to more traditional STI and HIV prevention and 
health promotion methods (47).   
Any effort to address STI and BBV must include actions to engage Aboriginal and Torres Strait 
Islander people. The over-representation of STI and BBV among this population 
demonstrates that a targeted approach is required to minimise the socio-demographic and 
behavioural factors that influence the risk of acquiring STI and BBV. Any approach should 
align with the National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually 
Transmissible Infections Strategy (48).  
Let’s Talk About It 2019, was a pilot to test the feasibility of delivering a modified version of 
the GOANNA survey online. The online survey format was a successful approach for engaging 
young people, particularly Aboriginal and Torres Strait Islander people. Overwhelmingly, 
most participants found the survey easy to complete and preferred an online format to 
collect such questionnaires. For a survey such as Let’s Talk About It 2019, which ask questions 
of a sensitive nature, young people may be more willing to disclose sensitive information due 
to the anonymity of the online method. Other studies have indicated online self-completion 
questionnaires are preferred to paper self-completion questionnaires (49, 50). Let’s Talk 
About It 2019 data were collected over a relatively short time period (six-weeks) but yielded 
a substantial number of participants, demonstrating the strength of this data collection 
method.   
3.7. Limitations  
The study had several limitations, including: 
• Participants self-selected to participate in Let’s Talk About It 2019, and as such, may 
not be representative of the South Australian population aged 16-29. The marketing 
of Let’s Talk About It 2019 on social media indicated that the survey was about young 
people’s sexual health, knowledge and behaviours – and it may be that as a result, 
young people who either were not sexually active or not willing to disclose this 
information about themselves decided not to participate. 
• It is unclear how representative Aboriginal and/or Torres Strait Islander participants 
were of the Aboriginal and Torres Strait Islander population aged 16-29 years, as 
most Aboriginal and/or Torres Strait Islander participants were female, higher than 
the 2016 Census data for South Australia (31). However, females are most often 
overrepresented in the collection of such information.  
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• The marketing of Let’s Talk About It 2019 on social media, mainly Facebook, 
determines that only young people with a Facebook account and active users had 
access to participating in Let’s Talk About It 2019; however, most young people have 
a Facebook profile and access it daily (51), thus potentially minimise sampling bias. 
• None of Let’s Talk About It 2019 questions were compulsory, and therefore 
responses may have been affected by declaration bias and some participants may 
have only responded to questions which they felt comfortable to declare.  
3.8. Conclusion  
Let’s Talk About It 2019 is the first study to describe current sexual health, knowledge, 
behaviours and access to health services for STI and BBV and related issues amongst young 
South Australians, both Aboriginal and Torres Strait Islander and non-Indigenous. It is evident 
that young South Australians are engaged in behaviours which increase the risk of acquiring 
STI. This evidence is important for informing development of public health practice and 
policies, and the development of STI and BBV preventative health programs, particularly 
those that target young Aboriginal and Torres Strait Islander people. 
From here there will be ongoing discussions with the Department of Health and Wellbeing, 
SA (SA Health) to investigate whether this pilot project could be adopted annually or every 
few years to assess trends and assess the impact of interventions. The preliminary results of 
this survey have been posted to the same social media applications we recruited from to give 
participants a snapshot of the results in an infographic format. In response to Let’s Talk About 
It 2019, SA Health has commenced an online health promotion campaign regarding condom 
use among this age demographic using their own social media platforms. This swift action 
demonstrates the power of such data and the potential to translate these data at a 
population level.  
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Let’s Talk About It Survey 2019
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Let's Talk About It!
Please complete the survey below.
Thank you!
  
  Participant Information
  Let's Talk About It: An online survey of sexual health, knowledge and behaviour in South Australian young people.
  About the study...
  You are invited to take part in a survey about sexual health, alcohol and other drug use being led by the South
Australian Health and Medical Research Institute (SAHMRI). The survey is only for South Australian young people aged
16-29 years.  We hope to learn about what young people know about sexually transmitted infections and related
diseases, what the risks are and how easy or difficult it is to get medical help for these diseases.  This project has been
approved by the Aboriginal Health Research Ethics Committee (AHREC Protocol #:04-18-798) and Flinders University
Social and Behavioural Ethics Committee (Flinders SBREC Project #OH-00202).
  Do I have to do the survey?
  No, it is your choice - you don't need to do it and you can stop at any time. This will not disadvantage you in any way.
  What will happen if I do the survey?
  This survey is anonymous: we will not collect any of your personal contact details such as your name, phone number
and address.
  The survey will take about 10-15 minutes. Some questions are very personal and might be embarrassing or upsetting
for some people. It is recommended you complete the survey in a private place.
  Questions include topics like:
  Visits that you've made to doctors, nurses or health workers about your sexual health
    Drugs that you might have used in the past
    Your experiences with sex
    How you've been feeling in the past four weeks.
  We want you to do the survey even if you've never used drugs or had sex.
  Following completion of the survey you may submit your email to go into a prize draw to win one of 10 gift vouchers
valued at $100 each. Emails will be stored separately from survey submissions and cannot be traced back to your
answers.
  What if I have questions or feel upset?
  You can stop the survey at any time. If you have any further questions, concerns or feel upset and need support,
please contact your local GP/health service or one of the organisations listed below.
  Will anyone else see or know about my answers?
  No one will see your answers except the researchers. All information that is collected in this study is anonymous. Your
answers will not be identifiable in any report or publication that results from this survey.
  What will happen with my answers?
  All completed surveys will be stored on computers at SAHMRI with password protection. All people's surveys will be
combined, and we will publish the results in a report on our website and in research papers. We will keep all the results
for at least seven years in case we repeat the survey later and want to compare to see how answers have changed.
  What if I have a complaint or concern about the research?
  Complaints and concerns may be directed to the researchers (see details below), or the Senior Research and Ethics
Officer, Aboriginal Health Council of South Australia (AHCSA), Dr Gokhan Ayturk (Ph: 08 8273 7200, email:
Gokhan.Ayturk@ahcsa.org.au) or Flinders SBREC Executive Officer (Ph:  08 8201 3116).
  How can I find out about the survey results?
  The results of the survey can be downloaded from our Young Deadly Free website (http://youngdeadlyfree.org.au) from
2020.
  How do I get more information?
  If you have any questions, Associate Professor James Ward (Ph: 08 8128 4270, email: james.ward@sahmri.com) or
Dr Salenna Elliott (Ph: 08 8128 4073, email: salenna.elliott@sahmri.com) from SAHMRI will be happy to answer them.
  â€ƒ
  Support services and resources
  Adelaide Sexual Health Centre
  1/275 North Terrace, Adelaide SA 5000
  (08) 7117 2800
  https://www.sahealth.sa.gov.au/adelaidesexualhealthcentre
   
  Shine SA
  (Sexual health and relationships)
  ph 1300 794 584 (general inquiries)
  ph 1300 883 793 (sexual healthline)
  https://www.shinesa.org.au
  Nunkuwarrin Yunti
  (Aboriginal community controlled health service)
  182 - 190 Wakefield Street
  Adelaide SA 5000
  Phone: (08) 8406 1600
  Or
  28-30 Brady street
  Elizabeth Downs SA 5113
  Phone: (08) 8254 5300
  Beyond Blue
  (Mental health support)
  Ph 1300 22 4636
  https://www.beyondblue.org.au
  Lifeline
  (Crisis support and suicide prevention)
  Ph 13 11 14 (24hrs a day) 
  https://www.lifeline.org.au
  1800RESPECT
  (National sexual assault, domestic family violence counselling service)
  Ph 1800 737 732
  https://www.1800respect.org.au
 
PRIVATE AND CONFIDENTIAL
Do you live in South Australia? Yes
No
Are you 16 to 29 years old? Yes
No
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BEFORE YOU START: Agree
Disagree
This means you can say No.
â€¢ I have read the Participant Information
statement. I understand the aims of the survey   and
what I will be asked to do.
â€¢ I understand that I can stop at any stage without
giving a reason and without any consequence.
â€¢ I understand that I may not directly benefit from
taking part.
â€¢ I understand that all answers are anonymous and I
will not be identified in any way in reports of the
results. 
â€¢ I freely agree to take part in the survey.
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How old are you (in years)?
__________________________________
Are you Aboriginal or Torres Strait Islander? No
Yes, Aboriginal
Yes, Torres Strait Islander
Yes both Aboriginal and Torres Strait Islander
Were you born in Australia? Yes
No
Where were you born?
__________________________________
How long have you lived in Australia? One year or less
2-5 years
5-10 years
More than 10 years
Is English your first language? Yes
No
Postcode or town where you currently live
__________________________________
Who do you currently live with? Check all that apply. Parents
Partner
Children
Other family member(s)
Friends/housemates
Alone
Are you currently... Married
In a defacto relationship (Living with a partner
but not married)
Not married
Are you currently studying? Yes
No
Where are you studying? High school
TAFE/college
University - undergraduate
University - post-graduate
Other
What is the highest level of education you have I completed primary school only
completed? I left high school before finishing Year 10
I completed Year 10
I completed Year 12
I completed a TAFE/college course
I completed a university degree
I completed a post-graduate qualification (eg.
Masters, PhD)
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Are you currently employed? No
Yes, partâˆ’time/casual
Yes, fullâˆ’time
Do you identify as... Female
Male
Transgender female (trans woman, sistergirl)
Transgender male (trans man, brotherboy)
Other
At the moment do you think of yourself as... Straight/Heterosexual
Gay/Homosexual
Lesbian/Homosexual
Bisexual
I don't know/unsure
Other
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These questions check what you know about sex diseases (sexually transmissible infections - STIs
eg. chlamydia, gonorrhoea), HIV (the virus that causes AIDS) and hepatitis.
If a woman with HIV is pregnant, can her baby become Yes
infected with HIV? No
Don't know
Does a person with a STI always have symptoms? Yes
No
Don't know
Are people who have injected drugs at risk for Yes
Hepatitis C? No
Don't know
Does the pill (birth control) protect a woman from Yes
HIV infection? No
Don't know
Can Chlamydia make a woman unable to have a baby? Yes
No
Don't know
If condoms are used during sex, does this help to Yes
protect people from getting HIV? No
Don't know
Is there medicine that can cure hepatitis C? Yes
No
Don't know
Could someone who looks healthy pass on HIV Yes
infection? No
Don't know
Can Hepatitis B be passed on by sex? Yes
No
Don't know
Can Chlamydia be easily treated with antibiotics? Yes
No
Don't know
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 This section asks you about your own personal experiences with sex.  Some people have had sex
and others have not.
25% Complete - keep going!
Have you had oral sex (mouth on genitals) before? Yes
No
How old were you when you first had oral sex?
__________________________________
Have you had vaginal sex (penis in vagina) before? Yes
No
How old were you when you first had vaginal sex?
__________________________________
Have you had anal sex (penis in anus) before? Yes
No
How old were you when  you first had anal sex?
__________________________________
In the last year how many people have you had sex None
with (vaginal or anal)? 1 person
2 people
3 people
4 people
5 to 10 people
11 or more people
Was the last person you had sex with... Your current partner
Someone you met for the first time
Someone you had known for a while, but not your
current partner
Was the last person you had sex with... Aboriginal or Torres Strait Islander
Not Aboriginal or Torres Strait Islander
I'm not sure
Was the last person you had sex with... Female
Male
Transgender female (trans woman, sistergirl)
Transgender male (trans man, brotherboy)
Other
How old was the last person you had sex with? Under 16 years old
16-17 years old
18-19 years old
20-24 years old
25-29 years old
30 years of age or older
I'm not sure
In the last year, have you used the internet/mobile Yes
phone apps to meet partners? No
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Do you currently have a regular sexual partner Yes
(someone you have an ongoing sexual relationship No
with)?
In this relationship, do you only have sex with your Yes
partner? No
In this relationship, does your partner have sex only Yes
with you? No
The last time you had sex (vaginal or anal), what Condom
contraception did Oral contraception (the pill)
you or the person you had sex with use? (Tick all Emergency/morning after pill
that apply) Withdrawal/pulling out
Safe period/natural family planning
Tubal ligation/vascectomy
Implant (Implanon)
Injection (Depoâ€•Provera or Ralovera)
Nuva-Ring
Diaphragm/cervical cap
Other
None
When you had sex (vaginal or anal) with a regular Always used condoms
partner in the last year, how often were condoms used? Sometimes used condoms
Never used condoms
N/A: no regular partner in the last year
When you had sex (vaginal or anal) with a casual Always used condoms
partner in the last year, how often were condoms used? Sometimes used condoms
Never used condoms
N/A: No casual partner in the last year
If you use condoms, where do you usually get them Shop/local store/chemist
from? Medical clinic/General Practice
Aboriginal Medical Service
Never use condoms
Friends
Family member(s)
My sexual partner(s)
Other (eg. vending machine, condom tree)
Were you drunk or high last time you had sex? Yes
No
The last time you had sex did you want to have sex? Yes
No
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This section asks about your personal experiences with cigarette smoking, alcohol and other drug
use.
50% Complete - half way!
Do you smoke cigarettes? Yes
No
How many cigarettes a day do you smoke?
__________________________________
Have you drunk alcohol (beer, wine, spirits) in the Yes
past 12 months? No
In the last 12 months, how often did you have an Every day
alcoholic drink of any kind? Once a week or more
About once a month
Every few months
Once or twice a year
On the days that you have an alcoholic drink, how 1 to 2 drinks
many alcoholic drinks do you usually have? 3 to 4 drinks
5 to 6 drinks
7 or more drinks
Have you used marijuana (yarndi, gunga, grass, dope, Yes
pot, cannabis) in the last 12 months? No
In the last 12 months, how often did you use Every day
marijuana (yarndi, gunga, grass, dope, pot, cannabis)? Once a week or more
About once a month
Every few months
Once or twice a year
Have you used meth/amphetamine (speed, ice, go-e, Yes
base, gas, crystal) in the last 12 months? No
In the last 12 months, how often did you use Every day
meth/amphetamine (speed, ice, go-e, base, gas, Once a week or more
crystal)? About once a month
Every few months
Once or twice a year
When you used meth/amphetamine in the last 12 months, Ice or crystal (white crystal)
what kind did you usually use? Base (brown paste or toffee-like)
Speed (powder, tablet or capsule)
When you used meth/amphetamine in the last 12 months, Inhaling/smoking (inhaling vapours "chasing" or
how did you usually take it? smoking a pipe)
Swallowing
Snorting
Injection
Have you used ecstasy (E's, eccies, Molly, MDMA, XTC, Yes
Ex) in the last 12 months? No
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In the last 12 months, how often did you use ecstasy Every day
(E, eccies, MDMA, XTC, Ex)? Once a week or more
About once a month
Every few months
Once or twice a year
Have you used any other drugs in the last 12 months? No other drugs
Tick all the ones you used. Cocaine
Heroin
Petrol / paint / glue
Fantasy/ GHB / GBH / G
Benzos / Rholies
Ketamine
LSD/Acid/Mushrooms
Other
In the last 12 months, have you injected any drugs? Yes
No
What drug(s) have you injected in the last 12 months? Meth/amphetamine (ice, go-e, speed, gas, crystal,
Tick all the ones you injected. base)
Heroin
Methadone
Morphine, pethidine, oxycodone, oxycontin, MS
contin
Performance-enhancing drugs
Cocaine
LSD or other hallucinogens
Benzodiazepines
Other drugs
In the last 12 months, did you use any of the None of these
following for injecting a drug after someone else Needle/Syringe
used it (even if it was cleaned)? Tick all those you Tourniquet
used. Spoon
Filter
Swab
What do you think is the best way for a person to get Medical clinic/General Practice
help for alcohol and/or drug use? Aboriginal Medical Service
Drug and alcohol service
Hospital
Get help from friends or family
Internet
Other
Do you have any tattoo(s)? Yes
No
Where did you get the tattoo(s)? Tick all the places Professional parlour
where they were done. In my community (home, park)
Prison /jail/ juvenile justice centre
Other
Have you ever been in prison/jail or a juvenile No
justice centre for more than 24 hours? Yes, in the last 12 months
Yes, more than 12 months ago
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This section has questions about getting advice, testing and treatment for sexually transmissible
infections (STIs eg. chlamydia, gonorrhoea), HIV (the virus that causes AIDS) and hepatitis.
What is the main way you get information about sex Medical clinic/General Practice
and STIs, including HIV? Family planning / Sexual health clinic
Aboriginal Medical Service
School /TAFE/ university
Boyfriend / girlfriend / friends
Family member(s)
Internet
Magazines
Never look for information
Other
Have you ever been tested for an STI? Yes. In the last year
Yes. More than a year ago
I don't know
Never tested
Where did you get your last STI test? Medical clinic/General Practice
Aboriginal Medical Service
Family planning clinic / Sexual health clinic
Other
Have you ever tested positive for an STI? Yes, in the last year
Yes, more than a year ago
No
Which STI(s)? Tick all those that apply. Chlamydia
Gonorrhea
Syphilis
Trichomoniasis (Trich/"trike")
Genital Herpes
Genital Warts
Other
Have you ever been tested for HIV? Yes, in the last year
Yes, more than a year ago
I don't know
Never tested
Where did you get your last HIV test? Medical clinic/General Practice
Aboriginal Medical Service
Sexual Health Clinic/Family Planning Clinic
Hospital
Prison/jail or juvenile justice centre
Other
Are you HIV positive? Yes
No
Are you on treatment for HIV? Yes
No
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75% Complete - nearly done!
Have you been tested for hepatitis C? Yes, in the last year
Yes, more than a year ago
Never tested
I don't know
Where did you get your last hepatitis C test? Medical clinic/General Practice
Aboriginal Medical Service
Sexual Health Clinic/Family Planning Clinic
Hospital
Prison/jail or juvenile justice centre
Other
Are you hepatitis C positive? Yes
No
Are you having, or have you had, treatment for No
hepatitis C? Yes I had treatment in 2015 or earlier
Yes I had treatment in 2016 or later
Have you had a full health check up in the last year? Yes
No
Where did you have your health check? Medical clinic/General Practice
Aboriginal Medical Service
Other
Were you offered a check for STIs? Yes
No
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 This section asks questions about how you have been feeling in the past 4 weeks.
In the past 4 weeks, about how often did you feel All of the time
nervous? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel so All of the time
sad that nothing could cheer you up ? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel All of the time
restless or jumpy? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel All of the time
without hope? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel All of the time
that everything was an effort? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel All of the time
calm and peaceful? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often have you been a All of the time
happy person? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you feel All of the time
full of life? Most of the time
Some of the time
A little of the time
None of the time
In the past 4 weeks, about how often did you have a All of the time
lot of energy? Most of the time
Some of the time
A little of the time
None of the time
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In the past 4 weeks, about how often  did you feel All of the time
worthless? Most of the time
Some of the time
A little of the time
None of the time
What is your preferred way to complete a survey? In person/face-to-face
Online
Telephone/mobile
Mail
How did you hear about this survey? Facebook
Instagram
Snapchat
Email
QR code
Other
Did you find this survey easy to complete? Yes
No
What made it difficult? Too long
Words I didn't understand
Questions were confusing
Embarrassing
Other
You have finished the survey! Thank you.
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Appendix 3.B 
Sexually transmitted infections and blood-borne viruses 
knowledge questions answered correctly, by Indigenous status, 
South Australia, Let’s Talk About It 2019 
N.B. The table only report results for those that are correct and not reported. Counts less than 10 are reported 
without a percentage.   
Test for independence by Indigenous status and STI and BBV knowledge question, Pearson Chi-square test* and 
Fisher’s exact test†. 
 
   Total  Indigenous status  
 All 
participants 
n (%) 
N=2,380 
Aboriginal 
and or Torres 
Strait Islander 
n (%) 
N=231 
Non-
Indigenous 
n (%) 
N=2,062 
Not 
stated 
n (%) 
N=87 
 
p-value 
If a woman with HIV is pregnant, can her baby 
become infected with HIV? 
1,548 (65%) 157 (68%) 1,340 (65%) 51 (59%)  
0.414* 
Not reported  97 (4%) 11 (5%) 77 (4%) 9   
Does a person with a STI always have 
symptoms? 
2,085 (88%) 192 (83%) 1,823 (88%) 70 (80%) 0.029* 
Not reported 99 (4%) 11 (5%) 79 (4%) 9   
Are people who have injected drugs at risk for 
Hepatitis C? 
1,777 (75%) 181 (78%) 1,535 (74%) 61 (70%) 0.013* 
Not reported 98 (4%) 11 (5%) 79 (4%) 8   
Does the pill (birth control) protect a woman 
from HIV infection? 
2,125 (89%) 201 (91%) 1,853 (90%) 71 (82%) 0.218* 
Not reported 101 (4%) 81 (4%) 11 (5%) 9   
Can Chlamydia make a woman unable to have 
a baby? 
1,035 (43%) 105 (45%) 894 (43%) 36 (41%) 0.540* 
Not reported 100 (4%) 11 (5%) 80 (4%) 9   
If condoms are used during sex, does this help 
to protect people from getting HIV? 
1,979 (83%) 164 (71%) 1,745 (85%) 70 (80%) <0.001* 
Not reported 101 (4%) 81 (4%) 11 (5%) 9   
Is there medicine that can cure hepatitis C? 422 (18%) 61 (26%) 341 (17%) 20 (23%) <0.001* 
Not reported 102 (4%) 11 (5%) 11 (5%) 9   
Could someone who looks healthy pass on 
HIV infection? 
2,043 (86%) 192 (83%) 1,782 (86%) 69 (79%) 0.303* 
Not reported 104 (4%) 11 (5%) 11 (5%) 9  
Can Hepatitis B be passed on by sex? 1,013 (43%) 90 (39%) 885 (43%) 38 (44%) 0.046* 
Not reported 103 (4%) 11 (5%) 83 (4%) 9  
Can Chlamydia be easily treated with 
antibiotics? 
1,437 (60%) 160 (69%) 1,229 (60%) 48 (55%) 0.002* 
Not reported 102 (4%) 11 (5%) 82 (4%) 9  
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Appendix 3.C 
Sexually active, sexual intercourse and oral sex, by Indigenous 
status, South Australia, Let’s Talk About It 2019 
 All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value* 
Sexually active (oral, 
vaginal or anal) 2,380 231 2,062 87  
Yes  1,867 (78%) 186 (81%) 1,618 (78%) 63 (72%) 0.028* No  287 (12%) 17 (7%) 261 (13%) 9 
Not reported  226 (10%) 28 (12%) 183 (9%) 15 (17%)  
Ever had sexual intercourse 
(vaginal or anal) 1,867 186 1,618 63  
Yes  1,755 (94%) 180 (97%) 1,516 (94%) 59 (94%) 0.006* No 109 (6%) 6 99 (6%) 4 (6%) 
Not reported <5 0 <5 0  
Median age at first vaginal 
sex 
 
16.6 16.0 16.7 17.0 <0.001‡ 
Median age at first anal sex 
 18.9 18.5 18.9 19.0 <0. 074
‡ 
Ever had oral sex 2,380 231 2,062 87  
Yes  1,827 (77%) 174 (75%) 1,591 (77%) 62 (71%) 0.570* No 327 (14%) 28 (12%) 289 (14%) 10 (11%) 
Not reported 226 (10%) 29 (13%) 182 (9%) 15 (17%)  
Median age at first oral sex 
 16.5 16.0 16.5  16.9 0.177
‡ 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and sexually active, sexual intercourse and oral sex, Pearson Chi-
square test* and Kruskal Wallis test‡.  
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Appendix 3.D 
Contraception used at last sexual encounter, by Indigenous status, 
South Australia, Let’s Talk About It 2019 
    Total Indigenous status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value* 
Number who reported being sexually active (n)  
 1,867 186 1,618 63  
Contraception used at last sexual encounter   
Condoms  744 (49%) 65 (47%) 654 (49%) 25 (46%) 0.688* 
The pill 651 (43%) 33 (24%) 595 (45%) 23 (43%) 0.000* 
Morning after pill 34 (2%) 9 22 (2%) <5 0.000* 
Withdrawal  343 (23%) 18 (13%) 307 (23%) 18 (33%) 0.007* 
Safe period  30 (2%) <5 27 (2%) 0 0.755† 
Tuballigation  11 (1%) <5 9 <5 1.000† 
Implant 205 (14%) 37 (27%) 160 (12%) 8 (15%) 0.000* 
Injection 29 (2%) 9 20 (2%) 0 0.000* 
Nuvaring  <5 0 <5 <5 1.000† 
Diaphragm  6 <5 5 0 0.446† 
Other  102 (7%) 13 (9%) 84 (6%) 5 0.156* 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and contraception used at last sexual encounter, Pearson Chi-
square test* and Fisher’s exact test†. 
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Appendix 3.E 
Other drug use, by Indigenous status, South Australia, Let’s Talk 
About It 2019 
 
 Total  Indigenous status  
 
 
All 
participants 
n (%) 
N=2,380 
Aboriginal 
and or Torres 
Strait slander 
n (%) 
N=231 
Non-
Indigenous 
n (%) 
N=2,062 
Not stated 
n (%) 
N=87 
 
p-value 
Type of other drugs used    
None  1,613 (68%) 159 (69%) 1,402 (68%) 52 (60%) 0.795* 
Cocaine  254 (11%) 23 (10%) 221 (11%) 10 (%) 0.722* 
LSD/Acid/Mushroom 135 (6%) 8 122 (6%) 5 0.126* 
Benzodiazepines 48 (2%) <5 45 (2%) <5 0.081† 
Ketamine 44 (2%) 0 42 (2%) <5 0.018† 
Other 113 (5%) 10 (4%) 103 (5%) <5 0.657* 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and other drug use, Pearson Chi-square test* and Fisher’s exact 
test†. 
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Appendix 3.F 
Ever tested for an STI and location of test, by Indigenous status, 
South Australia, Let’s Talk About It 2019 
 
 Total Aboriginal status  
 All 
participants 
n (%) 
Aboriginal  
and or Torres 
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Even been tested for an STI 
(n) 1,867 186 1,618 63  
Yes, in the last year  539 (29%) 85 (46%) 437 (27%) 17 (27%) 
<0.001* Yes, more than a year ago 359 (19%) 43 (23%) 309 (19%) 7 I don’t know 42 (2%) 10 (5%) 29 (2%) <5 
Never tested  865 (46%) 44 (24%) 789 (29%) 32 (51%) 
Not reported  62 (3%) <5 54 (3%) <5  
Location of last STI test (n) 898 128 746 24  
Medical clinic/ General 
Practice 
627 (70%) 77 (60%) 534 (72%) 16 (67%) 
<0.001* 
Aboriginal Medical Service 30 (3%) 28 (22%) <5 0 
Family planning/Sexual 
health clinic 
228 (25%) 21 (16%) 199 (27%) 7 
Other  14 (2%) <5 11 (1%) <5 
Tested positive for an STI (n) 898 128 746 24  
Yes, in the last year  77 (9%) 14 (11%) 60 (8%) <5 
0.104* Yes, more than a year ago 124 (14%) 24 (19%) 98 (13%) <5 
No  695 (77%) 90 (70%) 587 (79%) 18 (75%) 
Not reported  <5 0 <5 <5  
Ever tested positive for an 
STI 
201 (22%) 38 (30%) 158 (21%) 5 0.034* 
N.B. Counts less than 5 are presented as <5 and counts less than are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and ever tested for an STI and location of STI test, Pearson Chi-
square test*. 
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Appendix 3.G 
Univariate Logistic regression analysis – among sexually active 
participants who have ever been tested for an STI, by Indigenous 
status, Let’s Talk About It 2019 
 All participants 
N=1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
1,564 
 OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value 
Indigenous status       
Non-Indigenous Reference       
Aboriginal and or 
Torres Strait 
Islander 
2.60 
(1.86-3.63) 
<0.001     
Gender        
Male  Reference  Reference  Reference  
Female 2.60 
(2.14-3.15) 
<0.001 1.69 
(0.82-3.51) 
0.158 2.45 
(1.99-3.01) 
<0.001 
Age group       
16-19  Reference  Reference  Reference  
20-24 4.60 
(3.63-5.81) 
<0.001 3.23 
(1.49-7.01) 
0.003 4.67 
(3.63-6.01) 
<0.001 
25-29 9.50 
(7.18-12.56) 
<0.001 6.31 
(2.54-15.71) 
<0.001 10.06 
(7.42-13.64) 
<0.001 
Sexuality        
Straight/heterosexu
al  
Reference  Reference  Reference  
LGBTI/homosexual  1.92 
(1.56-2.36) 
<0.001 1.24 
(0.62-2.48) 
0.534 1.95 
(1.57-2.44) 
<0.001 
Remoteness       
Rural and remote  Reference  Reference  Reference  
Urban 1.29 
(1.00-1.66) 
0.047 1.51 
(0.66-3.46) 
0.328 1.31 
(0.99-1.72) 
0.055 
Marital status       
Not married  Reference  Reference  Reference  
Married/De-facto 2.31 
(1.86-2.87) 
<0.001 1.24 
(0.61-2.50) 
0.553 2.52 
(2.00-3.19) 
<0.001 
Education level       
Completed less 
than year 12  
Reference  Reference  Reference  
Completed year 12 1.93 
(1.50-2.48) 
<0.001 1.86 
(0.86-4.04) 
0.116 2.04 
(1.55-2.68) 
<0.001 
TAFE/University 4.61 
(3.58-5.94) 
<0.001 2.87 
(1.28-6.46) 
0.011 5.16 
(3.90-6.81) 
<0.001 
Employed       
No  Reference  Reference  Reference  
Yes 1.37 
(1.11-1.70) 
0.004 1.87 
(0.98-3.56) 
0.056 1.50 
(1.18-1.90) 
0.001 
Concurrency - partner only has sex with you  
Yes  Reference  Reference  Reference  
No  2.17  
(1.47-3.21) 
<0.001 2.65 
(0.57-12.40) 
0.216 2.10 
(1.38-3.20) 
0.001 
No. of sexual partners in past 12 months  
1  Reference  Reference  Reference  
2-4 1.38 
(1.10-1.72) 
0.005 0.82 
(0.38-1.76) 
0.607 1.44 
(1.13-1.83) 
0.003 
5 or more  3.93 
(2.77-5.57) 
<0.001 10.6 
(1.37-82.36) 
0.024 3.65 
(2.53-5.25) 
<0.001 
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 All participants 
N=1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
1,564 
 OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value 
Used internet/mobile apps to meet partners 
No Reference  Reference  Reference  
Yes  1.60 
(1.31-1.95) 
<0.001 1.16 
(0.59-2.27) 
0.663 1.60 
(1.30-1.98) 
<0.001 
Used a condom last time had sex 
Yes Reference  Reference  Reference  
No  1.79 
(1.48-2.17) 
<0.001 1.21 
(0.63-2.34) 
0.562 1.83 
(1.49-2.25) 
<0.001 
Used a condom with casual partner  
Yes  Reference  Reference  Reference  
No  0.80 
(0.66-0.97) 
0.025 0.37 
(0.18-0.77) 
0.007 0.86 
(0.70-1.06) 
0.163 
Drunk or high last sexual encounter  
No  Reference  Reference  Reference  
Yes  1.01 
(0.80-1.28) 
0.928 0.67 
(0.33-1.33) 
0.251 1.02 
(0.78-1.32) 
0.892 
No. alcohol drinks per session  
5 or more  Reference  Reference  Reference  
1-4  1.38 
(1.14-1.68) 
0.001 1.26 
(0.64-2.48) 
0.512 1.47 
(1.19-1.81) 
<0.001 
Used marijuana        
No  Reference  Reference  Reference  
Yes  1.29 
(1.07-1.55) 
0.008 0.97 
(0.51-1.83) 
0.914 1.24 
(1.01-1.51) 
0.037 
Used meth/amphetamine 
No  Reference  Reference  Reference  
Yes  1.99 
(1.08-3.67) 
0.027 1.06 
(0.20-5.62) 
0.948 1.91 
(0.98-3.72) 
0.057 
Used ecstasy        
No  Reference  Reference  Reference  
Yes  1.78 
(1.40-2.74) 
<0.001 0.94 
(0.43-2.02) 
0.865 1.90 
(1.46-2.47) 
<0.001 
Used cocaine        
No  Reference  Reference  Reference  
Yes 2.19 
(1.65-2.90) 
<0.001 1.23 
(0.46-3.30) 
0.688 2.41 
(1.78-3.27) 
<0.001 
Drug score        
0 Reference   Reference  Reference  
1  1.22 
(0.97-1.52) 
0.086 1.24 
(0.58-2.65) 
0.584 1.16 
(0.91-1.47) 
0.237 
2 or more  1.95 
(1.54-2.46) 
<0.001 1.03 
(0.47-2.23) 
0.947 2.04 
(1.59-2.63) 
<0.001 
OR – Odds ratio; CI – Confidence interval. 
63 participants were not included as their indigenous status was not stated.  
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Appendix 3.H 
Univariate Logistic regression analysis – among sexually active 
participants who have ever tested positive for an STI, by 
Indigenous status, Let’s Talk About It 2019 
 All participants 
N=1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
N=1,564 
 OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value 
Indigenous status       
Non-Indigenous Reference       
Aboriginal and or 
Torres Strait 
Islander 
1.57 
(1.03-2.38) 
0.035     
Gender        
Male  Reference  Reference  Reference  
Female 1.27 
(0.90-1.81) 
0.179 1.59 
(0.58-4.35) 
0.364 1.13 
(0.77-1.65) 
0.540 
Age group       
16-19  Reference  Reference  Reference  
20-24 1.73 
(1.06-2.82) 
0.029 1.31 
(0.41-6.05) 
0.651 1.94 
(1.11-3.38) 
0.020 
25-29 1.72 
(1.04-2.84) 
0.035 1.91 
(0.60-6.05) 
0.270 1.73 
(0.97-3.08) 
0.061 
Sexuality        
Straight/heterosexu
al  
Reference  Reference  Reference  
LGBTI/homosexual  1.01 
(0.73-1.40) 
0.944 0.70 
(0.31-1.60) 
0.402 1.09 
(0.76-1.56) 
0.647 
Remoteness       
Rural and remote  Reference  Reference  Reference  
Urban 0.96 
(0.62-1.50) 
0.864 0.97 
(0.34-2.76) 
0.950 0.93 
(0.57-1.51) 
0.764 
Marital status       
Not married  Reference  Reference  Reference  
Married/De-facto 1.05 
(0.76-1.46) 
0.762 0.92 
(0.41-2.08) 
0.847 1.11 
(0.77-1.59) 
0.592 
Education level       
Completed less 
than year 12  
Reference  Reference  Reference  
Completed year 12 0.89 
(0.56-1.42) 
0.641 0.28 
(0.09-0.81) 
0.019 1.22 
(0.71-2.12) 
0.474 
TAFE/University 0.91 
(0.59-1.41) 
0.670 0.77 
(0.31-1.92) 
0.580 1.06 
(0.62-1.79) 
0.838 
Employed       
No  Reference  Reference  Reference  
Yes 0.95 
(0.65-1.39) 
0.807 0.50 
(0.23-1.08) 
0.079 1.25 
(0.78-1.99) 
0.348 
Concurrency - partner only has sex with you  
Yes  Reference  Reference  Reference  
No  1.68 
(1.03-2.74) 
0.036 0.95 
(0.27-3.34) 
0.931 1.86 
(1.08-3.19) 
0.025 
No. of sexual partners in past 12 months  
1  Reference  Reference  Reference  
2-4 1.52 
(1.04-2.22) 
0.032 4.90 
(1.83-13.10) 
0.002 1.29 
(0.85-1.97) 
0.233 
5 or more  2.68 
(1.79-4.01) 
<0.001 4.11 
(1.47-11.49) 
0.007 2.35 
(1.50-3.69) 
<0.001 
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 All participants 
N=1,805 
Aboriginal and or  
Torres Strait Islander  
N=182 
Non-Indigenous 
N=1,564 
 OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value OR  
(95% CI) 
p-value 
Used internet/mobile apps to meet partners 
No Reference  Reference  Reference  
Yes  1.76 
(1.28-2.41) 
<0.001 2.59 
(1.19-5.66) 
0.017 1.70 
(1.19-2.42) 
0.004 
Used a condom last time had sex 
Yes Reference  Reference  Reference  
No  1.29 
(0.92-1.82) 
0.143 1.20 
(0.53-2.68) 
0.665 1.38 
(0.94-2.03) 
0.103 
Used a condom with casual sexual partner  
Yes  Reference  Reference  Reference  
No  0.67 
(0.49-0.93) 
0.016 0.47 
(0.21-1.02) 
0.055 0.74 
(0.52-1.06) 
0.100 
Drunk or high last sexual encounter  
No  Reference  Reference  Reference  
Yes  1.34 
(0.91-1.97) 
0.134 1.62 
(0.69-3.76) 
0.266 1.21 
(0.78-1.88) 
0.404 
No. alcohol drinks per session  
5 or more  Reference  Reference  Reference  
1-4  0.79 
(0.57-1.10) 
0.164 0.58 
(0.25-1.32) 
0.191 0.91 
(0.62-1.32) 
0.606 
Used marijuana        
No  Reference  Reference  Reference  
Yes  1.35 
(0.99-1.85) 
0.059 1.03 
(0.48-2.22) 
0.932 1.38 
(0.97-1.96) 
0.074 
Used meth/amphetamine 
No  Reference  Reference  Reference  
Yes  2.26 
(1.08-4.73) 
0.031 3.77 
(0.60-23.55) 
0.155 1.90 
(0.80-4.52) 
0.147 
Used ecstasy        
No  Reference  Reference  Reference  
Yes  1.68 
(1.18-2.39) 
0.004 2.31 
(0.96-5.57) 
0.063 1.56 
(1.05-2.32) 
0.026 
Used cocaine        
No  Reference  Reference  Reference  
Yes 1.88 
(1.29-2.73) 
0.001 1.81 
(0.63-5.17) 
0.270 1.97 
(1.31-2.98) 
0.001 
Drug score        
0 Reference   Reference  Reference  
1  1.09 
(0.73-1.62) 
0.086 1.02 
(0.41-2.57) 
0.964 1.06 
(0.67-1.66) 
0.814 
2 or more  1.57 
(1.09-2.27) 
0.015 1.72 
(0.69-4.33) 
0.247 1.53 
(1.02-2.29) 
0.041 
OR – Odds ratio; CI – Confidence interval. 
24 participants were not included as their indigenous status was not stated.  
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Appendix 3.I 
Ever tested for HIV and hepatitis C and location of test, by 
Indigenous status, South Australia, Let’s Talk About It 2019 
 Total  Indigenous status  
 All 
participants 
n (%) 
Aboriginal 
and or Torres  
Strait Islander 
n (%) 
Non-
Indigenous 
n (%) 
Not stated 
n (%) 
 
p-value 
Ever tested for HIV 1,867 186 1,618 63  
Yes, in the last year  304 (16%) 49 (26%) 247 (15%) 8 
<0.001* Yes, more than a year ago 216 (12%) 28 (15%) 185 (11%) <5 I don’t know  243 (13%) 38 (20%) 195 (12%) 10 (16%) 
Never tested 1,041 (56%) 67 (36%) 937 (58%) 37 (59%) 
Not reported  63 (3%) <5 54 (3%) 5  
Location of last HIV test 520 77 432 11  
Medical clinic/ General Practice  343 (66%) 44 (57%) 291 (67%) 8 
<0.001† 
Aboriginal Medical Service 20 (4%) 19 (25%) <5 0 
Family planning/Sexual health clinic 137 (26%) 10 (13%) 124 (29%) <5 
Hospital  11 (2%) <5 7 0 
Prison/jail or juvenile justice centre 0 0 0 0 
Other  9 0 9 0 
Ever tested for Hepatitis C 1,867 186 1,618 63  
Yes, in the last year  255 (14%) 45 (24%) 202 (12%) 8 
<0.001* Yes, more than a year ago 194 (10%) 30 (16%) 161 (10%) <5 Don’t know  858 (46%) 61 (33%) 768 (47%) 29 (46%) 
Never  491 (26%) 46 (25%) 426 (26%) 19 (30%) 
Not reported  69 (4%) <5 61 (4%) <5  
Location of last Hepatitis C test 449 75 363 11  
Medical clinic/ General Practice  313 (70%) 42 (56%) 236 (72%) 8 
<0.001† 
Aboriginal Medical Service 22 (5%) 21 (28%) <5 0 
Family planning/Sexual health clinic 94 (21%) 9 84 (23%) <5 
Hospital  10 (2%) <5 6 <5 
Prison/jail or juvenile justice centre 0 0 0 0 
Other  10 (2%) 0 9 <5 
N.B. Counts less than 5 are presented as <5 and counts less than 10 are reported without a percentage; 
percentages have been rounded up to the nearest whole number, columns may not equal 100%. 
Test for independence by Indigenous status and ever tested for HIV and hepatitis C and location of test, Pearson 
Chi-square test* and Fisher’s exact test†. 
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4.1. Prologue  
4.1.1. My role  
For the preliminary evaluation of the ATLAS Aboriginal and Torres Strait Islander Sexual 
Health Surveillance Network (ATLAS), I:  
• designed the preliminary evaluation and drafted an evaluation proposal 
• engaged with stakeholders 
• drafted the stakeholder interview questions  
• conducted stakeholder interviews and transcribed them 
• completed the thematic analysis of interviews  
• interpreted the data and drafted an evaluation report 
• worked with the other authors and stakeholders to finalise the evaluation report.  
4.1.2. Lessons learnt  
The main lesson I learnt from this project was how simple, although complex, a surveillance 
system can be. The Centre for Disease Control and Prevention Updated Guidelines for 
Evaluating Public Health Surveillance Systems, provides a framework to assess the attributes 
of a surveillance system. These guidelines are useful for identifying all the components within 
a system critical to ensuring the surveillance system is operating as intended, each process is 
informing the system, and is meeting the needs of all stakeholders. For example, for 
Aboriginal Community-Controlled Health Services (ACCHS), it is essential that ATLAS is 
acceptable, simple, timely and useful. While the system may appear to be simple to services, 
ATLAS is anything but simple. The establishment and setup of ATLAS has taken a significant 
amount of resources and time to ensure it is acceptable and right. Similarly, the process of 
data extraction, analysis and interpretation, may also appear to be simple, however, it is 
complex and involves several systems and processes. Additionally, working in partnership 
with stakeholders is essential to ensuring the evaluation is focused and achieves the desired 
outcome.  
4.1.3. Public health impact 
The Aboriginal and Torres Strait Islander population are overrepresented in sexually 
transmissible infections (STIs) and blood borne viruses (BBVs). As a surveillance system, 
ATLAS has the potential to enhance the current knowledge of STIs and BBVs among the 
Aboriginal and Torres Strait Islander population and reduce the overall burden of disease. 
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network will be 
able to provide important information and data on STIs and BBVs among the Aboriginal and 
Torres Strait population. Utilising ACCHS, often the preferred providers of primary health 
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care of Aboriginal and Torres Strait Islander peoples, will provide a unique opportunity to 
strengthen STI and BBV testing, care and management for health services and improve 
surveillance, monitoring and evaluation of STI and BBV.  
This preliminary evaluation of ATLAS demonstrates how ATLAS is acceptable, simple, timely 
and flexible. While more time is required for ATLAS to prove and fulfil its intended objective, 
it was generally agreed that ATLAS is a useful addition to enhanced efforts in STI and BBV 
control. Importantly, one of the strengths of ATLAS as a surveillance system is its network of 
ACCHS; 29 services have joined ATLAS since it was established. The ongoing engagement of 
those services is critical to the ongoing success of ATLAS. This evaluation provides the ATLAS 
research team with an extensive summary of ATLAS, its establishment as a surveillance 
system and provides several recommendations which aim to strengthen ATLAS and ensure 
ATLAS meets its intended objective. 
4.1.4. Acknowledgements 
Firstly, I would like to acknowledge and thank the two ACCHS involved in the preliminary 
evaluation of ATLAS. Additionally, I would like to acknowledge and thank the ATLAS research 
team, particularly Professor James Ward (Chief Investigator) and Dr Clare Bradley (Study 
Coordinator) for your guidance, support and involvement in the evaluation.  
4.1.5. MAE core requirements  
This project fulfils the evaluation of a surveillance system component of the Master of 
Philosophy in Applied Epidemiology. A copy of this chapter was formatted into a preliminary 
evaluation report and provided to the two ACCHS involved in the preliminary evaluation. A 
literature and document review were undertaken as part of the evaluation. 
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4.2. Abstract  
4.2.1. Objective  
The overall aim was to undertake a preliminary evaluation of the ATLAS Aboriginal and Torres 
Strait Islander Sexual Health Surveillance Network (ATLAS). The primary objective was to 
evaluate the attributes of ATLAS and assess if ATLAS is meeting its intended objective. The 
secondary objective was to provide recommendations to the ATLAS research team to 
strengthen the system. 
4.2.2. Method  
ATLAS was evaluated using a document review, stakeholder interviews and secondary 
analysis of ATLAS data were undertaken to assess the system attribute of ATLAS, using the 
Centre for Disease Control and Prevention Updated Guidelines for Evaluating Public Health 
Surveillance Systems. 
4.2.3. Results  
Out of the 29 Aboriginal community-controlled health services from around Australia 
involved in ATLAS, two Aboriginal community-controlled health services were eligible to be 
involved in the preliminary evaluation. We found ATLAS to be acceptable, simple, timely and 
flexible, and a useful addition to enhance efforts in sexually transmitted infections and blood-
borne viruses’ control. In addition, data quality and completeness of data were generally 
high. However, more time and evidence is required for ATLAS to demonstrate its value as a 
surveillance system. Despite this, there are several areas that could be addressed to 
strengthen ATLAS and its network. Six recommendations have been suggested to inform the 
strengthening of ATLAS as a surveillance system.  
4.2.4. Conclusion  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network provides 
important information and data on sexually transmitted infections and blood-borne viruses 
in the Aboriginal and Torres Strait Islander population; however, several remaining 
challenges need to be addressed in order to ensure ATLAS is successful in meeting its 
objective. The preliminary evaluation recommendations aim to inform the strengthening of 
ATLAS and contribute to ATLAS fulfilling its intended objective: to establish a national sentinel 
surveillance system specifically focussed on sexually transmitted infections and blood-borne 
viruses testing, care and management for Aboriginal community-controlled health services 
and other health services in the areas of surveillance, monitoring and evaluation. 
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4.3. Introduction  
The Aboriginal and Torres Strait Islander population is overrepresented in STIs and BBVs 
notifications nationally (1). Higher notification rates have been consistently high for over two 
decades and the greatest disparity occurs in regional and remote areas of Australia (1). 
Common STIs in Aboriginal and Torres Strait Islander communities include Chlamydia 
trachomatis (chlamydia), Neisseria gonorrhoea (gonorrhoea), Trichomonas vaginalis 
(trichomonas) and infectious syphilis (1). These STIs are easy to diagnose and treat but can 
lead to serious sexual and reproductive health consequences if left untreated; chlamydia and 
gonorrhoea can lead to pelvic inflammatory disease, ectopic pregnancy, epididymitis and 
tubal factor infertility (2-4).  
Chlamydia is the most common notifiable STI in Australia (1, 5). In 2017 the Aboriginal and 
Torres Strait Islander population accounted for 7% of all notifications despite representing 
just 3% of the total Australian population (1, 5). Chlamydia notification rates for the 
Aboriginal and Torres Strait Islander population were 2.8 times higher than the non-
Indigenous population (1). Gonorrhoea is also common in Aboriginal and Torres Strait 
Islander communities, particularly among those living in remote areas (1). Similarly, in 2017, 
notifications among the Aboriginal and Torres Strait Islander population accounted for 15% 
of all gonorrhoea notifications in Australia (1). Overall, gonorrhoea notification rates were six 
times higher for the Aboriginal and Torres Strait Islander population than for the non-
Indigenous population and 30 times higher in remote areas (1).   
Trichomonas is only notifiable in the Northern Territory, but positivity data from a range of 
studies highlight the extent of the problem across jurisdictions. A systematic review and 
meta-analysis of prevalence of STIs in Aboriginal and Torres Strait Islander Australians 
identified 11 studies that reported a prevalence of trichomonas (6). The pooled prevalence 
of trichomonas for Aboriginal and Torres Strait people was 22.6% and was highest in 
pregnant females (6). It is speculated, other areas of Australia experience high prevalence of 
trichomonas, however, because trichomonas is only notifiable in the Northern Territory it is 
difficult to ascertain this. Trichomonas is implicated with poor reproductive health outcomes 
and greatly increases transmissibility of human immunodeficiency viruses (HIV) (7, 8). 
In 2017, 18% of infectious syphilis notifications were among the Aboriginal and Torres Strait 
Islander population, and diagnoses rates were five times higher than the non-Indigenous 
population (1). Untreated syphilis can progress to tertiary syphilis and result in cardio-
vascular syphilis, neurosyphilis, meningitis, dementia and general paresis (9). In pregnant 
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women, syphilis can cause congenital syphilis and result in stillborn babies (10, 11). Over half 
(26 of 44) of congenital syphilis notifications in the last 10 years were among Aboriginal and 
Torres Strait Islander infants (1). An ongoing outbreak of syphilis in northern,  central and 
western Australia has resulted in a 300% increase in notifications for people from remote 
Aboriginal and Torres Strait Islander communities since 2011 (12-14).  
Blood borne viruses such as viral hepatitis and HIV are also of major concern to the Aboriginal 
and Torres Strait Islander population, with increasing notifications occurring over the last five 
years despite decreasing rates of diagnoses in the non-Indigenous population (15). Of the 
notifications of newly-diagnosed hepatitis B in Australia, in 2017, 2% were in the Aboriginal 
and Torres Strait Islander population where notification rates were  2.3 times higher than the 
non‑Indigenous population (1, 5). In 2017, the Aboriginal and Torres Strait Islander 
population accounted for 11% of all diagnosed hepatitis C, 4.4 times higher than the non-
Indigenous population (1, 5). Moreover, the rate of newly-acquired hepatitis C (hepatitis C 
diagnosis with evidence of acquisition in the 24 months prior to diagnosis) in the Aboriginal 
and Torres Strait Islander population in 2017 was 13.7 times that of the non‑Indigenous 
population and more prevalent in younger age groups (1, 5). 
In 2017, the Aboriginal and Torres Strait Islander population accounted for 3% of all 
notifications for HIV (1, 5), with a notification rate 1.6 times higher in the Aboriginal and 
Torres Strait Islander population than for the Australian-born non-Indigenous population (1, 
5). Notification rates of HIV had previously been comparable with the non-Indigenous 
population, for over two decades, 1992-2011; however, have diverged in recent years (1, 5).   
To reduce the prevalence and burden of STIs and BBVs, we need to better understand 
epidemics and their context (5). This requires not only notification data as mandatorily 
reported to jurisdictional health departments (such as the data outlined above), but also 
testing, incidence, positivity and treatment data. Notification data alone has limitations for 
assessing an epidemic status, as they do not account for testing and treatment outcomes, 
nor changes in clinical practice guidelines or interventions impacting these issues (16). 
Combined with routinely collected socio-demographic and risk behaviour data, this 
combination of data sets would enable an in-depth understanding of STIs and BBVs 
epidemics, as well as assessments regarding the impact of interventions to control these 
infections/viruses on communities/populations.  
The main source of information regarding STIs and BBVs within Australia currently comes 
from routine clinical notification data through the National Notifiable Diseases Surveillance 
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System (NNDSS) (5, 17). This surveillance system requires laboratories and/or clinicians 
report all diagnoses of notifiable STIs and BBVs to their local public health department. 
Several limitations impact this system’s ability to truly understand the burden of disease. 
Firstly, the system only reports on diagnoses, and not testing data, making it difficult to 
determine if notifications are influenced by testing rates. While this system is important for 
understanding the burden of disease for notifiable conditions, it does not enable an 
understanding of the burden of undiagnosed infections in a population; coupling this data 
with testing data would close this gap somewhat. Secondly, NNDSS notifications often do not 
contain Aboriginal and Torres Strait Islander status, and as such, there is often 
underreporting and or underestimation of STIs and BBVs in the Aboriginal and Torres Strait 
Islander population (5, 18). For example, in New South Wales, Victoria and Tasmania less 
than 50% of all chlamydia notifications are complete for Aboriginal and Torres Strait Islander 
status (1).  
Further information is required to address the persistently high and disproportionate over-
representation of STI and BBV among Aboriginal and Torres Strait Islander people. The 
majority of STIs and BBVs in Australia are diagnosed in primary health care services (19), and 
ACCHS are a preferred provider of primary health care for Aboriginal and Torres Strait 
Islander people (20). The ATLAS Aboriginal and Torres Strait Islander Sexual Health 
Surveillance Network has been developed to utilise this network of ACCHS and fill some of 
the gaps in data on clinical testing and management of STIs and BBVs to supplement national 
notification data (16).  
This paper outlines a preliminary evaluation conducted in 2019 to assess if ATLAS is 
effectively meeting its intended objective, and to establish a national sentinel surveillance 
system of ACCHS specifically focussed on STI and BBV testing, care and management for 
health service use in the areas of surveillance, monitoring and evaluation.  
4.4. ATLAS  
4.4.1. Description of ATLAS  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network is a 
national sentinel surveillance system of ACCHS established within clinical hubs in 2018. The 
aim of ATLAS is to improve understanding of STI and BBV testing and management within 
ACCHS across Australia (16). As of the end of July 2019, there were 29 Aboriginal health 
services involved in ATLAS, across five clinical hubs in four states (New South Wales, 
Queensland, South Australia and Western Australia) (Figure 4.1) (16). The ATLAS ACCHS sites 
138 
 
were chosen based on convenience, representativeness of ACCHS, geographical locations 
and relationships through existing research partnerships. The ATLAS network is expected to 
grow, with other ACCHS joining ATLAS in late 2019 and set to join in 2020. Further, the ATLAS 
network has the potential to be one of the largest networks of ACCHS for any condition in 
the country. 
 
FIGURE 4.1: MAP SHOWING THE GEOGRAPHICAL LOCATIONS OF ATLAS CLINICAL HUBS 
 
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network is part of 
the Centre for Research Excellence in Aboriginal Sexual Health and Blood-Borne Viruses (CRE-
ASH), which aims to investigate the ability of strategies, both novel and current best practice, 
to control STIs and BBVs, while addressing policy-relevant questions and influencing clinical 
practice (16). The CRE-ASH is funded by a National Health and Medical Research Council grant 
(#1100302) and led by the South Australian Health and Medical Research Institute (SAHMRI).   
4.4.2. Objectives of ATLAS 
The primary objective of ATLAS is to establish a national sentinel surveillance system 
specifically focussed on STI and BBV testing, care and management for ACCHS and other 
health services in the areas of surveillance, monitoring and evaluation (16). In addition, there 
are five secondary objectives: (i) To develop a national agreed set of STI and BBV clinical 
performance measures that will exist beyond the life of the CRE-ASH; (ii) To monitor trends 
in STI and BBV testing, positivity, and clinical management as per clinical performance 
measures over time; (iii) To monitor trends in STI and BBV knowledge, risk practices and 
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health service access of young people in order to help shape future primary care 
interventions; (iv) To establish a network to enable planners to determine where 
interventions are most required and how well they are working; and (v) To build the capacity 
of participating hubs and sites to use data for continuous quality improvement (CQI) 
processes (16).  
4.4.3. Governance of ATLAS 
The CRE-ASH governance structure was established to oversee activities of CRE-ASH including 
ATLAS. There are several components to the governance structure and the membership and 
responsibilities for each group are outlined below (16). Figure 4.2 provides a diagrammatic 
representation of the governance structure (21).  
The Clinical Hub Group comprises of members from five clinical hubs representative of 
geographical regions nationally and ACCHS; key partners in CRE-ASH (listed below). This 
Clinical Hub Group oversees study development and conduct; comes together as a forum for 
focussed and ongoing collaboration with Aboriginal and Torres Strait Islander communities; 
ensures the projects, processes and findings of the CRE-ASH are relevant and have resonance 
with ACCHS and communities; and promotes quality research that will benefit Aboriginal and 
Torres Strait Islander communities (16).  
• the Aboriginal Health Council of South Australia  
• Apunipima Cape York Health Council 
• Kimberley Aboriginal Medical Services 
• Institute for Urban Indigenous Health (Brisbane) 
• Aboriginal Health and Medical Research Council of NSW.  
The Investigator Group is comprised of all CRE-ASH Chief Investigators (CI) and Associate 
Investigators (AI). The group’s role is to provide scientific expertise in the design and conduct 
of the study and to take scientific responsibility for analysis and reporting of study outcomes 
(16).  
The Operational Group and SAHMRI supports the day to day management of the study and 
oversees the development of study procedures, ensures the routine operations of the study 
proceed in accordance with the protocols and procedures endorsed by the Executive 
Committee, and engages with stakeholders and participating ACCHS on an ongoing basis (16). 
The Operational Group comprises a subset of Chief investigators, Associate Investigators and 
CRE-ASH research team members.  
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The External Advisory Board comprises of senior researchers and experts in sexual health: 
Professor David Lewis (Chair), Professor Frank Bowden, Dr Christine Selvey, Ms Lisa Bastian, 
and Professor Gracelyn Smallwood. The External Advisory Board’s role is to provide advice 
and oversight to the development and implementation of CRE-ASH activities and assist with 
the creation of a dissemination and translation strategy in consultation with the CRE-ASH 
Clinical Hub Reference Group and the Capacity Building Group (16).  
The Capacity Strengthening Group comprises of Chief Investigators, Associate Investigators 
and the ATLAS Study Coordinator, who direct and provide opportunities for capacity 
development by Professional Research Persons throughout the ATLAS network (16). 
A face-to-face meeting is held annually with clinical hub and ACCHS representatives, the 
operation group and external advisory board. The face-to-face meetings provide an 
opportunity to update the ATLAS network on the progress of ATLAS and the CRE-ASH 
activities and to seek their feedback and guidance.  
4.4.4. Engagement and implementation of ATLAS  
4.4.4.1. Engagement 
Prior to the implementation of ATLAS, a significant amount of engagement was conducted 
(and is ongoing) with each clinical hub and ACCHS to discuss engagement within the ATLAS 
network.  Each service was visited by the Chief Investigator A , who met with senior ACCHS 
staff, clinicians and ACCHS board members, to ensure the approach used by ATLAS was 
appropriate. The Chief Investigators group also sought to ensure that ACCHS understood the 
potential impact of their involvement and the overall benefit to ACCHS, their community and 
the broader Aboriginal and Torres Strait Islander population, and addressing any concerns 
ACCHS might have.  
Concerns included those related to privacy; storage, management and security of data; the 
process for data extraction, including having a third-party data extraction software installed 
on their ACCHS patient management system; services already undertake regular analysis of 
their data; the potential impact of results on the ACCHS and staff; and the stigmatisation of 
STI and BBV. It is worth noting that addressing the concerns of ACCHS contributed to delaying 
their involvement in ATLAS. 
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FIGURE 4.2: ATLAS GOVERNANCE STRUCTURE, 2019 
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4.4.4.2. Implementation  
To establish ATLAS within an ACCHS is relatively simple. Where compatible, a data extraction 
tool GRHANITE™ (22) is installed onto the ACCHS system with IT support. Where GRHANITE™ 
is not compatible, other arrangements for data extraction are made and agreed upon 
between the ACCHS and SAHMRI.  
GRHANITE™ has been designed to extract routinely collected administrative data from 
multiple health services and organisations and can link deidentified records for the same 
individual. GRHANITE™ ensures privacy and confidentiality by generating encrypted keys that 
can be used to link records with and between independent databases. GRHANITE™ is 
compatible with several general practice electronic patient management systems including 
many of those used by ACCHS.   
The use of GRHANITE™ within ATLAS is expected to improve data quality, overcoming issues 
faced by prior projects that manually extracted data from paper or electronic patient 
management systems. GRHANITE™ has been tailored for ATLAS to extract data variables 
related to STI and BBV at the population level. Variables extracted from the system include 
demographics (e.g. gender, age, suburb, postcode), Aboriginal and Torres Strait Islander 
status, appointment date and type and by health professional, specimen collection date and 
type, treatment date and type, and immunisation date and type.  
GRHANITE™ connects to ACCHS to passively acquire the data, then SAHMRI IT staff connect 
to a GRHANITE™ portal to import the data into a database at SAHMRI (Figure 4.3). Whether 
data has been extracted by GRHANITE™ or by another mechanism, once the data has been 
received at SAHMRI, the data is checked, cleaned and analysed. From the perspective of the 
ACCHS, the day-to-day operation of ATLAS requires minimal involvement.  
FIGURE 4.3: SIMPLIFIED FLOW DIAGRAM OF DATA COLLECTION, CLEANING AND ANALYSIS ATLAS, 2019 
 
 
4.4.5. Reporting of ATLAS  
An initial baseline report was provided to each ACCHS summarising their data for the 24-
month period from January 2017 to December 2018. Moving forward, regular six-monthly 
reports will be provided. Each report provides data on the ACCHS client demographics and 
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12 key performance measures developed and agreed upon between the study team, the 
clinical hub and ACCHS representatives. The conceptualisation of the 12 key performance 
measures started with previous projects and have evolved over time to meet the need of all 
stakeholders within ATLAS. The key performance measures focus on testing, treatment and 
retesting of STI and BBV that reflect clinical requirements, guidelines and reporting 
requirements. The 12 key performance measures are:  
1. STI Testing Rate: Proportion of medical consultation attendees tested for STIs 
(chlamydia, gonorrhoea, trichomonas, syphilis and HIV) during the reporting period. 
2. STI Testing Coverage: Proportion of current clients for medical consultations tested 
for STIs once in a 12-month period. 
3. Unique STI Test Positivity: Proportion of medical consultation attendees with at least 
one positive STI test in a 12-month period. 
4. Completeness of STI Screening: Proportion of positive chlamydia and/or gonorrhoea 
and/or trichomonas results among medical consultation attendees also tested for 
syphilis and HIV within 30 days from the date of initial specimen collection. 
5. STI Treatment Interval: Time (days) from date of positive STI (chlamydia, gonorrhoea, 
trichomonas) investigation request to date of treatment. 
6. STI Retesting Rate: Proportion of medical consultation attendees retested at 
approximately three months (60 to 120 days) following treatment for an initial 
positive STI (chlamydia/gonorrhoea/trichomonas) result. 
7. STI Repeat Positivity Rate: Proportion of medical consultation attendees retested at 
approximately three months (60 to 120 days) after treatment for an initial positive 
chlamydia/gonorrhoea result and who retested positive for chlamydia/gonorrhoea 
at this time. 
8. Hepatitis B Testing Rate: Proportion of medical consultation attendees receiving an 
hepatitis B test and among those testing negative, the proportion subsequently 
vaccinated. 
9. Hepatitis C Testing Rate: Proportion of medical consultation attendees tested for 
hepatitis C and among those testing positive, the proportion subsequently tested for 
ribonucleic acid or viral load. 
10. Hepatitis C Treatment Uptake: Proportion of hepatitis C ribonucleic acid positive 
medical consultation attendees prescribed Direct Acting Antiviral treatment. 
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11. Hepatitis C Sustained Virological Response (SVR): Proportion of medical consultation 
attendees who, after having been prescribed Direct Acting Antiviral treatment, 
achieve undetectable viral load (at completion of Direct Acting Antiviral treatment). 
12. Human Papillomavirus Screening Rate: Proportion of female medical consultation 
attendees screened for human papillomavirus in line with national guidelines. 
4.4.6. Resources required to operate ATLAS 
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network is funded 
by an National Health and Medical Research Council grant which covers the cost of the 
establishment and ongoing management of ATLAS until the end of 2020. The ATLAS 
Aboriginal and Torres Strait Islander Sexual Health Surveillance Network requires several 
resources, including the procurement of GRHANITE™, direct staff and operating costs and 
costs associated with engagement with ACCHS and ATLAS governance structures. Direct staff 
costs include in total 2.4 full-time equivalent staff across three positions; the ATLAS Study 
Coordinator, ATLAS Data Manager and Epidemiologist. All these resources have financial 
implications and ongoing funding for ATLAS is required to sustain the infrastructure.  
4.5. Evaluation method 
The aim of this preliminary evaluation was to assess if ATLAS was meeting its intended 
objective, to establish a national sentinel surveillance system specifically focussed on STI and 
BBV testing, care and management for ACCHS and other health services in the areas of 
surveillance, monitoring and evaluation. Additionally, the evaluation identified strengths, 
areas for improvement and provided recommendations.  
4.5.1. Design  
To assess the effectiveness of ATLAS in meeting its primary objective, the United States 
Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) 
Updated Guidelines for Evaluating Public Health Surveillance Systems (23) were utilised to 
provide a framework to systematically evaluate ATLAS. The CDC Updated Guidelines for 
Evaluating Public Health Surveillance Systems aim is ‘to promote the best use of public health 
resources through the development of efficient and effective public health surveillance 
systems’ (23), by assisting with the integration of surveillance and health information 
systems and the electronic exchange of health data.  
Document review, stakeholder interviews and secondary analysis of ATLAS data were 
undertaken to assess the CDC attributes and evaluate ATLAS. The following system attributes 
were assessed:  
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Acceptability – Acceptability includes both participant and the organisational willingness to 
be involved or contribute to the surveillance system (23). We assessed the willingness of 
ACCHS involvement in the ATLAS network.  
Simplicity – Simplicity of a surveillance system refers to both its structure and ease of 
operation (23). We assessed the simplicity of operation of ATLAS as a system and its 
processes.  
Flexibility – Flexibility is the ability of a surveillance system to accommodate change and 
adapt appropriately (23). We assessed ATLAS’s ability to respond to ACCHS feedback.  
Data Quality – Data quality refers to completeness and validity of information gathered by 
the surveillance system (23). We assessed overall data quality and completeness of data 
variables extracted within the ATLAS system.  
Representativeness – Representativeness encompasses accuracy to describe the population 
(person and place) over time (23). We assessed whether the outcomes are generalisable to 
the wider population.  
Timeliness – Timeliness incorporates timeframes of all steps within the surveillance system 
(23). We assessed the timeliness of ATLAS processes.  
Stability – Stability of a surveillance system assesses the reliability and availability of the 
system to operate without failure (23). We assessed whether the resourcing of ATLAS was 
sufficient.  
Usefulness – Usefulness of a surveillance system is demonstrated through its contribution to 
prevent, control and improve understanding of health events and ability to influence (23). 
Usefulness was assessed by how useful ATLAS has been for ACCHS.  
Positive predictive value and sensitivity were not assessed due to lack of primary data at the 
time of this preliminary evaluation to assess these attributes. Furthermore, positive 
predictive value and sensitivity are not essential features of ATLAS. The ATLAS Aboriginal and 
Torres Strait Islander Sexual Health Surveillance Network is a sentinel surveillance system 
and therefore is not focussed on identifying all STI and BBV cases; rather, it is focused on 
monitoring trends in testing and positive results of the target population. The additional 
information that ATLAS does acquire on the 12 key performance measures and knowledge 
of risk practices and health service access of young people will be helpful in understanding 
whether ATLAS is meeting its intended objectives as a surveillance system.  
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4.5.2. Eligibility  
To be eligible to participate in the preliminary evaluation, ACCHS must be part of the ATLAS 
network and have received their initial baseline report prior to the commencement of the 
evaluation. ACCHS that have received a baseline report will have had a greater level of 
engagement with ATLAS and are therefore able to provide insight into the operation of ATLAS 
within their ACCHS. ACCHS that have met these criteria were invited to participate in the 
preliminary evaluation.  
4.5.3. Literature and document review 
A literature and document review were undertaken to review the public health importance 
of STI and BBV surveillance in Australia, particularly for Aboriginal and Torres Strait Islander 
people and communities. PubMed was searched using the terms ‘sexually transmissible 
infection’, ‘blood borne virus’, ‘chlamydia’, ‘gonorrhoea’, ‘trichomonas’, ‘syphilis’, ‘human 
immunodeficiency virus’, ‘hepatitis C’, ‘surveillance’, ‘Aboriginal’, ‘Torres Strait Islander’, 
‘Indigenous’, ‘Australia’. Grey literature and key ATLAS documents were also included.   
4.5.4. Stakeholder interviews 
Stakeholder interviews were conducted with individual ACCHS staff and with members of the 
ATLAS research team using a semi-structured questionnaire (Appendix 4.1). The aim of the 
interviews was to discuss the usefulness, simplicity, flexibility, acceptability, timeliness, data 
quality, representativeness, and stability of ATLAS through assessing and understanding 
responses of stakeholders. The questionnaire was administered either face-to-face or by 
using video conferencing software Zoom and were recorded with participant’s consent for 
further analysis. Stakeholder interviews were thematically analysed against the  CDC 
Guidelines for Evaluating Public Health Surveillance Systems attributes (23). 
4.5.5. Analysis of ATLAS data 
Baseline data (January 2017 to December 2018) from ACCHS were analysed to assess 
completeness (e.g. missing data), including those data used to inform the calculations for 
performance measures and demographic variables. The following variables were assessed; 
patient age at time of appointment, Aboriginal and Torres Strait Islander status, patient 
gender, patient active status, appointment date, appointment type, STI test type, STI test 
result, test request date, prescribing date, product name (treatment type – medication/drug 
name), vaccination status, vaccination date, vaccination type, and practitioner category.     
4.5.6. Ethics approval  
This preliminary evaluation was approved by The Australian National University (2017/909). 
Written consent was obtained from all interview participants. 
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4.6. Results  
4.6.1. Public health importance 
National notifications for STI and BBV are captured through the NNDSS, which was 
established in 1990 (17). The NNDSS coordinates the national surveillance of over 50 
communicable diseases or disease groups including STI and BBV (17). Notifications are made 
to state and territory health authorities under the provisions of the public health legislation, 
which inform the NNDSS (17). However, there are limitations to relying on notifications 
within this system, particularly the underreporting of Aboriginal and Torres Strait Islander 
status (18, 24).  
Underreporting of Aboriginal and Torres Strait Islander status has the potential to 
misrepresent the true extent of STI and BBV infections in the Aboriginal and Torres Strait 
Islander population (1, 18, 24) and exacerbate the overrepresentation of the Aboriginal and 
Torres Strait Islander population in STI and BBV notification rates (1, 25-27). Often, national 
STI and BBV data does not include data from jurisdictions where Aboriginal and Torres Strait 
Islander status is not reported in at least 50% of notifications of STI and BBV, including 
chlamydia, hepatitis B and newly acquired hepatitis B, hepatitis C and gonorrhoea (1). This is 
concerning as the Aboriginal and Torres Strait Islander population is a priority population in 
relation to STI and BBV control (28-30).  
The high notifications rates of STI and BBV among the Aboriginal and Torres Strait Islander 
population are of major concern and require focussed attention to redress. In rural and 
remote Australia, notification rates among the Aboriginal and Torres Strait Islander 
population are significantly higher than those in urban areas (1). An ongoing outbreak of 
syphilis among the Aboriginal and Torres Strait Islander population in northern, central and 
western Australia, which commenced in January  2011, highlights the challenges in STI and 
BBV surveillance and control (12-14, 31). These challenges are compounded by various 
factors, such as sexual behaviour and number of sexual partners, health seeking behaviour, 
access to health services, and demographic characteristics that influence the incidence of STI. 
Additionally, BBV (32) are found to be more complex among the Aboriginal and Torres Strait 
Islander population (15, 33, 34).  
Enhanced surveillance can be used to better understand the complexity of STI and BBV 
incidence in priority populations. In Australia, sentinel surveillance has been used to provide 
a more comprehensive understanding of STI and BBV among priority populations, including 
the Aboriginal and Torres Strait Islander population (30). Evidence indicates, in two studies 
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by Goller et al. and O’Conner et al., that the high incidence of chlamydia among the Aboriginal 
and Torres Strait Islander populations is associated with certain factors such as being of 
younger age and heterosexual (35, 36). Additionally, sentinel surveillance can be used to 
measure the impact of interventions among the Aboriginal and Torres Strait Islander 
population (37).   
4.6.2. Stakeholder interviews 
As of July 2019, there were 29 ACCHS engaged in the ATLAS network; however, only two 
ACCHS from one clinical hub were at the stage of having had baseline data extracted, 
analysed and reported back. Therefore, only staff from those two ACCHS and the clinical hub 
were involved in the preliminary evaluation. Additionally, CRE-ASH ATLAS research team 
members were also interviewed.  
4.6.2.1. Interview characteristics  
Five interviews were completed with seven individuals, including one group interview with 
three individuals. The group interview involved staff from one of ATLAS’s clinical hubs, and 
all were either involved in the establishment, the day-to-day management or uses of ATLAS 
output within the clinical hub. The remaining interviews were with CRE-ASH ATLAS research 
team members, including a Chief Investigator, CRE-ASH Study Coordinator, ATLAS Data 
Manager and Epidemiologist (Table 4.1).    
TABLE 4.1: CHARACTERISTICS OF PARTICIPANTS INTERVIEWED FOR THE EVALUATION OF THE ATLAS SENTINEL 
SURVEILLANCE SYSTEM, 2019 
Interview format ATLAS involvement  Role  
Group  ATLAS ACCHS Manager – Data and Research 
Analyst – Data and Research 
Doctor and Clinical Director 
Individual  ATLAS research team 
member 
 
Epidemiologist 
CRE-ASH Study Coordinator 
ATLAS Data Manager 
Chief Investigator 
 
4.6.3. Data collection, cleaning and analysis  
A flow diagram of the process of data collection, cleaning and analysis used by the ACCHS 
included in this preliminary evaluation is illustrated in Figure 4.4. GRHANITE™ was not used 
in this instance as it was not compatible with the electronic patient management systems 
used by the two ACCHS. Instead, data was extracted manually by the ACCHS and transferred 
to SAHMRI. Further comments about this process are provided below.  
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4.6.4. Evaluation outcomes against CDC attributes 
4.6.4.1. Acceptability 
Acceptability includes both participant and the organisational willingness to be involved in or 
contribute to the surveillance system (23). 
Of the ACCHS involved in the preliminary evaluation, ATLAS appears to be well accepted as a 
sentinel surveillance system by both ACCHS staff involved. Staff from ACCHS identified 
several reasons as to the acceptability of ATLAS, including ATLAS having the potential to 
provide:  
• Streamlining of data extraction, analysis and reporting of data in a format that is user 
friendly 
• Provision of additional resources to the ACCHS that are not necessarily available (e.g. 
specialist expertise) 
• Opportunity to benchmark and compare their service to others 
• A methodological approach that is consistent with their organisation values and 
principles  
• Added credibility by having their data analysed by an external 
organisation/individual 
• Experience and reputation of CRE-ASH ATLAS research team, Chief Investigators and 
host organisation 
• Overall benefit and potential impact of being a part of a national surveillance system 
and network. 
It was noted that support from ACCHS was important and demonstrated the level of 
acceptability of one ACCHS, as stated by one of the ATLAS research team members,  
They have given us support that we just couldn’t buy, having people there that know 
their system, that know their data and know how it works and prepared to help us, 
to allow us to get to the data, is an incalculable value to us; it just couldn’t have 
happened without that. (ATLAS research team member)   
Engagement is important to the ongoing acceptability of ATLAS, particularly face-to face 
engagement. It was suggested that ATLAS is a system based on trust, and trust must be 
strengthened; the more you know people properly the more you have a relationship with 
people, and it is difficult to do that over the phone. Most stakeholders believe it was 
important to continue the annual face-to-face meeting.  
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FIGURE 4.4: FLOW DIAGRAM OF THE PROCESS OF DATA COLLECTION, CLEANING AND ANALYSIS OF ACCHS INCLUDED IN THE PRELIMINARY EVALUATION OF THE ATLAS SYSTEM, 2019. 
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4.6.4.2. Simplicity 
Simplicity of a surveillance system refers to both its structure and ease of operation (23).  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network has been 
designed to passively extract data from ACCHS’s electronic patient management systems, 
minimising the impact ATLAS has on ACCHS. From the perspective of the ACCHS the 
operation of ATLAS is simple; data is extracted, cleaned, analysed and presented back. The 
day-to-day operation of ATLAS requires minimal involvement from ACCHS, other than their 
ongoing engagement in ATLAS. However, the back-end of the system is more complex and 
requires several processes for cleaning, analysis and reporting before the data is presented 
back to ACCHS.  
The amount of time and resources required to report on the 12 key performance measures 
is not insignificant. The two ACCHS included in this preliminary evaluation were the test sites 
for ATLAS and its establishment as a surveillance system. The processes for cleaning, analysis 
and reporting of the data were reported to require a significant amount of work; revisions of 
cleaning, analysis and reporting processes are ongoing and evolving through an iterative 
process. Additionally, the data extracted from the two ACCHS was extracted as several 
datasets (e.g. appointments, STI test, treatment, immunisation for human papillomavirus & 
hepatitis B, cervical screening, pap smear (Papanicolaou test)), requiring a significant amount 
of cleaning and linking before it could be analysed. Scripts developed by the ATLAS research 
team used during the cleaning process of the ATLAS system have minimised the volume of 
filtering, checks and cleaning required.    
Moving forward, the operation of ATLAS should be simplified, as its systems and structures 
will be well established. The extraction, cleaning, analysis and reporting aspects of ATLAS will 
be simplified, streamlined and automated and should only require monitoring and 
maintenance. Similarly, as the network grows, the implementation of ATLAS within other 
ACCHS should be straightforward.  
4.6.4.3. Flexibility  
Flexibility is the ability of a surveillance system to accommodate change and adapt 
appropriately (23).  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network has been 
designed to be flexible in its approach, the setup of ATLAS within services and in its analysis 
and reporting of data. Moreover, ATLAS has been designed to operate with most of the 
electronic patient management systems that ACCHS may use. This will ensure there are no 
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limitations to ACCHS involvement, by working closely with ACCHS and their data in the initial 
set up of ATLAS.  
At the CRE-ASH annual face-to-face meeting in December 2018, ACCHS staff provided 
feedback on the ATLAS performance measures and reporting. The feedback included the 
format of reports, length of reports, what is seen as important and what was not, frequency 
of reporting, and the way in which data can be presented so it is palatable and easy to digest 
for busy ACCHS staff. This feedback was noted and incorporated, with changes made to the 
performance measures and reporting. In addition, ongoing feedback has been sought and 
provided by ACCHS staff since the annual face-to-face meeting in relation to ATLAS reports 
and has informed future ATLAS reporting.   
Furthermore, ATLAS has been designed as an infrastructure for research. CRE-ASH will be 
able to facilitate access to the ATLAS network, and with approval from contributing ACCHS, 
be available to provide researchers with data to answer research questions, either on specific 
diseases, health services delivery or on population health.  
4.6.4.4. Data Quality 
Data quality refers to completeness and validity of information gathered by the surveillance 
system (23).  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network extracts 
data directly from ACCHS, any issues with data quality within the ATLAS system are largely 
due to data quality issues with the ACCHS data itself. Therefore, the quality of data within 
ATLAS is dependent on the quality of ACCHS data. Due to the limitation of this evaluation 
being a preliminary evaluation, there was not the capacity to assess the quality of data 
extraction or completeness of data between the two ACCHS and ATLAS. Overall, data quality 
was reported as being good and any previous issues had been addressed during the early 
stages of ATLAS being established. However, data quality issues were noted by the ATLAS 
research team in relation to data extracted from ACCHS, specifically completeness of 
variables and variables with free text.  
The following variables were used to inform the performance measures calculations (Table 
4.2) and were assessed for completeness; patient age at time of appointment, Aboriginal and 
Torres Strait Islander status, gender, patient active status, appointment type, STI test type, 
STI test result, test request date, prescribing date, product name, vaccination status, 
vaccination date, vaccination type, and practitioner category.  
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TABLE 4.2: VARIABLES USED TO INFORM ATLAS SYSTEM PERFORMANCE MEASURES, 2019  
Performance 
measures 
Denominator 
variable(s) (N) 
Sample variable(s) 
(n) 
Other variables used  
STI testing rate Practitioner category 
(doctor, nurse, 
Aboriginal health 
practitioner)  
STI test type 
(chlamydia, 
gonorrhoea, 
trichomonas, 
syphilis, HIV) 
Patient gender 
Patient age at time of appointment 
Aboriginal and Torres Strait 
Islander status 
Appointment date 
STI testing 
coverage 
Practitioner category 
(doctor, nurse, 
Aboriginal health 
practitioner)  
Patient active status 
STI test type 
(chlamydia, 
gonorrhoea, 
trichomonas, 
syphilis, HIV) 
Patient gender 
Patient age at time of appointment  
Aboriginal and Torres Strait 
Islander status  
Appointment date 
Unique STI test 
positivity 
STI test type 
(chlamydia, 
gonorrhoea, 
trichomonas, syphilis, 
HIV) Practitioner 
category (doctor, 
nurse, Aboriginal 
health practitioner) 
STI test result 
(positive) 
Patient gender 
Patient age at time of appointment  
Test request date  
Completeness 
of testing 
STI test result 
(positive (chlamydia, 
gonorrhoea, 
trichomonas) 
Practitioner category 
(doctor, nurse, 
Aboriginal health 
practitioner) 
STI test type 
(syphilis and HIV) 
Patient gender 
Patient age at time of appointment  
Appointment date  
Treatment 
interval 
STI test result 
(positive chlamydia, 
gonorrhoea, 
trichomonas)  
Prescribing date Patient gender 
Test request date 
Patient age at time of appointment  
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner)  
STI retesting 
rate 
STI test results 
(positive chlamydia, 
gonorrhoea, 
trichomonas) 
 
STI test type  
Test request date, 
Prescribing date 
Patient gender 
Patient age at time of appointment  
Appointment date 
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner)  
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Performance 
measures 
Denominator 
variable(s) (N) 
Sample variable(s) 
(n) 
Other variables used  
STI repeat 
positivity rate 
STI test results 
(positive) 
Product type 
Prescribing date 
 
STI test type  
STI test result 
(positive) 
Appointment date  
Patient age at time of appointment  
Test request date  
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner) 
Hepatitis B 
testing rate 
STI test type 
(hepatitis B) 
 
STI test type 
(hepatitis B) 
STI test results 
(negative) 
Patient gender 
Patient age at time of appointment  
Test request date 
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner) 
Hepatitis C 
testing rate 
STI test type 
(hepatitis C) 
 
STI test type 
(hepatitis C) 
STI test result 
(hepatitis C 
positive) 
STI test type 
(hepatitis C 
ribonucleic acid) 
Patient gender 
Patient age at time of appointment  
Appointment date  
Test request date 
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner) 
Hepatitis C 
treatment 
uptake 
STI test results 
(hepatitis C 
ribonucleic acid 
positive) 
 
Product type (Direct 
Acting Antiviral 
therapies*) 
Prescribing date 
Patient gender 
Patient age at time of appointment 
Appointment date 
Test request date 
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner) 
Hepatitis C 
sustained 
virological 
response 
Product type (Direct 
Acting 
Antiviral 
therapies*) 
STI test result (viral 
load) 
Patient gender 
Patient age at time of appointment 
Appointment date 
Test request date 
Practitioner category (doctor, 
nurse, Aboriginal health 
practitioner) 
Human 
papillomavirus 
screening rate 
Practitioner category 
(doctor, nurse, 
Aboriginal health 
practitioner) 
Test type (human 
papillomavirus) 
 
Patient age at time of appointment 
Aboriginal and Torres Strait 
Islander status 
Test request date 
 
Overall, completeness of data was generally high among the variables extracted, only five 
issues were identified as having missing data and have been illustrated in Table 4.3. The 
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Practitioner category variable accounted for four of the five issues related to completeness. 
It is important to note, these issues related to data-entry at the ACCHS end and are not the 
results of ATLAS systems or processes. ATLAS can only extract data that is there, if data is 
missing it cannot be extracted.  
TABLE 4.3: COMPLETENESS OF ACCHS VARIABLES USED TO INFORM PERFORMANCE, ATLAS SYSTEM PERFORMANCE 
MEASURES, 2019 
 ACCHS 1 ACCHS 2 
Variable  Total  Missing 
n (%) 
Total  Missing 
n (%) 
Appointment data     
Aboriginal and Torres 
Strait Islander status  
 
150,229 0  
(0%) 
87,281 1  
(0.00%) 
Practitioner category 
 
121,526 101 
(0.08%) 
87,281 1,961 
(2.2%) 
Treatment data     
Practitioner category 4,199 135 (3.2%) 2,300 111  
(4.8%) 
 
Where data was missing, observations were excluded from calculations. Additionally, there 
were several data entry issues noted, particularly for the variable Test results. For example, 
results for a chlamydia test were variously recorded (1, detected, negative, not detected, not 
done and positive). Also, a common data entry error was different spellings of words 
(treatment (drug) name).    
Processes have been implemented to assist with these issues. Scripts have been developed 
by the ATLAS research team to filter, check and clean the data. These checks are performed 
when data has been received and any issues with variables with incomplete information or 
incorrect coding are flagged. They are subsequently investigated by the ATLAS Data Manager 
and followed up. This process of checking and cleaning the data has made the overall process 
more streamlined and comprehensive. It should ensure the reporting of key performance 
measures and other data for both static reports and, in future, the web-based dashboard are 
consistent. However, this is an ongoing and iterative process.  
4.6.4.5. Representativeness 
Representativeness encompasses accuracy to describe the population (person and place) 
over time (23).  
At this stage limited evidence is available to determine representativeness of the data in 
ATLAS. The overall ATLAS network is intended to be representative of the broader ACCHS, 
Aboriginal and Torres Strait Islander population structure and STIs in the Aboriginal and 
Torres Strait Islander population (Figure 4.1). The two ACCHS included in the preliminary 
156 
 
evaluation are both located in an urban area of a major capital city and are representative of 
the communities they serve but not necessarily of the broader ATLAS network or Aboriginal 
and Torres Strait Islander population nationally and it is unclear if individuals presenting at 
the ACCHS are representative of the target population.  
In saying this, ACCHS staff from the two ACCHS have indicated the baseline report data helps 
reaffirm current knowledge, is consistent with ACCHS data and reporting processes and 
clinician’s knowledge. At this early stage of ATLAS implementation, it is difficult to say if, at a 
more localised level, the trends being seen in the ACCHS population were reflective of the 
broader (local) population.  This would be difficult to determine for several reasons. Firstly, 
most people with an STI are asymptomatic. Secondly, not everyone with symptoms seeks 
medical care. Finally, of those that do, not all are tested or test positive or are notified and 
reported.   
4.6.4.6. Timeliness 
Timeliness incorporates timeframes of all steps within the surveillance system (23).  
As ATLAS is still in its infancy, it is difficult to give a true assessment of its timeliness. 
Nevertheless, timeliness of processes and communication of the surveillance system can 
always be improved, particularly in relation to maintaining enthusiasm of ACCHS and staff 
and their ongoing commitment to their involvement in ATLAS.   
Concerns were raised in relation to the timeliness of ATLAS processes and many of those 
concerns were associated with a lack of communication from the ATLAS research team about 
delays specific to collating, analysing and reporting of data, the reason and length of delays. 
These initial delays related to the development of the back-end of the system. The processes 
for cleaning, analysis and reporting of the data required a significant amount of work to 
establish, which ultimately delayed ACCHS receiving their baseline report. Suggestions for 
mitigating issues around timeliness in the future include, regular and frequent 
communication between the ATLAS research team and ACCHS, consistent and regular data 
extraction, six-monthly reporting periods, and clarity of expectations and timeframes for 
providing feedback, these should be negotiated between the ATLAS research team and 
ACCHS.  
4.6.4.7. Stability 
Stability of a surveillance system assesses the reliability and availability of the system to 
operate without failure (23). 
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Moving forward, the reliability of ATLAS as a surveillance system of ACCHS will be dependent 
on its ability to fulfil its intended objective. The value of ATLAS is in part demonstrated by the 
involvement of ACCHS. Their ongoing support, involvement and belief in ATLAS should 
ensure that the stability of ATLAS as a surveillance system. The stability of ATLAS will be 
dependent on ongoing funding and maintaining infrastructure, technical knowledge and 
skills and personnel to ensure ATLAS operates as it is intended too.  
4.6.4.8. Usefulness 
Usefulness of a surveillance system is demonstrated through its contribution to prevent, 
control and improve understanding of health events and ability to influence (23).  
It is too early to determine the true usefulness of ATLAS as a surveillance system to prevent 
and control STIs and BBVs and address adverse health-related events including an improved 
understanding of the public health implication of such events. However, ACCHS staff 
reported ATLAS to be useful in terms of helping to better understand their own sexual health 
data, specifically testing data, improving clinician’s knowledge around testing and treatment 
and as a potential resource and reference for all staff. At one ACCHS, the baseline report has 
informed CQI activities by identifying priorities and gaps in service delivery. Overall, feedback 
on the baseline report has been positive. The reports have been well received by staff; they 
felt information is presented in a clear and concise manner, and reports were visually 
appealing and useful. Feedback on the baseline reports will inform future reporting.  
Additionally, through the establishment of ATLAS, several secondary outcomes have been 
achieved. These include:  
• 12 key performance measures focused on testing, treatment and retesting of STI and 
BBV 
• Support for strengthening capacity within ACCHS in relation to:  
o collection, analysis and reporting of STI and BBV data 
o management of an automated data system and web-based dashboard 
o opportunities for ACCHS staff and others involved in the ATLAS network to 
engage in research activities.  
Further, the following secondary outcomes are planned to occur over the life of the system: 
• Support strengthening capacity within ACCHS in relation to enhanced long term 
control and ownership of data at the ACCHS level 
• Inform CQI activities at individual ACCHS 
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• Inform clinical guidelines and policy in relation to the Aboriginal and Torres Strait 
Islander population and the broader population.  
Overall, ATLAS has significant potential as a resource to inform service delivery, CQI and 
clinical guidelines at the ACCHS level; more broadly, as a resource for research. The ATLAS 
Aboriginal and Torres Strait Islander Sexual Health Surveillance Network will add depth to 
what is currently known about STI and BBV, by supplementing current notification data with 
a surveillance system that captures not only diagnoses but important testing and treatment 
data.  
Additionally, there will be opportunity to expand the ATLAS network to other Aboriginal and 
Torres Strait Islander (government) health services and linking into other projects such as the 
The Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of STIs and 
BBVs. It will provide a level of understanding around patterns of care and access that has 
never been available before.  
4.7. Discussion 
It was generally agreed by stakeholders that ATLAS is a useful addition to enhance efforts in 
STI and BBV control. The aim of this evaluation was to undertake a preliminary assessment 
of whether ATLAS is effectively meeting its intended objective: to establish a national sentinel 
surveillance system specifically focussed on STI and BBV testing, care and management for 
ACCHS and other health services in the areas of surveillance, monitoring and evaluation. 
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network is on its 
way to meeting its primary objective, the establishment of a national sentinel surveillance 
system of ACCHS specifically focussed on STI and BBV. However, more time is required for 
ATLAS to demonstrate its value as a surveillance system, particularly in supporting work to 
reduce the high notifications rates of STI and BBV among the Aboriginal and Torres Strait 
Islander population. This includes fulfilling its additional objectives, as only one so far is 
complete: to develop a national agreed set of STI and BBV clinical performance measures. 
Over the coming years ATLAS should be able to meet its four additional objectives. 
Unfortunately, it is too early to monitor and identify trends in STI and BBV testing and 
positivity; to monitor and identify STI and BBV knowledge; risk practices and health service 
access of young people; identify interventions; build the capacity of participating hubs; and 
inform CQI processes. However, this should not be too difficult to achieve.  
Out of the 29 ACCHS from around Australia involved in ATLAS, two ACCHS were eligible to be 
involved in the preliminary evaluation as they had received baseline reports. In those two 
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sites, ATLAS was considered acceptable, simple, timely and flexible. However, components 
within these attributes such as timeliness and communication between ACCHS and the ATLAS 
research team, stability and securing of future funding, demonstrating value and importance 
in relation to STI and BBV testing and management and representativeness, could be 
improved. 
It is worth noting, a significant amount of engagement has occurred with ACCHS in the design 
and implementation of ATLAS. Not only has this been critical to ensuring the success of 
establishing ATLAS as a sentinel surveillance system, it is equally important to the ongoing 
success of ATLAS and the continuing engagement of ACCHS. The ATLAS network currently 
involves 29 ACCHS from around Australia. This demonstrates the acceptability of an initiative 
such as ATLAS and the potential role it can have in reducing the gap in knowledge, clinical 
testing and management of STIs and BBVs in the Aboriginal and Torres Strait Islander 
population. High levels of engagement with stakeholders and end users have been noted as 
being successful with other surveillance systems, including those focused on STI such as the 
Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of STIs and BBVs 
(formally the Australian Collaboration for Chlamydia Enhanced Sentinel Surveillance) (30) or 
more broadly the NNDSS (18) and the Australasian Maternity Outcomes Surveillance System 
(38). A significant amount of time, effort and resources have gone into guaranteeing the 
partnership between ACCHS and SAHMRI is fruitful. This is aided by the fact ATLAS is a simple 
surveillance system to run and maintain once the system has been established. Simplicity has 
been identified in the evaluation of other surveillance systems as a key factor in ensuring 
useability and success (30).  
The timeliness of ATLAS will improve as the system becomes more established and processes 
are refined. This will be supported by the implementation of a web-based dashboard in late 
2019 or early 2020, which will enable ACCHS to securely access their data when required. 
The aim is that the web-based dashboard will be almost real time, with regular data 
extraction from ACCHS, and cleaning and analysis of data occurring at regular intervals 
(dependent on the ACCHS’s preference). The web-based dashboard will allow ACCHS to 
analyse their data on any STI or BBV, time period, or population and download the data. This 
will empower services to have increased control of their data. Overall, the dashboard will 
enable a greater degree of timeliness, simplicity and flexibility of ATLAS.  
Not all Aboriginal and Torres Strait Islander people with STI and BBV will be identified through 
ATLAS; however, ATLAS has been designed to focus on ACCHS with the aim of monitoring STI 
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and BBV testing and positivity in this target population. The two ACCHS included in the 
preliminary evaluation were representative of the communities they serve but not 
necessarily of the broader ATLAS network or Aboriginal and Torres Strait Islander population 
nationally. Representativeness of ATLAS could improve overtime as the network grows and 
more ACCHS join. Additionally, this has the potential to improve the underreporting of 
Aboriginal and Torres Strait Islander status that occurs with other surveillance systems. Our 
assessment of data quality and completeness found of the two ACCHS, only one observation 
from the data had Aboriginal and Torres Strait Islander status missing. This demonstrates 
ACCHS ability to accurately record and report Aboriginal and Torres Strait Islander status. 
This is a significant difference to the underreporting that occurs in the NNDSS, where for 
some STI and BBV reporting of Aboriginal and Torres Strait Islander status is less than 50% of 
all notifications (1). 
In addition to notification data, ATLAS also captures testing data. Testing data can be used to 
inform notification data and indicate whether increases in notifications are true increases of 
incidence or due to increases in testing. Furthermore, testing data can be used to inform 
mathematical modelling of undiagnosed infections in a population (e.g. HIV (39), chlamydia 
(40), gonorrhoea (5)).  
The potential impact of ATLAS as a network of ACCHS to identify, inform, respond and 
measure the impact of interventions related to outbreaks is significant. As previously 
mentioned, the ongoing syphilis outbreak in northern, central and western Australia could 
benefit from the additional knowledge drawn from an enhanced sentinel surveillance system 
such as ATLAS. It could possibly improve timely reporting of notifications and enhance early 
detection of increases in cases and facilitate early public health interventions, ultimately 
minimising the severity and length of the outbreak. This impact has been seen in relation to 
other sentinel surveillance systems. For example, the Australian Collaboration for 
Coordinated Enhanced Sentinel Surveillance of STIs and BBVs data has been used to inform 
a HIV Pre-exposure Prophylaxis study in Victoria, Australia (41).  
The challenge moving forward is ATLAS needs to demonstrate its value as a surveillance 
system and its impact on reducing the disproportionately higher rates of STIs and BBVs 
among the Aboriginal and Torres Strait population. Additionally, ATLAS will need to improve 
service delivery, CQI activities and inform guidelines and policy in relation to STIs and BBVs 
within its initial funding timeframe. Furthermore, to ensure ATLAS continues to be successful 
ongoing funding is required. Appropriate actions should be taken to address this issue.   
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4.8. Recommendations 
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network has the 
potential to provide an important infrastructure and mechanism for the surveillance of STI 
and BBV within ACCHS and reduce STI and BBV within the Aboriginal and Torres Strait 
Islander population. Despite this, there are several areas requiring attention to strengthen 
ATLAS and its network. Based on this preliminary evaluation I recommend that: 
1. A face-to-face meeting between ACCHS, clinical hubs, the ATLAS research team and 
investigators be held annually to update the ATLAS network on the progress of ATLAS 
and the CRE-ASH activities and seek their feedback and guidance. 
2. A reporting framework be developed outlining regular reporting requirements and 
timeframes, with a formalised communication channel. 
3. Use of ATLAS be encouraged and facilitated as a research resource both within the 
ATLAS network and externally. This will contribute toward ATLAS being able to 
demonstrate its usefulness and value.    
4. Appropriate funding sought to ensure ATLAS is maintained as a surveillance system 
to fulfil its role in monitoring trends in STI and BBV testing, positivity, and clinical 
management in the Aboriginal and Torres Strait Islander population.   
5. An investment made in both ATLAS itself and in staffing – ACCHS staff and the ATLAS 
research team – to ensure technical knowledge and skills are developed and retained 
within the network.  
6. Regular and/or ongoing monitoring and evaluation of ATLAS as a surveillance system 
and network be conducted to ensure stability of the system.  
4.9. Evaluation limitations  
There were limitations to this evaluation. The first, being a preliminary evaluation. ATLAS 
Aboriginal and Torres Strait Islander Sexual Health Surveillance Network has only been 
operating since the second half of 2018, at the time of conducting the evaluation only two 
ACCHS had received their baselines reports and were eligible to participate. Given the size of 
the ATLAS network it would have been preferable to have more ACCHS involved in the 
evaluation, which would have given a more in-depth insight into the operation and impact of 
ATLAS and the network. Additionally, it is unknown how representative individuals attending 
ACCHS are in terms of the whole target population. The ATLAS Aboriginal and Torres Strait 
Islander Sexual Health Surveillance Network is a sentinel surveillance system, however, it is 
not focussed on identifying all STI/BBV cases. However, ATLAS focuses on ACCHS with the 
aim of monitoring STI and BBV testing and positivity in this target population. Also, it is 
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unclear if there has been changes in testing or clinicians’ behaviour, or whether there have 
been campaigns to target particular individuals or populations, over the period of reporting; 
all these factors will have an impact on positivity rates. ATLAS Aboriginal and Torres Strait 
Islander Sexual Health Surveillance Network 
4.10. Conclusion  
The ATLAS Aboriginal and Torres Strait Islander Sexual Health Surveillance Network provides 
important information and data on STI and BBV in the Aboriginal and Torres Strait Islander 
population; however, several remaining challenges need to be addressed in order to ensure 
ATLAS is successful in meeting its objective. Firstly, ongoing funding needs to be sourced for 
the sustained management of ATLAS and secondly, the value of ATLAS as a surveillance 
system and its impact in reducing STI and BBV and improving service delivery in relation to 
STI and BBV needs to be demonstrated. 
The preliminary evaluation recommendations presented above are proposed to inform the 
strengthening of ATLAS, and contribute to ATLAS fulfilling its intended objective: to establish 
a national sentinel surveillance system specifically focussed on STI and BBV testing, care and 
management for ACCHS and other health services in the areas of surveillance, monitoring 
and evaluation.
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Appendix 4.1  
Evaluation of ATLAS – Interview Questions  
Questions will be asked about usefulness, simplicity, data quality, representativeness, 
flexibility, acceptability, timeliness and stability. All questions are not relevant to every 
stakeholder. Sample questions are provided below, questions asked during the interview are 
dependent on stakeholder involvement in ATLAS.  
 
Attributes  Questions  
 
 
Usefulness  
 
 
 
 
 
 
 
 
Representativeness  
 
 
 
Simplicity  
 
 
 
 
 
Data quality  
 
 
 
 
 
 
 
 
 
 
Flexibility  
 
 
Acceptability 
 
 
 
 
Timeliness   
1. What is your role and how are you involved in ATLAS? 
 
2. How useful is ATLAS for you and your service? (Probe: use, 
application of findings, increased testing, informed clinical 
knowledge, work or funding as a result of findings, how 
could you use it?) 
3. What outputs from ATLAS are you aware of? How has that 
information been used? (Probe: ask for an example) 
4. Have the data/outputs been used to detect outbreaks, 
trends? 
 
5. Do you think the outcomes are representative of the wider 
service/Aboriginal and or Torres Strait Islander 
community?  
6. Are the outcomes consistent with other evidence?  
 
7. What input is required from your service? (Probe: staffing)  
8. How is data managed? (Probe: entering, access, storage) 
9. What is the process of maintaining ATLAS? 
(Probe: time and resources, running and maintaining, 
process of coordination, training required) 
 
10. Is the data easy to collect?  
11. Are there any issues with data quality and completeness? 
(Probe: sample size, conclusions, trend over time) 
12. Are all the indicators useful? 
13. Are there other indicators that should be included? 
(Probe: ask for an example and reason) 
14. How is ATLAS reported? 
15. Is the report easy to understand and use? (probe: positive 
and negative aspects of the report) 
16. How would you improve reporting of ATLAS? 
 
17. Is ATLAS easy to modify? (probe: ease of change, 
limitation and ability to modify in the future) 
 
18. Do you consider ATLAS a valid and necessary undertaking? 
(probe: why, why not, in terms of surveillance use) 
19. What are the implications of your service not participating 
in ATLAS? (Probe: application of data, surveillance) 
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Stability  
20. Are the timeframes of the system adequate? (Probe: just 
the timeframes on the aspects you are involved in, 
collection, analysis and reporting) 
21. How long does it take from receiving data to producing a 
report? 
 
22. How is ATLAS funded?  
23. What would be a more sustainable way to operate ATLAS? 
24. What time, resources and organisational support are 
needed to maintain ATLAS? 
25. How do you see ATLAS working in the future? 
 
26. Is there anything else you would like to tell me about 
ATLAS? 
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5.1. Prologue  
5.1.1. My role  
During my Master of Philosophy in Applied Epidemiology I was not placed in a public health 
unit. However, my field supervisor and I took the opportunity to make arrangements with 
the Disease Surveillance and Investigation team, Communicable Disease Control Branch 
(CDCB), South Australian Department for Health and Wellbeing (SA Health), to be involved in 
an outbreak investigation.  
In June 2018, I was contacted regarding an outbreak and took the opportunity to be involved. 
I was brought into this outbreak investigation to assist the Disease Surveillance and 
Investigation team with the epidemiological investigations. My primary roles were: 
• to review the case-control study questionnaire  
• to draft a ministerial brief regarding the outbreak (Appendix A) 
• to enter data from the completed case-control questionnaires  
• to clean and analyse the data. 
In addition, I participated in risk assessment meetings regarding the outbreak and other 
relevant meetings including high-level decision-making meetings with the Chief Public Health 
Officer of South Australia. I also wrote the outbreak investigations as a manuscript which was 
published in Communicable Diseases Intelligence and forms the main component of this 
chapter (Appendix B); 
Harfield S, Beazley R, Denehy E, Centofanti A, Dowsett P, Housen T, et al. An outbreak 
and case-control study of Salmonella Havana linked to alfalfa sprouts in South Australia, 
2018. Communicable Diseases Intelligence (2018). 2019;43. 
5.1.2. Lessons learnt  
The outbreak investigation provided an excellent real-time exercise to put epidemiological 
theory into practice. I gained experience in outbreak investigations which was highly 
valuable. I learnt how foodborne disease outbreak investigations are complex, requiring a 
team effort and close cooperation and communication between relevant government 
agencies and experts to ensure several components came together: information and data 
collection, the synthesis of findings from the laboratory investigation, environmental health 
investigations and the epidemiology investigations.  
This outbreak involved the CDCB, the Food and Controlled Drugs Branch of SA Health, SA 
Pathology and South Australian Local Government. As the implicated food source was a 
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primary produce, the Department of Primary Industries and Regions South Australia were 
also involved. This outbreak used the three components of a foodborne disease outbreak 
investigation: laboratory investigation, epidemiological investigation and environmental 
investigation. As previously mentioned, I was part of the epidemiological investigation, 
Disease Surveillance and Investigation team.  
The main purpose of an outbreak investigation is to identify and eliminate the source of the 
outbreak to stop further cases, by stopping exposure to the outbreak source. The role of the 
outbreak investigation is to identify the exposure. Traditionally, outbreak investigations are 
described as involving ten steps (1). However, not every investigation will require all ten 
steps, nor are they conducted in order from step one through to step ten. I was involved as 
a member of the investigation team; in the descriptive analysis of cases and controls; 
development, testing and comparing of hypothesis; implementation of control and 
prevention measures; and the preparation of a written report and communication of 
findings.  
There were several challengers in relation to undertaking this outbreak investigation. 
Outbreak investigation often require a quick response, however, this is dependent on the 
level and appropriateness of information available. While we were able to undertake a case-
control study within a day, this required a significant amount of resources to undertake, 
particularly, several peoples’ time which would have otherwise been allocated to monitoring 
other notifications and diseases. This outbreak investigation utilised information from 
laboratory, environmental and epidemiological investigations, which required time to 
acquire. Importantly, while there was an urgency to make an announcement about the 
outbreak to the public and to prevent further cases from occurring, an important discussion 
between the outbreak investigation team, the Chief Public Health Officer and other SA Health 
staff was held, weighing up the evidence against, public safety versus the implications of 
being incorrect about the source of the outbreak and its potential impact on industry and 
reputation. A decision was made to wait for laboratory confirmation, which in the end 
supported environmental and epidemiological investigations.       
We chose to conduct a case-control study for this outbreak as opposed to a cohort study. 
The primary reason for this decision was the outbreak did not have an appropriate number 
of cases to make it feasible to undertake a cohort study and there was no defined population. 
Waiting for the outbreak to reach an appropriate number of cases or to be a defined 
population would risk delaying public health action and public safety. For the case-control 
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study we also chose to un-match the controls, while statistically there was no difference 
between cases and controls by sex and age for our case-control study, there are often 
benefits and limitations as to whether controls are matched or un-matched. Benefits for 
matching controls minimises confounding and biases by considering sex, age and other 
population characteristics or risk factors. At the same time there are benefits to un-matching 
controls, such as, it provides an opportunity to develop a greater understanding of the 
disease of interest. Additionally, factors already known to be risk factors for the disease can 
be limited. Further, certain statistical analysis (logistic regression) allow for confounding 
factors to be accounted for in the analysis. Finally, un-matching makes it easier to identify 
and recruit controls.  
5.1.3. Public health impact 
The aim of this outbreak investigation was to determine the cause of illness and to prevent 
further illness from occurring. To our knowledge, this is the first documented outbreak of 
Salmonella Havana (S. Havana) in Australia.  
Efforts to control this outbreak were successful. Once laboratory confirmation was received, 
prompt and effective actions were taken to stop further members of the community from 
falling ill – a media release and announcement was made by the Chief Public Health Officer 
(Appendix C & D). A coordinated effort was required, including an immediate notification to 
the producer to stop production and a state-wide recall of all alfalfa sprout products made 
by the producer.  
5.1.4. Acknowledgements  
I would like to acknowledge and thank the Communicable Disease Control Branch, 
particularly the Disease Surveillance and Investigation team led by Emma Denehy and 
Rebecca Beazley outbreak investigation lead, for their assistance and support in allowing me 
to be a part of the outbreak investigation and their team. Iwould also like to acknowledge 
and thank the Food and Controlled Drugs Branch and Primary Industries and Regions South 
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5.1.5. MAE core requirements 
This project fulfils the outbreak investigation component of the Master of Philosophy in 
Applied Epidemiology. The outbreak investigation was written up as a manuscript and 
published in Communicable Diseases Intelligence.  
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5.2. Abstract  
An epidemiological investigation and a retrospective case-control study were conducted into 
an outbreak of S. Havana in alfalfa sprouts, in Adelaide, Australia. In total, 31 cases of S. 
Havana were notified during June and July 2018 and linked to the outbreak. Eighteen cases 
and 54 unmatched controls were included in a case-control study. Results from the case-
control study indicated an increased risk of illness linked to the consumption of alfalfa 
sprouts; this was supported by trace-back, sampling and environmental investigations. This 
outbreak of S. Havana was caused by consumption of alfalfa sprouts from one local sprout 
producer. It is unclear as to when in the production of alfalfa sprouts, contamination 
occurred. However, contaminated seeds and poor pest control are the most likely causes. 
This investigation highlights the importance of ensuring producers take appropriate action 
to minimise the likelihood of contamination and comply with legislation and standards for 
primary production and food safety. 
5.3. Introduction  
Salmonellosis is commonly associated with foodborne outbreaks. Outbreaks are often linked 
to infected produce, animals and contaminated animal feed used in food production (2). The 
incubation period for salmonellosis is 6 to 72 hours, usually 12 to 36 hours. Symptoms may 
include fever, diarrhoea, loss of appetite, headache, stomach cramps, nausea and vomiting 
(2). Salmonellosis may be particularly severe in young children, the elderly and people with 
immune suppression (2). 
In Australia, Salmonella is a nationally notifiable disease and accounted for 33.4% of all 
foodborne notifications in South Australia (SA) between 2013 and 2017 (3). During June 2018, 
a notable increase in S. Havana notifications was detected through routine surveillance by 
the Communicable Disease Control Branch (CDCB), South Australian Department for Health 
and Wellbeing (SA Health). Notifications of S. Havana are relatively infrequent in Australia. 
During the period 2013–2017, 3 to 14 S. Havana cases were reported annually to CDCB. No 
previous outbreaks have been attributed to S. Havana in Australia (3). Internationally, only 
one other outbreak reported in 1998 in the United States of America linked S. Havana to 
alfalfa sprouts (4). S. Havana has also been previously identified in poultry (5-8) and feedstock 
(7, 9, 10). 
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This investigation included a description of the outbreak, a retrospective case control study, 
microbiological investigation, and trace-back that led to the identification of cases and the 
prevention of further cases.  
5.4. Method  
A descriptive epidemiological investigation and a retrospective case-control study were 
conducted. This epidemiological investigation was covered by the South Australian Public 
Health Act 2011 (the Act) and approval from the Australian National University Human 
Research Ethics Committee (2017/909). Informed consent was obtained from all 
participants. A case for the outbreak investigation was defined as laboratory-confirmed 
infection with S. Havana in SA reported to CDCB from 1 June until 31 July 2018. 
5.4.1. Epidemiological investigation 
In SA, reporting of notifiable conditions to the CDCB, by medical practitioners and diagnostic 
pathology services, is required under the Act. Notifications are monitored by CDCB staff to 
determine whether further investigations are required. 
Interviewing of laboratory-confirmed salmonellosis cases was conducted by trained CDCB 
staff using the OzFoodNet Salmonella Hypothesis Generating Questionnaire  (11). The 
questionnaire collected information on demographics, onset of illness, symptoms, recent 
travel, environmental exposures, food history, and locations where food was purchased 
during the seven days prior to illness onset. Information from the hypothesis-generating 
interviews informed the case-control hypothesis and was used to assist trace-back. 
5.4.2. Case-control study 
A case-control study was conducted to test the hypothesis, that illness was associated with 
consumption of frequently identified foods from the hypothesis-generating questionnaires. 
A case for the case-control study was defined as a laboratory-confirmed case of S. Havana in 
SA reported to CDCB from 1 June until 20 June 2018. A case was eligible for the case-control 
study if initially interviewed with the Hypothesis Generating Questionnaire and interviewed 
with the case-control study questionnaire prior to the media announcement regarding the 
outbreak on 20 June 2018. Cases not interviewed with the case-control study questionnaire 
prior to the media announcement were excluded. Controls were recruited using a list 
randomly generated from the South Australian Monitoring and Surveillance System (SAMSS) 
survey, a population health survey that monitors trends in health risk factors and chronic 
disease (12). The SAMSS survey is collected monthly from about 600 adults and children using 
a Computer-Assisted Telephone Interviewing system. Participants must be residents of SA 
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with access to a telephone (including mobile phone). The sampling strategy uses a ‘dual 
overlapping sampling technique applied (mobile phone 70%: landline 30%) through random 
digit dialling’ (13). 
An unmatched control sample was calculated by the Prevention and Population Health 
Branch of SA Health using the 2018 SAMSS recontacting spreadsheet. Sample size was 
estimated using the percentage of cases consuming sprouts in the hypothesis-generating 
study and data from the Victorian Food Frequency study, which estimated the prevalence of 
eating alfalfa sprouts among healthy community controls. Controls were interviewed by 
telephone by trained interviewers between 9:30 am and 2:00 pm on 20 June 2018. Controls 
were excluded if they were not reached prior to the media announcement at 2:00 pm on 20 
June 2018, reported being ill, had returned from interstate or overseas within the last seven 
days or if another member of the household had an onset of diarrhoea in the two weeks prior 
to the onset of diarrhoea in the laboratory-confirmed control-case selected for the study. 
Only one attempt by telephone was made to contact each control. 
5.4.3. Statistical analysis 
Data obtained from the case-control study questionnaire were entered into a MS Excel® 2016 
before analysis using Stata® version 15. Univariate analysis was conducted on all food 
exposures, and generated crude odds ratios, p-values and 95% confidence intervals (exact). 
The statistical significance threshold was 5%. Categorical variables were assessed via chi-
squared test (sex) and continuous variables via t-test (age). 
5.4.4. Trace-back, sampling and environmental investigation 
Information from hypothesis-generating interviews informed trace-back, sampling and 
environmental investigations. Business and retailer records were used to identify common 
suppliers and product producers. Environmental and product samples were collected during 
environmental inspections. Retail samples of products were collected in the marketplace. All 
samples were submitted for microbiological analysis. Investigations were conducted by local 
government council environmental health officers as authorised by the Food Act 2001 (SA) 
(14), at a hotel implicated in the outbreak, included inspection of kitchen facilities and 
observation of food preparation procedures. Details of staff illness, absenteeism, and 
product suppliers’ details were requested. Food samples were also collected. Additional 
inspections of businesses implicated by cases were carried out by Food and Controlled Drugs 
Branch of SA Health (FCDB) and Department of Primary Industries and Regions South 
Australia (PIRSA) through trace-back of distributors and product producers. Environmental 
and product samples were collected from the production site at the time of this inspection. 
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Several follow-up inspections of the producer were conducted by FCDB and PIRSA. Food 
samples and environmental samples were sent to SA Pathology, for microbiological analysis 
using standardised methods (15). 
5.5. Results  
5.5.1. Epidemiological investigation 
In total, 31 cases of S. Havana were notified to the CDCB from 1 June to 31 July 2018 and 
linked to the outbreak investigation (Figure 5.1), comprising 19 females (61%) and 12 males 
(39%),  with an age range of 22–87 years and a median age of 65 years. Cases were from both 
rural SA (17 cases) and metropolitan Adelaide (14 cases). The most frequently reported 
symptoms were diarrhoea (97%), lethargy (94%), abdominal pain (81%), nausea (77%), fever 
(74%), headache (68%), muscle ache (61%) and vomiting (42%). The days unwell ranged from 
2 to 23 days with a median of 8. Thirteen (42%) cases were hospitalised.   
 
FIGURE 5.1: EPIDEMIOLOGICAL CURVE OF S. HAVANA NOTIFICATIONS IN SOUTH AUSTRALIA BY DATE OF ONSET, 29 MAY 
– 23 JUNE 2018 
 
The hypothesis-generating interviews were conducted between 13 and 19 June 2018 with 17 
cases. The interviews identified eight cases with the same hotel (Hotel X) as a common 
exposure. No meals were common between the eight cases. Foods identified from 
hypothesis generating interviews as frequently consumed included carrots, apples, bananas, 
pasteurised milk, cheese, potatoes, tomatoes, chicken and avocado. Five cases who did not 
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eat at the hotel identified eating alfalfa sprouts purchased from one of the following: a 
supermarket, bakery, fruit and vegetable store, or health food store. 
5.5.2. Environmental investigation 
Local government council environmental health officers inspected Hotel X on 14 June 2018. 
The environmental health officers identified alfalfa sprouts were served as a garnish on all 
hot meals, along with snow pea shoots and mesclun lettuce. Seven food samples were 
collected, four alfalfa sprouts samples (two from open bags and two from closed bags), one 
mesclun lettuce leaves sample and two snow pea sprouts samples. Overall, the inspection 
showed general compliance with the Australian and New Zealand Food Standards Code (16) 
was satisfactory. One staff member, a food handler, was identified as being unwell; however, 
it was unclear if the food handler had worked while ill.  No stool sample was obtained for this 
person. Hotel X used alfalfa sprouts supplied by a local distributer who sourced the alfalfa 
sprouts from one local sprout producer (producer A). Traceback of alfalfa sprouts implicated 
by cases not linked to Hotel X were also conducted with a supermarket, bakery, fruit and 
vegetable store, and health food store. Trace-back identified alfalfa sprouts were all from the 
one sprout producer (producer A). 
Random retail sampling occurred on 18 June 2018 and 146 samples of alfalfa and other 
sprout products were collected. Two South Australian alfalfa producers provided product to 
the SA marketplace. To ensure a thorough and open investigation both producers were 
investigated (producer A, producer B). The FCDB and PIRSA undertook joint environmental 
investigations at both South Australian alfalfa producers on 19 June 2018. Significant food 
safety issues at one producer (producer A) included vermin control: an inspection identified 
vermin faeces underneath pallets in the bulk storage area storing seeds. Fifty-one samples 
were collected along the production line from producer A: 42 were food and seed samples 
including a variety of alfalfa and snow pea sprouts, and nine were environment samples 
including vermin faeces. At producer B, 117 samples were collected from a mix of different 
sprout products. 
Of the seven food samples collected by local council environmental health officers at Hotel X 
on 14 June 2018, three alfalfa sprouts samples returned positive results for S. Havana on 20 
June 2018. Of the random retail samples collected, five returned positive results for S. Havana 
and were from the same sprout producer (producer A). Eleven positive results were returned 
on sprout product samples collected from producer A, with six S. Havana and five Salmonella 
Oranienburg (S. Oranienburg). While S. Oranienburg was identified from samples collected 
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from the sprout producer, no cases of S. Oranienburg had been notified in SA since April 
2018. No positive results were identified from producer B. 
5.5.3. Case control study  
Eighteen cases were identified and included in the case-control study. Cases included seven 
males (39%) and 11 females (61%), with an age range 22–87 years and a median age of 69 
years. Of the 268 potential controls contacted, 54 unmatched controls were eligible to be 
enrolled into the study. Exclusion of controls was due to individuals being non-contactable 
(96%), reportedly ill (3%) or reportedly having travelled recently (1%). Controls included 19 
males (30%) and 35 females (70%), with an age range 21–94 years and a median age of 71 
years. There was no statistically significant difference between cases and controls in age (t-
test = 1.70, p-value = 0.10), nor in sex (chi2(1) = 0.53, p-value = 0.47). 
Table 5.1 shows the results for the univariate epidemiological analysis. Increased risk of 
illness was shown for alfalfa sprouts (odds ratio 26.0, 95% CI 2.62–1217.60, p-value <0.001). 
Multivariate analysis was not conducted as only one food exposure, alfalfa sprouts, was 
statistically significant (p-value <0.05) and had a crude odds ratio greater than 2.0 with the 
95% confidence interval not crossing unity. 
TABLE 5.1: S. HAVANA OUTBREAK – ODDS RATIOS FOR FOOD EXPOSURES, SOUTH AUSTRALIA, 1ST–20TH JUNE 2018 
 Cases (n=18) Control (n=54) Univariate analysis  
Exposure Exposed % Exposed % Crude OR 95% CI p-value 
Alfalfa sprouts 6 33.33 1 1.85 26.00 2.62-1217.60 0.00 
Black pepper 6 33.33 38 70.37 0.21 0.06-0.75 0.02 
Cauliflower 8 44.44 20 37.04 2.67 0.79-9.44 0.07 
Capsicum 5 27.78 27 50.00 0.42 0.10-1.51 0.14 
Eggs 12 66.67 46 85.19 0.42 0.10-1.95 0.18 
Avocado 9 50.00 19 35.19 1.84 0.54-6.21 0.26 
Lettuce 11 61.11 27 50.00 1.83 0.52-6.90 0.29 
Raw tomato 9 50.00 36 66.67 0.56 0.16-2.00 0.31 
Broccoli 10 55.56 36 66.67 0.59 0.17-2.07 0.34 
Fresh garlic 4 22.22 16 29.63 0.68 0.14-2.64 0.54 
Chicken 7 38.89 27 50.00 0.78 0.21-2.75 0.66 
Yoghurt 9 50.00 24 44.44 1.25 0.37-4.18 0.68 
Snow pea shoot 1 5.56 2 3.70 1.53 0.02-30.92 0.73 
Pumpkin 10 55.56 34 62.96 0.84 0.24-3.05 0.76 
Cucumbers 7 38.89 20 37.04 1.08 0.30-3.66 0.89 
Raw onions 6 33.33 20 37.04 0.93 0.24-3.26 0.90 
Almonds 8 44.44 24 44.44 1.00 0.29-3.32 1.00 
OR, odds ratio; CI, confidence interval 
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5.5.4. Public health action  
Based on epidemiology, laboratory results and trace-back, an emergency order under the 
Food Act 2001 (SA) was served on producer A to cease distributing products, which were only 
distributed within SA, and a consumer level recall of all alfalfa products from the supply chain 
was issued on 21 June 2018. A media release and public health alert to warn South 
Australians not to eat alfalfa sprout products from producer A was issued on 20 June 2018. 
PIRSA returned to producer A to evaluate the effectiveness of the food recall and conduct a 
more intensive overview of the facility and processes on 22 June 2018. No breakdown in the 
production process was identified; however, there were several structural deficiencies 
identified. Producer A was advised to rectify issues around vermin entry points and remove 
any equipment that could not be easily cleaned and sanitised, and to review their food safety 
programme to ensure it adequately addressed critical control points as required under the 
Food Standards Code – Production and Processing Standard for Seed Sprouts (4.2.6). The 
producer committed to cease the production of all sprout products and to rectify issues 
identified. Food and Controlled Drugs Branch returned to producer A on 29 June 2018 to 
witness the secure destruction of the recalled product. 
5.6. Discussion  
Consumption of alfalfa sprouts linked to one sprout producer showed a significant 
association with illness, an odds ratio of 26.0 (95% CI 2.62–1217.60, p-value <0.001). The 
findings and observations from the environmental investigation and laboratory results, which 
included positive results for S. Havana from three samples collected from Hotel X, five 
samples from random retail samples and six from samples collected from sprout producer A, 
provided further support to the epidemiological evidence. This was a significant achievement 
given that the case-control study was conducted in one day. This outbreak was the largest 
identified S. Havana outbreak in Australia to date. In total, 31 cases of S. Havana were 
reported and linked to the outbreak.  
Alfalfa sprouts are considered a high-risk product due to the risk of microbial contamination 
inherent in sprout seeds and production (17), sprouts require warm and humid conditions to 
grow, which is also ideal for bacterial pathogens (18). It is unclear as to when in the 
production of alfalfa sprouts contamination occurred. However, contaminated seeds are the 
most likely cause given their high risk. Alfalfa sprouts are usually consumed raw which 
increases the risk of human infection. Alfalfa sprouts (19-25) and other sprouts(24, 26-28) 
have been linked to other Salmonella outbreaks internationally. Only one other outbreak was 
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identified in the literature, in 1998 in the United States of America, which linked S. Havana 
to alfalfa sprouts (4). This particular outbreak involved 18 cases from California and Arizona 
and identified contaminated seed as the likely source. 
With 13 (44%) cases hospitalised, the hospitalisation rate in this outbreak was high, in 
comparison to the normal hospitalisation rate for salmonellosis of 21% in 2018 for SA (29). 
This suggests either there might have been a high dose of contamination on the alfalfa 
sprouts or the outbreak strain might be more pathogenic than other Salmonella strains, thus 
leading to a higher burden of disease for this specific strain. 
To minimise future outbreaks linked to alfalfa sprouts and other sprouts, it is suggested 
sprouts producers take appropriate action to minimise the likelihood of contaminated 
products, including using a decontamination step to minimise the bacterial load on sprout 
seeds and in the sprouting process and ensuring they comply with legislation and standards 
for primary production and food safety. In SA, all sprouts producers are required to hold 
accreditation under the Primary Produce (Food Safety Schemes) Act 2004 and the Primary 
Produce (Food Safety Schemes) (Plant Products) Regulations 2010; comply with Food 
Standards Code – Production and Processing Standard for Seed Sprouts (4.2.6); and have an 
approved food safety arrangement. 
There are several limitations to our outbreak investigation. Firstly, recall by individuals of 
foods eaten is always a concern in a retrospective case-control study, as asking someone to 
recall what they ate before becoming ill can be a challenge, particularly if it has been several 
days since the incident. Also, the Hypothesis Generating Questionnaire asks about what food 
did you eat, requesting a person to recall the food they consumed, whereas the case-control 
study questionnaire is framed as ‘did you eat…’, which is more likely to prompt a person’s 
memory. This might help explain why those who ate at Hotel X did not recall being served 
alfalfa sprouts on their meal as a garnish when asked about at it during the Hypothesis 
Generating Questionnaire. However, one case who ate at Hotel X recalled eating alfalfa 
sprouts when asked using the case-control study questionnaire. Secondly, controls were not 
matched, however, statistically there was no difference between the cases and controls for 
age or sex. Thirdly, univariant analysis identified alfalfa sprouts were the most likely cause 
with statistically significant odds ratio. However, the confidence interval is wide (2.62–
1217.60), which is related to the small sample size. 
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5.7. Conclusion  
This outbreak of S. Havana in SA was caused by consumption of alfalfa sprouts from one local 
sprout producer. Alfalfa sprouts are considered a high-risk product due to risk of microbial 
contamination in sprout seeds, and production occurring in an environment which is ideal 
for growth of bacterial pathogens. In this outbreak it is unclear as to when in the production 
of alfalfa sprouts contamination occurred. However, contaminated seeds and poor pest 
control are the most likely causes. This investigation highlights the importance of ensuring 
producers comply with legislation and standards for primary production and food safety and 
equipment is adequately maintained to minimise the likelihood of contamination. 
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Original article
An outbreak and case-control study of 
Salmonella Havana linked to alfalfa sprouts in 
South Australia, 2018
Stephen Harfield, Rebecca Beazley, Emma Denehy, Alessia Centofanti, Paul Dowsett, 
Tambri Housen and Louise Flood
Abstract
An epidemiological investigation and a retrospective case-control study were conducted into an out-
break of Salmonella Havana in alfalfa sprouts, in Adelaide, Australia. In total, 31 cases of S. Havana 
were notified during June and July 2018 and linked to the outbreak. Eighteen cases and 54 unmatched 
controls were included in a case-control study. Results from the case-control study indicated an 
increased risk of illness linked to the consumption of alfalfa sprouts; this was supported by trace-back, 
sampling and environmental investigations. This outbreak of S. Havana was caused by consumption 
of alfalfa sprouts from one local sprouts producer. It is unclear as to when in the production of alfalfa 
sprouts the contamination occurred. However, contaminated seeds and poor pest control are the most 
likely causes. This investigation highlights the importance of ensuring that producers take appropri-
ate action to minimise the likelihood of contamination and to comply with legislation and standards 
for primary production and food safety.
Keywords: Salmonella Havana, alfalfa sprouts, outbreak, case-control study, South Australia
Control Branch (CDCB), South Australian 
Department for Health and Wellbeing (SA 
Health). Notifications of S. Havana are relatively 
infrequent in Australia. During the period 
2013–2017, three to fourteen S.  Havana cases 
were reported annually to CDCB. No previous 
outbreaks have been attributed to S. Havana 
in Australia.2 Internationally, only one other 
outbreak reported in 1998 in the United States 
of America (USA) linked S. Havana to alfalfa 
sprouts.3 S. Havana has also been previously 
identified in poultry 4–7 and feedstock.6,8,9
This investigation included a description of the 
outbreak, a retrospective case control study, 
microbiological investigation, and trace-back 
that led to the identification of cases and the 
prevention of further cases.
Introduction
Salmonellosis is commonly associated with 
foodborne outbreaks. Outbreaks are often 
linked to infected produce, animals and con-
taminated animal feed used in food produc-
tion.1 The incubation period for salmonellosis is 
6 to 72 hours, usually 12–36 hours. Symptoms 
may include fever, diarrhoea, loss of appetite, 
headache, stomach cramps, nausea and vomit-
ing.1 Salmonellosis may be particularly severe 
in young children, the elderly and people with 
immune suppression.1
In Australia, Salmonella is a nationally notifiable 
disease and accounted for 33.4% of all foodborne 
notifications in South Australia (SA) between 
2013 and 2017.2 During June 2018, a notable 
increase in Salmonella Havana (S.  Havana) 
notifications was detected through routine 
surveillance by the Communicable Disease 
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Method
A descriptive epidemiological investigation 
and a retrospective case-control study were 
conducted. This epidemiological investigation 
was covered by the South Australian Public 
Health Act 2011 (the Act) and approval from the 
Australian National University Human Research 
Ethics Committee (2017/909). Informed con-
sent was obtained from all participants. A case 
for the outbreak investigation was defined as 
laboratory-confirmed infection with S. Havana 
in SA reported to CDCB from 1 June until 31 
July 2018.
Epidemiological investigation
In South Australia, reporting of notifiable con-
ditions to the CDCB, by medical practitioners 
and diagnostic pathology services, is required 
under the Act. Notifications are monitored by 
CDCB staff to determine whether further inves-
tigations are required.
Interviewing of laboratory-confirmed salmonel-
losis cases was conducted by trained CDCB staff 
using the OzFoodNet Salmonella Hypothesis 
Generating Questionnaire (HGQ).10 The ques-
tionnaire collected information on demograph-
ics, onset of illness, symptoms, recent travel, 
environmental exposures, food history, and 
locations where food was purchased during the 
seven days prior to illness onset. Information 
from the hypothesis-generating interviews 
informed the case-control hypothesis and was 
used to assist trace-back.
Case-control study
A case-control study was conducted to test the 
hypothesis that illness was associated with con-
sumption of frequently identified foods from the 
hypothesis-generating questionnaires.
A case for the case-control study was defined 
as a laboratory-confirmed case of S. Havana in 
SA reported to CDCB from 1 June until 20 June 
2018. A case was eligible for the case-control 
study if initially interviewed with the HGQ 
and interviewed with the case-control study 
questionnaire prior to the media announcement 
regarding the outbreak on 20 June 2018. Cases 
not interviewed with the case-control study 
questionnaire prior to the media announce-
ment were excluded. Controls were recruited 
using a list randomly generated from the South 
Australian Monitoring and Surveillance System 
(SAMSS) survey, a population health survey 
that monitors trends in health risk factors and 
chronic disease.11 The survey is collected monthly 
from about 600 adults and children using a 
Computer-Assisted Telephone Interviewing sys-
tem. Participants must be residents of SA with 
access to a telephone (including mobile phone). 
The sampling strategy uses a ‘dual overlapping 
sampling technique applied (mobile phone 70%: 
landline 30%) through random digit dialling’.12
An unmatched control sample was calculated by 
the Prevention and Population Health Branch of 
SA Health using the 2018 SAMSS recontacting 
spreadsheet. Sample size was estimated using 
the percentage of cases consuming sprouts in 
the hypothesis-generating study and data from 
the Victorian Food Frequency study, which esti-
mated the prevalence of eating alfalfa sprouts 
among healthy community controls. Controls 
were interviewed by telephone by trained inter-
viewers between 9:30 am and 2:00 pm on 20 
June 2018. Controls were excluded if they were 
not reached prior to the media announcement 
at 2 pm on 20 June 2018, reported being ill, had 
returned from interstate or overseas within 
the last seven days or if another member of the 
household had an onset of diarrhoea in the two 
weeks prior to the onset of diarrhoea in the 
laboratory-confirmed control-case selected for 
the study. Only one attempt by telephone was 
made to contact each control.
Statistical analysis
Data obtained from the case-control study 
questionnaire were entered into a Microsoft 
Excel® 2016 database before analysis using Stata® 
version 15. Univariate analysis was conducted 
on all food exposures, and generated crude odds 
ratios, p-values and 95% confidence intervals 
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(exact). The statistical significance threshold 
was 5%. Categorical variables were assessed via 
chi-squared test (sex) and continuous variables 
via t-test (age).
Trace-back, sampling and environmental 
investigation
Information from hypothesis-generating inter-
views informed trace-back, sampling and envi-
ronmental investigations. Business and retailer 
records were used to identify common suppliers 
and product producers. Environmental and 
product samples were collected during environ-
mental inspections. Retail samples of products 
were collected in the marketplace. All samples 
were submitted for microbiological analysis.
Investigations conducted by local government 
council environmental health officers (EHO) as 
authorised by the Food Act 2001 (SA),13 at a hotel 
implicated in the outbreak, included inspection 
of kitchen facilities and observation of food 
preparation procedures.  Details of staff illness, 
absenteeism, and product suppliers’ details were 
requested. Food samples were collected.
Additional inspections of businesses implicated 
by cases were carried out by the Food and 
Controlled Drugs Branch, SA Health (FCDB) 
and by the Department of Primary Industries 
and Regions, South Australia (PIRSA) through 
trace-back of distributors and product producers. 
Environmental and product samples were col-
lected from the production site at the time of this 
inspection. Several follow-up inspections of the 
producer were conducted by FCDB and PIRSA.
Food samples and environmental samples were 
sent to SA Pathology, SA Health, for microbio-
logical analysis using standardised methods.14
Results
Epidemiological Investigation
In total, 31 cases of S. Havana were notified 
to the CDCB from 1 June to 31 July 2018 and 
linked to the outbreak investigation (Figure 1), 
comprising 19 females (61%) and 12 males (39%), 
with an age range of 22–87 years and a median 
age of 65 years. Cases were from both rural SA 
(17 cases) and metropolitan Adelaide (14 cases). 
The most frequently reported symptoms were 
diarrhoea (97%), lethargy (94%), abdominal pain 
(81%), nausea (77%), fever (74%), headache (68%), 
muscle ache (61%) and vomiting (42%). The days 
unwell ranged from 2 to 23 days with a median 
of 8. Thirteen (42%) cases were hospitalised.
The hypothesis-generating interviews were 
conducted between 13 and 19 June 2018 with 
17 cases. The interviews identified eight cases 
with the same hotel (Hotel X) as a common 
exposure. No meals were common between the 
eight cases. Foods identified from hypothesis-
generating interviews as frequently consumed 
included carrots, apples, bananas, pasteurised 
milk, cheese, potatoes, tomatoes, chicken and 
avocado. Five cases who did not eat at the hotel 
identified eating alfalfa sprouts purchased from 
one of the following: a supermarket, bakery, 
fruit and vegetable store, or health food store.
Environmental investigation
Local government council EHOs inspected 
Hotel X on 14 June 2018. The EHOs identified 
alfalfa sprouts were served as a garnish on all 
hot meals, along with snow pea shoots and 
mesclun lettuce. Seven food samples were col-
lected, four alfalfa sprouts samples (two from 
open bags and two from closed bags), one mes-
clun lettuce leaves sample and two snow pea 
sprouts samples. Overall, the inspection showed 
that general compliance with the Australian 
and New Zealand Food Standards Code15 was 
satisfactory. One staff member, a food handler, 
was identified as being unwell; however, it was 
unclear if the food handler had worked while ill. 
No stool sample was obtained for this person. 
Hotel X used alfalfa sprouts supplied by a local 
distributer who sourced the alfalfa sprouts from 
one local sprouts producer (producer A). Trace-
back of alfalfa sprouts implicated by cases not 
linked to Hotel X were also conducted with a 
supermarket, bakery, fruit and vegetable store, 
4 of 10 health.gov.au/cdiCommun Dis Intell (2018)  2019;43(https://doi.org/10.33321/cdi.2019.43.45) Epub 15/10/2019
Fi
gu
re
 1
. E
pi
de
m
io
lo
gi
ca
l c
ur
ve
 o
f S
. H
av
an
a n
ot
ifi
ca
tio
ns
 in
 S
ou
th
 A
us
tr
al
ia
 b
y d
at
e o
f o
ns
et
, 2
9 
M
ay
 –
 2
3 
Ju
ne
 2
01
8
0123456
Case count
Da
te
 o
f o
ns
et
5 of 10 health.gov.au/cdi Commun Dis Intell (2018)  2019;43(https://doi.org/10.33321/cdi.2019.43.45) Epub 15/10/2019
Ta
bl
e 1
. S
. H
av
an
a o
ut
br
ea
k 
– 
re
la
tiv
e r
isk
s f
or
 fo
od
 ex
po
su
re
s, 
So
ut
h 
Au
st
ra
lia
, 1
–2
0 
Ju
ne
 2
01
8
Ca
se
s 
(n
=1
8)
Co
nt
ro
l (
n=
54
)
U
ni
va
ri
at
e 
an
al
ys
is
Ex
po
su
re
Ex
po
se
d
%
Ex
po
se
d
%
Cr
ud
e 
O
Ra
95
%
 C
Ib
p-
va
lu
e
A
lf
al
fa
 s
pr
ou
ts
6
33
.3
3
1
1.
85
26
.0
0
2.
62
–1
21
7.
60
<0
.0
01
Bl
ac
k 
pe
pp
er
6
33
.3
3
38
70
.3
7
0.
21
0.
06
–0
.7
5
0.
02
Ca
ul
ifl
ow
er
8
44
.4
4
20
37
.0
4
2.
67
0.
79
–9
.4
4
0.
07
Ca
ps
ic
um
5
27
.7
8
27
50
.0
0
0.
42
0.
10
–1
.5
1
0.
14
Eg
gs
12
66
.6
7
46
85
.1
9
0.
42
0.
10
–1
.9
5
0.
18
Av
oc
ad
o
9
50
.0
0
19
35
.1
9
1.
84
0.
54
–6
.2
1
0.
26
Le
tt
uc
e
11
61
.11
27
50
.0
0
1.
83
0.
52
–6
.9
0
0.
29
Ra
w
 to
m
at
o
9
50
.0
0
36
66
.6
7
0.
56
0.
16
–2
.0
0
0.
31
Br
oc
co
li
10
55
.5
6
36
66
.6
7
0.
59
0.
17
–2
.0
7
0.
34
Fr
es
h 
ga
rli
c
4
22
.2
2
16
29
.6
3
0.
68
0.
14
–2
.6
4
0.
54
Ch
ic
ke
n
7
38
.8
9
27
50
.0
0
0.
78
0.
21
–2
.7
5
0.
66
Yo
gh
ur
t
9
50
.0
0
24
44
.4
4
1.
25
0.
37
–4
.1
8
0.
68
Sn
ow
 p
ea
 s
ho
ot
1
5.
56
2
3.
70
1.
53
0.
02
–3
0.
92
0.
73
Pu
m
pk
in
10
55
.5
6
34
62
.9
6
0.
84
0.
24
–3
.0
5
0.
76
Cu
cu
m
be
rs
7
38
.8
9
20
37
.0
4
1.
08
0.
30
–3
.6
6
0.
89
Ra
w
 o
ni
on
s
6
33
.3
3
20
37
.0
4
0.
93
0.
24
–3
.2
6
0.
90
A
lm
on
ds
8
44
.4
4
24
44
.4
4
1.
00
0.
29
–3
.3
2
1.
00
alv
er
e 
in
t
tio
O
R,
 o
dd
s 
ra
on
fid
en
c
CI
, c
  a b
6 of 10 health.gov.au/cdiCommun Dis Intell (2018)  2019;43(https://doi.org/10.33321/cdi.2019.43.45) Epub 15/10/2019
and health food store. Trace-back identified that 
alfalfa sprouts were all from the one sprouts 
producer (producer A).
Random retail sampling occurred on 18 June 
2018 and 146 samples of alfalfa and other sprout 
products were collected. Two South Australian 
alfalfa producers provided product to the SA 
marketplace. To ensure a thorough and open 
investigation both producers were investi-
gated (producer A, producer B). The Food and 
Controlled Drugs Branch and PIRSA undertook 
joint environmental investigations at both 
South Australian alfalfa producers on 19 June 
2018. Significant food safety issues at one pro-
ducer (producer A) included vermin control: an 
inspection identified vermin faeces underneath 
pallets in the bulk storage area storing seeds. 
Fifty-one samples were collected along the pro-
duction line from producer A: 42 were food and 
seed samples including a variety of alfalfa and 
snow pea sprouts, and nine were environment 
samples including vermin faeces. At producer B, 
117 samples were collected from a mix of differ-
ent sprout products.
Of the seven food samples collected by local 
council EHOs at Hotel X on 14 June 2018, three 
alfalfa sprouts samples returned positive results 
for S. Havana on 20 June 2018. Of the random 
retail samples collected, five returned positive 
results for S. Havana and were from the same 
sprout producer (producer A). Eleven positive 
results were returned on sprout product samples 
collected from producer A, with six S. Havana 
and five S. Oranienburg. While S. Oranienburg 
was identified from samples collected from the 
sprouts producer, no cases of S. Oranienburg 
had been notified in SA since April 2018. No 
positive results were identified from producer B.
Case-control study
Eighteen cases were identified and included in 
the case-control study. Cases included seven 
males (39%) and 11 females (61%), with an age 
range 22–87 years and a median age of 69 years. 
Of the 268 potential controls contacted, 54 
unmatched controls were eligible to be enrolled 
into the study. Exclusion of controls was due 
to individuals being non-contactable (96%), 
reportedly ill (3%) or reportedly having travelled 
recently (1%). Controls included 19 males (30%) 
and 35 females (70%), with an age range 21–94 
years and a median age of 71 years. There was no 
statistically significant difference between cases 
and controls in age (test t = 1.70, p-value = 0.10), 
nor in sex (chi2(1) = 0.53, p-value = 0.47).
Table 1 shows the results for the univariate epide-
miological analysis. Increased risk of illness was 
shown for alfalfa sprouts (odds ratio 26.0, 95% 
CI 2.62–1217.60, p-value <0.001). Multivariate 
analysis was not conducted as only one food 
exposure, alfalfa sprouts, was statistically sig-
nificant (p-value <0.05) and had a crude odds 
ratio greater than 2.0 with the 95% confidence 
interval not crossing unity.
Public Health Action
Based on epidemiology, laboratory results and 
trace-back, an emergency order under the Food 
Act 2001 (SA) was served on producer A to cease 
distributing products, which were only distrib-
uted within SA, and a consumer level recall of 
all alfalfa products from the supply chain was 
issued on 21 June 2018. A media release and 
public health alert to warn South Australians 
not to eat alfalfa sprout products from producer 
A was issued on 20 June 2018.
PIRSA returned to producer A to evaluate the 
effectiveness of the food recall and conduct 
a more intensive overview of the facility and 
processes on 22 June 2018. No breakdown in 
the production process was identified; how-
ever, there were several structural deficiencies 
identified. Producer A was advised to rectify 
issues around vermin entry points and remove 
any equipment that could not be easily cleaned 
and sanitised, and to review their food safety 
programme to ensure it adequately addressed 
critical control points as required under the 
Food Standards Code (FSC) – Production and 
Processing Standard for Seed Sprouts (4.2.6). 
The producer committed to cease the produc-
tion of all sprout products and to rectify issues 
identified. 
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Food and Controlled Drugs Branch returned to 
producer A on 29 June 2018 to witness the secure 
destruction of the recalled product.
Discussion
Consumption of alfalfa sprouts linked to one 
sprouts producer showed a significant associa-
tion with illness, an odds ratio of 26.0 (95% CI 
2.62–1217.60, p-value <0.001). The findings and 
observations from the environmental investi-
gation and laboratory results, which included 
positive results for S. Havana from three sam-
ples collected from Hotel X, five samples from 
random retail samples and six from samples 
collected from sprout producer A, provided 
further support to the epidemiological evidence. 
This was a significant achievement given that 
the case-control study was conducted in one 
day. This outbreak was the largest identified S. 
Havana outbreak in Australia to date. In total, 
31 cases of S. Havana were reported and linked 
to the outbreak.
Alfalfa sprouts are considered a high-risk prod-
uct due to the risk of microbial contamination 
inherent in sprout seeds and production:16 
sprouts require warm and humid conditions 
to grow, which is also ideal for bacterial patho-
gens.17 It is unclear as to when in the production 
of alfalfa sprouts the contamination occurred. 
However, contaminated seeds are the most 
likely cause given their high risk. Alfalfa sprouts 
are usually consumed raw which increases the 
risk of human infection. Alfalfa sprouts18–24 
and other sprouts23, 25–27 have been linked to 
other Salmonella outbreaks internationally. 
Only one other outbreak was identified in the 
literature, in 1998 in the USA, which linked 
S. Havana to alfalfa sprouts.3 This particular 
outbreak involved 18 cases from California and 
Arizona and identified contaminated seed as the 
likely source.
With 13 (44%) cases hospitalised, the hospi-
talisation rate in this outbreak was high, in 
comparison to the normal hospitalisation rate 
for salmonellosis of 21% in 2018 for SA.28 This 
suggests that either there might have been a high 
dose of contamination on the alfalfa sprouts or 
the outbreak strain might be more pathogenic 
than other Salmonella strains, thus leading to a 
higher burden of disease for this specific strain.
To minimise future outbreaks linked to alfalfa 
sprouts and other sprouts, it is suggested that 
sprouts producers take appropriate action 
to minimise the likelihood of contaminated 
product, including using a decontamination 
step to minimise the bacterial load on sprout 
seeds and in the sprouting process and ensuring 
they comply with legislation and standards for 
primary production and food safety. In South 
Australia, all sprouts producers are required to 
hold accreditation under the Primary Produce 
(Food Safety Schemes) Act 2004 and the Primary 
Produce (Food Safety Schemes) (Plant Products) 
Regulations 2010; comply with Food Standards 
Code – Production and Processing Standard for 
Seed Sprouts (4.2.6); and have an approved food 
safety arrangement.
There are several limitations to our outbreak 
investigation. Firstly, recall by individuals of 
foods eaten is always a concern in a retrospec-
tive case-control study, as asking someone to 
recall what they ate before becoming ill can be a 
challenge particularly if it has been several days 
in between. Also, the HGQ asks about what food 
did you eat, requesting a person to recall the food 
they consumed, whereas the case-control study 
questionnaire is framed as ‘did you eat…’, which 
is more likely to prompt a person’s memory. This 
might help explain why those who ate at Hotel X 
did not recall being served alfalfa sprouts on their 
meal as a garnish when asked about at it during 
the HGQ. However, one case who ate at Hotel X 
recalled eating alfalfa sprouts when asked using 
the case-control study questionnaire. Secondly, 
controls were not matched, however statisti-
cally there was no difference between the cases 
and controls for age or sex. Thirdly, univariant 
analysis identified alfalfa sprouts were the most 
likely cause with statistically significant odds 
ratio, p-value and confidence interval. However, 
the confidence interval is wide (2.62–1217.60), 
which is related to the small sample size.
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Conclusion
This outbreak of S. Havana in SA was caused by 
consumption of alfalfa sprouts from one local 
sprouts producer. Alfalfa sprouts are considered 
a high-risk product due to risk of microbial 
contamination in sprout seeds, and production 
occurring in an environment which is ideal for 
growth of bacterial pathogens. In this outbreak it 
is unclear as to when in the production of alfalfa 
sprouts the contamination occurred. However, 
contaminated seeds and poor pest control are the 
most likely causes. This investigation highlights 
the importance of ensuring that producers com-
ply with legislation and standards for primary 
production and food safety and that equipment 
is adequately maintained to minimise the likeli-
hood of contamination.
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Appendix 5.C 
Media release – Salmonella cases linked to alfalfa sprouts  
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Appendix 5.D 
Photos – Chief Public Health Officer media announcement 20 June 2018   
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6.1. Prologue 
As core competencies of the Master of Philosophy in Applied Epidemiology (MAE) we were 
asked to facilitate two teaching sessions, a teaching session to first year MAE scholars and to 
provide a ‘Lessons from the Field’ to our fellow scholars. Each teaching session provides an 
opportunity to share knowledge and skills that we have acquired or developed throughout 
our own MAE experience.  
6.1.1. My roles and lessons learnt 
The teaching session to first year MAE scholars was a group lesson with two other scholars, 
Anthea Katelaris and Mario Vittorino. The teaching session aimed to facilitate a basic 
understanding of a Single Overarching Communication Outcome in relation to the 
communication of a public health message. My role in the development and delivery of the 
teaching session was equally shared between myself and the other two members of the 
group. From the exercise, I learnt that the best way to teach is to be clear about the learning 
objectives, concise with the information provided, provide an example and a task for people 
to apply and assess their new knowledge. It is also important to ensure that the lesson is 
interesting, fun and interactive so people are engaged, and I think we achieved that.  
For my ‘Lessons from the Field’ I choose to share my knowledge on conducting research with 
Aboriginal and Torres Strait Islander communities. I have been involved in conducting 
research with Aboriginal and Torres Strait Islander people and communities for over five 
years and during that time have learnt a significant amount. Importantly, I have learnt about 
how to conduct research with Aboriginal and Torres Strait Islander communities the ‘right 
way’. These learnings make for valuable lessons for others, applicable not only to research 
with Aboriginal and Torres Strait Islander communities, but with other disadvantaged and 
diverse populations.  
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6.2. Teaching first years MAE scholars 
A presentation of our lesson was provided to first year MAE scholars (Appendix 6.A), it 
covered a lesson outline, learning objectives, what is a Single Overarching Communication 
Outcome (SOCO), components of a SOCO, SOCO example, SOCO template, when to use it 
and SOCO task and assessment.  
6.2.1. Learning objectives 
• Describe what a is SOCO
• When it can be used
• Practice developing a SOCO.
6.2.2. Task and assessment 
First year students were grouped into six small groups and were asked to develop a SOCO 
based on one of three scenarios provided to them: salmonella, measles or mosquitoes 
(Appendix 6.B). Each group was provided a SOCO Worksheet (Appendix 6.C) to assist with 
developing a SOCO. Each group presented their SOCO back to the class and fellow students 
were asked to provide feedback on each group’s presentation. In addition, one member from 
each group was selected to communicate their SOCO in a media interview style scenario.  
See scenarios (Appendix 6.B) and SOCO Worksheet (Appendix 6.C) for further detail about 
the small group work. 
6.2.3. Evaluation 
Our teaching session was evaluated at the end of the session. Most of the first year MAE 
scholars rated the objective and purpose of the session, presenters’ style, pace of session, 
content and likely future use of SOCOs highly (Figure 6.1, Figure 6.2, Figure 6.3, Figure 6.4 
and Figure 6.5). 
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FIGURE 6.1: FIRST YEAR MAE SCHOLARS RESPONSE TO, WERE THE OBJECTIVES AND PURPOSE OF THE SESSION CLEAR TO 
YOU? 
 
FIGURE 6.2: FIRST YEAR MAE SCHOLARS RESPONSE TO, WAS THE PRESENTATION STYLE ENGAGING?  
 
FIGURE 6.3: FIRST YEAR MAE SCHOLARS RESPONSE TO, HOW DID YOU FIND THE PACE OF THE SESSION?  
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FIGURE 6.4: FIRST YEAR MAE SCHOLARS RESPONSE TO, HOW USEFUL WAS THE CONTENT? 
 
FIGURE 6.5: FIRST YEAR MAE SCHOLARS RESPONSE TO, HOW LIKELY ARE YOU TO USE SOCOS IN THE FUTURE? 
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Overall, the teaching session was interesting, fun and interactive. It seemed that all students 
were participating and were engaged in the session. 
6.3. Lessons from the field 
6.3.1. Topic 
The topic for my lesson from the field was ‘Conducting research with Aboriginal and Torres 
Strait Islander communities’. 
6.3.2. Learning objectives 
• To understand the history of research with Aboriginal and Torres strait Islander
peoples and communities
• To understand the principles and values of conducting research with Aboriginal and
Torres Strait Islander communities
• To engage in discussions about appropriate research conduct with Aboriginal and
Torres Strait Islander peoples and communities
6.3.3. Required readings 
The group were asked to read the following documents, which provide some insight into 
conducting research with Aboriginal and Torres Strait Islander peoples and communities.   
• Chapter 1: setting the scene for research – Researching Indigenous Health: A
practical guide for researchers (pages 3-15)
• NHMRC Ethical conduct in research with Aboriginal and Torres Strait Islander
Peoples and communities: Guidelines for researchers and stakeholders
• The Blackfulla Test: 11 reasons that Indigenous health research grant/publication
should be rejected
6.3.4. Exercise 
After completing the required readings, the group were asked to: 
• One week prior to the lesson, provide a half page reflection on their interpretation
of the principles and values of Aboriginal and Torres Strait Islander research; and
• Consider the following in preparation for a group discussion
o History and its impact on Aboriginal and Torres Strait Islander research
o Knowledge and culture informing research practices
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o Principles and values of Aboriginal and Torres Strait Islander research 
o Facilitators and barriers to conducting research with Aboriginal and Torres 
Strait Islander peoples and communities 
o The implications of not considering Aboriginal and Torres Strait Islander 
principles and values when conducting research with Aboriginal and Torres 
Strait Islander peoples and communities. 
6.3.5. Overview  
A brief introduction to the topic was provided.  
6.3.5.1. History  
Aboriginal and Torres Strait Islander communities have had an interesting history with 
research practices in Australia. Early research in Australia included negative race-based 
research practices, which sought to prove that Aboriginal people were mentally and 
physically inferior human beings compared to Europeans (1). This history has been ‘ingrained 
in the psyches of successive generations of Aboriginal and Torres Strait Islander peoples and 
more recent examples of poor research practices have contributed to the degrees of distrust 
that developed towards researchers and research institutions’ (1 p4).  
Increasingly, Aboriginal and Torres Strait Islander community leaders and organisations have 
called for research 'on' Aboriginal and Torres Strait Islander peoples to end. Since then, there 
has been the development of ethics principles and guidelines to improve ethical frameworks 
for research that consider and include Aboriginal and Torres Strait Islander peoples.(1) Much 
of this work has included Aboriginal and Torres Strait Islander ways of knowing and being or 
worldview, encompassing cultural values and principles. The aim has been to improve 
research practices but also to increase research done in partnership with Aboriginal and/or 
Torres Strait Islander researchers and community members. This emphasises the need for 
researchers to work with Aboriginal and Torres Strait Islander communities to identify 
appropriate research questions, to design and conduct studies that have a strength base 
approach, to disseminate findings, and to translate findings into practice and policy. There is 
a strong desire from Aboriginal and Torres Strait Islander communities and organisations for 
all researchers to adhere to these guidelines.  
6.3.5.2. Ethics principles and guidelines 
The current version of the National Statement on Ethical Conduct in Human Research (the 
National Statement) is the result of over half a century of ethical review of human research 
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in Australia (2). Prior to this, there was no national standard for ethical conduct for research 
involving humans.  
The National Statement aims to promote ethically good human research by ensuring 
participants are respected and protected, and research is of benefit to the community (3). 
The National Statement clarifies the responsibilities of:  
• institutions and researchers for the ethical design, conduct and dissemination of 
results of human research; and 
• review bodies in the ethical review of research. 
The National Statement is intended for use by: 
• any researcher conducting research with human participants; 
• any member of an ethical review body reviewing that research; 
• those involved in research governance; and 
• potential research participants. 
The National Statement provides the foundations for which other guidelines and statements 
are based on, such as:   
• Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and 
communities: Guidelines for researchers and stakeholders 2018 
• Keeping research on track II 2018 
• South Australian Aboriginal Health Research Accord 
6.3.5.3. Human Research Ethics Committees  
Human Research Ethics Committees (HREC) have an important role in ensuring researchers 
conducting research with humans are conducting research in line with the National 
Statement and adhere to ethical standards and guidelines. There are over 200 HRECs in 
organisations across Australia and anyone intending on conducting research should apply to 
their institutions HREC (4).   
6.3.5.4. Aboriginal Human Research Ethics Committees  
Research involving Aboriginal and/or Torres Strait Islander peoples and communities will 
need to have approval by an Aboriginal HREC as well as another HREC. Often approval by an 
Aboriginal HREC is required prior to applying for approval from a non-Indigenous 
organisations HREC. This ensures the research meets local principles and values, as well as 
those outlines in the Ethical conduct in research with Aboriginal and Torres Strait Islander 
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Peoples and communities. In addition, Aboriginal HREC will ask researchers to demonstrate: 
how the researchers and research have and will consult and engage with Aboriginal 
organisations; how the research will benefit participants and communities and build research 
capacity within their community; and how the research aligns with the 6 values identified in 
the Ethical conduct in research with Aboriginal and Torres Strait Islander Peoples and 
communities.  
6.3.5.5. Additional readings  
• NHMRC Website – Ethical guidelines for research with Aboriginal and Torres Strait 
Islander Peoples 
• Lowitja Institute Ethics Hub 
• Guidelines for ethical research in Australian Indigenous studies 
• ANU – Ethics & integrity, Key ethical concerns 
6.3.5.6. References  
1. Australian Institute of Aboriginal and Torres Strait Islander Studies. Researching 
right way: Aboriginal and Torres Strait Islander health research ethics – A domestic and 
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Conduct in Human Research Canberra, Australia: NHMRC;  [Available from: 
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6.3.6. Lessons from the field session  
The lessons from the field session was conducted during a one-hour Zoom webinar. It 
provided an opportunity to discuss with the group their further reflections on the readings. 
Following on from this I facilitated a conversation on the following:   
• History and its impact on Aboriginal and Torres Strait Islander research  
• Knowledge and culture informing research practices  
• Principles and values of Aboriginal and Torres Strait Islander research 
• Facilitators and barriers to conducting research with Aboriginal and Torres Strait 
Islander peoples and communities 
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• The implications of not considering Aboriginal and Torres Strait Islander principles 
and values when conducting research with Aboriginal and Torres Strait Islander 
peoples and communities. 
From the discussions, it was evident that the group had developed an understanding of the 
principles and values of Aboriginal and Torres Strait Islander research. In addition, 
understood how previous research practices involving Aboriginal and Torre Strait Islander 
peoples has shaped current research practices involving the Aboriginal and Torre Strait 
Islander community; how Indigenous knowledge and values inform current research 
practices; learnt what the facilitators and barriers are to conducting appropriate research 
with Aboriginal and Torres Strait Islander community; and what the implications are for not 
considering Aboriginal and Torres Strait Islander principles and values principles and values 
when conducting research with Aboriginal and Torres Strait Islander community.  
Overall, the session was well received. I felt comfortable with the delivery of the lesson and 
that the amount of content was sufficient to meet the learning objectives and clearly they 
were met. I also felt that group were engaged in the session and informal feedback from 
them was positive. 
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218 
 
 
 
219 
 
 
 
220 
 
Appendix 6.B 
Scenario 1 
 
Easter mosquito messaging SOCO 
Key message 
• At this time of year, especially with wetter than normal summer, it is important people 
avoid being bitten by mosquitoes to prevent diseases like Ross River virus.   
Supporting messages 
• Apply mosquito repellent regularly, the most effective repellents have DEET or Picaridin 
• Cover up with light coloured clothing as much as possible 
• When camping make sure your tent is well protected with fly screens or sleep under 
mosquito nets 
Supporting information if asked 
• Ross River Virus symptoms include fever, rash, and joint pains.  
• Murray Valley Encephalitis infections cause no symptoms in most people but in some 
can cause a severe headache, neck stiffness, sensitivity to light and drowsiness.   
• Kunjin virus causes no symptoms in most people but in some can cause fever, enlarge 
lymph nodes, rash, and painful joints.  
Ross River notifications in NSW 
 
Year Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total 
2013 38 46 34 57 101 49 36 23 27 36 30 30 507 
2014 33 35 44 72 85 57 38 50 46 67 59 90 676 
2015 117 305 431 264 102 50 54 60 53 61 69 54 1,620 
2016 43 60 78 81 66 25 14 15 21 19 46 228 696 
2017 429 274 200 142 174 89 29 40 53 56 36 12 1,534 
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Scenario 2 
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Scenario 3 
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Appendix 6.C  
Single Overriding Communications Objective (SOCO) Worksheet 
Topic and/or incident 
What is the topic or 
incident?  
 
 
SOCO 
This is the single 
overriding 
communications 
objective. Include in one 
to two sentences the 
key message. This 
should be the message 
that if they quote 
nothing else that you 
would want them to 
play. 
 
 
 
 
Supporting statements 
This should include 
three to four supporting 
statements (key facts). 
These are not they key 
messages but supporting 
additional statements 
that contain useful 
additional information. 
 
 
 
 
 
 
 
 
 
 
 
Background 
This section should 
include background 
information and data 
that would be useful to 
know but not necessarily 
say to the media. It 
might include context 
regarding frequency of 
events or responses that 
have already been 
undertaken.  
 
 
 
 
 
 
 
Target audience  
Who is the main 
audience or population 
segment you would like 
this message to reach? 
 
 
